0000785786-23-000012.txt : 20230203 0000785786-23-000012.hdr.sgml : 20230203 20230203081733 ACCESSION NUMBER: 0000785786-23-000012 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 79 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230203 DATE AS OF CHANGE: 20230203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PLEXUS CORP CENTRAL INDEX KEY: 0000785786 STANDARD INDUSTRIAL CLASSIFICATION: PRINTED CIRCUIT BOARDS [3672] IRS NUMBER: 391344447 STATE OF INCORPORATION: WI FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-14423 FILM NUMBER: 23583785 BUSINESS ADDRESS: STREET 1: PLEXUS CORP STREET 2: ONE PLEXUS WAY CITY: NEENAH STATE: WI ZIP: 54956 BUSINESS PHONE: 9209696000 MAIL ADDRESS: STREET 1: PLEXUS CORP STREET 2: ONE PLEXUS WAY CITY: NEENAH STATE: WI ZIP: 54956 10-Q 1 plxs-20221231.htm 10-Q plxs-20221231
0000785786September 302023Q1falsehttp://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpensehttp://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrenthttp://www.plexus.com/20221231#LongTermDebtAndFinanceLeaseObligationsCurrenthttp://www.plexus.com/20221231#LongTermDebtAndFinanceLeaseObligationsCurrenthttp://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrenthttp://www.plexus.com/20221231#LongTermDebtAndFinanceLeaseObligationshttp://www.plexus.com/20221231#LongTermDebtAndFinanceLeaseObligations00007857862022-10-022022-12-3100007857862023-01-31xbrli:sharesiso4217:USD00007857862021-10-032022-01-01iso4217:USDxbrli:shares00007857862022-12-3100007857862022-10-010000785786us-gaap:CommonStockMember2022-10-010000785786us-gaap:CommonStockMember2021-10-020000785786us-gaap:CommonStockMember2022-10-022022-12-310000785786us-gaap:CommonStockMember2021-10-032022-01-010000785786us-gaap:CommonStockMember2022-12-310000785786us-gaap:CommonStockMember2022-01-0100007857862021-10-020000785786us-gaap:AdditionalPaidInCapitalMember2022-10-010000785786us-gaap:AdditionalPaidInCapitalMember2021-10-020000785786us-gaap:AdditionalPaidInCapitalMember2022-10-022022-12-310000785786us-gaap:AdditionalPaidInCapitalMember2021-10-032022-01-010000785786us-gaap:AdditionalPaidInCapitalMember2022-12-310000785786us-gaap:AdditionalPaidInCapitalMember2022-01-010000785786us-gaap:TreasuryStockMember2022-10-010000785786us-gaap:TreasuryStockMember2021-10-020000785786us-gaap:TreasuryStockMember2022-10-022022-12-310000785786us-gaap:TreasuryStockMember2021-10-032022-01-010000785786us-gaap:TreasuryStockMember2022-12-310000785786us-gaap:TreasuryStockMember2022-01-010000785786us-gaap:RetainedEarningsMember2022-10-010000785786us-gaap:RetainedEarningsMember2021-10-020000785786us-gaap:RetainedEarningsMember2022-10-022022-12-310000785786us-gaap:RetainedEarningsMember2021-10-032022-01-010000785786us-gaap:RetainedEarningsMember2022-12-310000785786us-gaap:RetainedEarningsMember2022-01-010000785786us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-10-010000785786us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-10-020000785786us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-10-022022-12-310000785786us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-10-032022-01-010000785786us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000785786us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-0100007857862022-01-010000785786us-gaap:InventoriesMember2022-12-310000785786us-gaap:InventoriesMember2022-10-010000785786plxs:A4.05SeniorNotesMemberus-gaap:SeniorNotesMember2022-12-31xbrli:pure0000785786plxs:A4.05SeniorNotesMemberus-gaap:SeniorNotesMember2022-10-010000785786us-gaap:SeniorNotesMemberplxs:A4.22SeniorNotesMember2022-12-310000785786us-gaap:SeniorNotesMemberplxs:A4.22SeniorNotesMember2022-10-010000785786us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2022-12-310000785786us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2022-10-010000785786us-gaap:RevolvingCreditFacilityMember2022-10-022022-12-310000785786us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000785786us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-10-010000785786us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2022-12-310000785786us-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2022-10-010000785786us-gaap:ForeignExchangeForwardMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000785786us-gaap:ForeignExchangeForwardMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-10-010000785786plxs:OtherAccruedLiabilitiesCurrentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000785786plxs:OtherAccruedLiabilitiesCurrentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-10-010000785786us-gaap:ForeignExchangeForwardMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2022-12-310000785786us-gaap:ForeignExchangeForwardMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMemberus-gaap:NondesignatedMember2022-10-010000785786plxs:OtherAccruedLiabilitiesCurrentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2022-12-310000785786plxs:OtherAccruedLiabilitiesCurrentMemberus-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2022-10-010000785786us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-10-022022-12-310000785786us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-10-032022-01-010000785786us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-10-032022-01-010000785786us-gaap:CostOfSalesMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-10-022022-12-310000785786us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-10-022022-12-310000785786us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-10-032022-01-010000785786us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2022-10-022022-12-310000785786us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeForwardMemberus-gaap:NondesignatedMember2021-10-032022-01-010000785786us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2022-12-310000785786us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel1Member2022-12-310000785786us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2022-12-310000785786us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel3Member2022-12-310000785786us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2022-10-010000785786us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel1Member2022-10-010000785786us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMember2022-10-010000785786us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeForwardMemberus-gaap:FairValueInputsLevel3Member2022-10-01plxs:segment0000785786us-gaap:OperatingSegmentsMemberplxs:AmericasSegmentMember2022-10-022022-12-310000785786us-gaap:OperatingSegmentsMemberplxs:AmericasSegmentMember2021-10-032022-01-010000785786us-gaap:OperatingSegmentsMemberplxs:AsiaPacificSegmentMember2022-10-022022-12-310000785786us-gaap:OperatingSegmentsMemberplxs:AsiaPacificSegmentMember2021-10-032022-01-010000785786us-gaap:OperatingSegmentsMemberplxs:EMEASegmentMember2022-10-022022-12-310000785786us-gaap:OperatingSegmentsMemberplxs:EMEASegmentMember2021-10-032022-01-010000785786us-gaap:IntersegmentEliminationMember2022-10-022022-12-310000785786us-gaap:IntersegmentEliminationMember2021-10-032022-01-010000785786us-gaap:CorporateNonSegmentMember2022-10-022022-12-310000785786us-gaap:CorporateNonSegmentMember2021-10-032022-01-010000785786us-gaap:OperatingSegmentsMemberplxs:AmericasSegmentMember2022-12-310000785786us-gaap:OperatingSegmentsMemberplxs:AmericasSegmentMember2022-10-010000785786us-gaap:OperatingSegmentsMemberplxs:AsiaPacificSegmentMember2022-12-310000785786us-gaap:OperatingSegmentsMemberplxs:AsiaPacificSegmentMember2022-10-010000785786us-gaap:OperatingSegmentsMemberplxs:EMEASegmentMember2022-12-310000785786us-gaap:OperatingSegmentsMemberplxs:EMEASegmentMember2022-10-010000785786plxs:CorporateAndReconcilingItemsMember2022-12-310000785786plxs:CorporateAndReconcilingItemsMember2022-10-010000785786srt:MinimumMember2022-10-022022-12-310000785786srt:MaximumMember2022-10-022022-12-310000785786plxs:A2022StockRepurchaseProgramMember2021-08-110000785786plxs:A2022StockRepurchaseProgramMember2021-10-032022-01-010000785786plxs:A2023StockRepurchaseProgramMember2022-08-180000785786plxs:A2023StockRepurchaseProgramMember2022-10-022022-12-310000785786plxs:A2023StockRepurchaseProgramMember2022-12-310000785786plxs:MUFGMember2022-12-310000785786plxs:HSBCMember2022-12-310000785786plxs:MUFGMember2022-10-022022-12-310000785786us-gaap:OperatingSegmentsMemberplxs:AmericasSegmentMemberplxs:IndustrialMember2022-10-022022-12-310000785786us-gaap:OperatingSegmentsMemberplxs:AsiaPacificSegmentMemberplxs:IndustrialMember2022-10-022022-12-310000785786us-gaap:OperatingSegmentsMemberplxs:EMEASegmentMemberplxs:IndustrialMember2022-10-022022-12-310000785786us-gaap:OperatingSegmentsMemberplxs:IndustrialMember2022-10-022022-12-310000785786us-gaap:OperatingSegmentsMemberplxs:AmericasSegmentMemberplxs:HealthcareLifeSciencesMember2022-10-022022-12-310000785786us-gaap:OperatingSegmentsMemberplxs:AsiaPacificSegmentMemberplxs:HealthcareLifeSciencesMember2022-10-022022-12-310000785786us-gaap:OperatingSegmentsMemberplxs:EMEASegmentMemberplxs:HealthcareLifeSciencesMember2022-10-022022-12-310000785786us-gaap:OperatingSegmentsMemberplxs:HealthcareLifeSciencesMember2022-10-022022-12-310000785786plxs:AerospaceDefenseMemberus-gaap:OperatingSegmentsMemberplxs:AmericasSegmentMember2022-10-022022-12-310000785786plxs:AerospaceDefenseMemberus-gaap:OperatingSegmentsMemberplxs:AsiaPacificSegmentMember2022-10-022022-12-310000785786plxs:AerospaceDefenseMemberus-gaap:OperatingSegmentsMemberplxs:EMEASegmentMember2022-10-022022-12-310000785786plxs:AerospaceDefenseMemberus-gaap:OperatingSegmentsMember2022-10-022022-12-310000785786us-gaap:OperatingSegmentsMember2022-10-022022-12-310000785786plxs:AmericasSegmentMemberus-gaap:IntersegmentEliminationMember2022-10-022022-12-310000785786us-gaap:IntersegmentEliminationMemberplxs:AsiaPacificSegmentMember2022-10-022022-12-310000785786plxs:EMEASegmentMemberus-gaap:IntersegmentEliminationMember2022-10-022022-12-310000785786plxs:AmericasSegmentMember2022-10-022022-12-310000785786plxs:AsiaPacificSegmentMember2022-10-022022-12-310000785786plxs:EMEASegmentMember2022-10-022022-12-310000785786us-gaap:OperatingSegmentsMemberplxs:AmericasSegmentMemberplxs:IndustrialMember2021-10-032022-01-010000785786us-gaap:OperatingSegmentsMemberplxs:AsiaPacificSegmentMemberplxs:IndustrialMember2021-10-032022-01-010000785786us-gaap:OperatingSegmentsMemberplxs:EMEASegmentMemberplxs:IndustrialMember2021-10-032022-01-010000785786us-gaap:OperatingSegmentsMemberplxs:IndustrialMember2021-10-032022-01-010000785786us-gaap:OperatingSegmentsMemberplxs:AmericasSegmentMemberplxs:HealthcareLifeSciencesMember2021-10-032022-01-010000785786us-gaap:OperatingSegmentsMemberplxs:AsiaPacificSegmentMemberplxs:HealthcareLifeSciencesMember2021-10-032022-01-010000785786us-gaap:OperatingSegmentsMemberplxs:EMEASegmentMemberplxs:HealthcareLifeSciencesMember2021-10-032022-01-010000785786us-gaap:OperatingSegmentsMemberplxs:HealthcareLifeSciencesMember2021-10-032022-01-010000785786plxs:AerospaceDefenseMemberus-gaap:OperatingSegmentsMemberplxs:AmericasSegmentMember2021-10-032022-01-010000785786plxs:AerospaceDefenseMemberus-gaap:OperatingSegmentsMemberplxs:AsiaPacificSegmentMember2021-10-032022-01-010000785786plxs:AerospaceDefenseMemberus-gaap:OperatingSegmentsMemberplxs:EMEASegmentMember2021-10-032022-01-010000785786plxs:AerospaceDefenseMemberus-gaap:OperatingSegmentsMember2021-10-032022-01-010000785786us-gaap:OperatingSegmentsMember2021-10-032022-01-010000785786plxs:AmericasSegmentMemberus-gaap:IntersegmentEliminationMember2021-10-032022-01-010000785786us-gaap:IntersegmentEliminationMemberplxs:AsiaPacificSegmentMember2021-10-032022-01-010000785786plxs:EMEASegmentMemberus-gaap:IntersegmentEliminationMember2021-10-032022-01-010000785786plxs:AmericasSegmentMember2021-10-032022-01-010000785786plxs:AsiaPacificSegmentMember2021-10-032022-01-010000785786plxs:EMEASegmentMember2021-10-032022-01-010000785786us-gaap:TransferredOverTimeMember2022-10-022022-12-310000785786us-gaap:TransferredOverTimeMember2021-10-032022-01-010000785786us-gaap:RestructuringChargesMember2021-10-032022-01-010000785786us-gaap:ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain2021-10-020000785786us-gaap:EmployeeSeveranceMember2021-10-020000785786us-gaap:ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain2021-10-032022-01-010000785786us-gaap:EmployeeSeveranceMember2021-10-032022-01-010000785786us-gaap:ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain2022-01-010000785786us-gaap:EmployeeSeveranceMember2022-01-01
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________________________________________________________________________________________
FORM 10-Q
____________________________________________________________________________________________________________________________________
(Mark One)
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 31, 2022
OR
☐TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______ to ______
Commission File Number 001-14423
____________________________________________________________________________________________________________________________________
plxs-20221231_g1.gif
PLEXUS CORP.
(Exact name of registrant as specified in charter)
____________________________________________________________________________________________________________________________________
Wisconsin39-1344447
(State or other jurisdiction of incorporation) (I.R.S. Employer Identification No.)
One Plexus Way
Neenah, Wisconsin 54957
(Address of principal executive offices) (Zip Code)
Telephone Number (920) 969-6000
(Registrant’s telephone number, including Area Code) 
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, $0.01 par valuePLXSThe Nasdaq Global Select Market
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  o 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  x    No  o 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
x
Accelerated filer
☐
Non-accelerated filer  
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒
As of January 31, 2023, there were 27,702,483 shares of common stock outstanding.    
1
PLEXUS CORP.
TABLE OF CONTENTS
December 31, 2022
 












2
PART I.    FINANCIAL INFORMATION

ITEM 1.    FINANCIAL STATEMENTS

PLEXUS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands, except per share data)
Unaudited
Three Months Ended
December 31, 2022January 1, 2022
Net sales$1,093,925 $817,456 
Cost of sales992,726 747,460 
Gross profit101,199 69,996 
Selling and administrative expenses43,858 37,502 
Restructuring and impairment charges— 2,021 
Operating income57,341 30,473 
Other income (expense):
Interest expense(6,894)(3,046)
Interest income934 271 
Miscellaneous, net(1,944)(923)
Income before income taxes49,437 26,775 
Income tax expense7,247 3,352 
Net income$42,190 $23,423 
Earnings per share:
Basic$1.53 $0.84 
Diluted$1.49 $0.82 
Weighted average shares outstanding:
Basic27,639 28,018 
Diluted28,305 28,709 
Comprehensive income:
Net income$42,190 $23,423 
Other comprehensive income (loss):
Derivative instrument and other fair value adjustments8,439 1,272 
     Foreign currency translation adjustments13,777 (1,578)
          Other comprehensive income (loss)22,216 (306)
Total comprehensive income$64,406 $23,117 
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
PLEXUS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)
Unaudited
December 31, 2022October 1, 2022
ASSETS
Current assets:
Cash and cash equivalents$247,880 $274,805 
Restricted cash31 665 
Accounts receivable, net of allowances of $2,531 and $1,961, respectively
733,962 737,696 
Contract assets119,016 138,540 
Inventories, net 1,645,011 1,602,783 
Prepaid expenses and other68,401 61,633 
Total current assets2,814,301 2,816,122 
Property, plant and equipment, net448,325 444,705 
Operating lease right-of-use assets64,069 65,134 
Deferred income taxes39,337 39,075 
Other assets29,260 28,189 
Total non-current assets580,991 577,103 
Total assets$3,395,292 $3,393,225 
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Current portion of long-term debt and finance lease obligations$329,076 $273,971 
Accounts payable753,755 805,583 
Customer deposits511,037 480,486 
Accrued salaries and wages64,126 88,876 
Other accrued liabilities296,466 357,273 
Total current liabilities1,954,460 2,006,189 
Long-term debt and finance lease obligations, net of current portion187,272 187,776 
Long-term accrued income taxes payable42,019 42,019 
Long-term operating lease liabilities32,149 33,628 
Deferred income taxes payable5,616 6,327 
Other liabilities23,517 21,555 
Total non-current liabilities290,573 291,305 
Total liabilities2,245,033 2,297,494 
Commitments and contingencies
Shareholders’ equity:
Preferred stock, $0.01 par value, 5,000 shares authorized, none issued or outstanding
— — 
Common stock, $0.01 par value, 200,000 shares authorized, 54,133 and 54,084 shares issued, respectively, and 27,612 and 27,679 shares outstanding, respectively
541 541 
Additional paid-in capital654,059 652,467 
Common stock held in treasury, at cost, 26,521 and 26,405 shares, respectively
(1,104,953)(1,093,483)
Retained earnings1,614,424 1,572,234 
Accumulated other comprehensive loss(13,812)(36,028)
Total shareholders’ equity1,150,259 1,095,731 
Total liabilities and shareholders’ equity$3,395,292 $3,393,225 
The accompanying notes are an integral part of these condensed consolidated financial statements.
4
PLEXUS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY
(in thousands)
Unaudited
Three Months Ended
December 31, 2022January 1, 2022
Common stock - shares outstanding
Beginning of period27,679 28,047 
Exercise of stock options and vesting of other share-based awards49 60 
Treasury shares purchased(116)(110)
End of period27,612 27,997 
Total stockholders' equity, beginning of period$1,095,731 $1,028,232 
Common stock - par value
Beginning of period541 538 
Exercise of stock options and vesting of other share-based awards— 1 
End of period541 539 
Additional paid-in capital
Beginning of period652,467 639,778 
Share-based compensation expense5,683 6,270 
Exercise of stock options and vesting of other share-based awards, including tax withholding(4,091)(3,394)
End of period654,059 642,654 
Treasury stock
Beginning of period(1,093,483)(1,043,091)
Treasury shares purchased(11,470)(10,131)
End of period(1,104,953)(1,053,222)
Retained earnings
Beginning of period1,572,234 1,433,991 
Net income42,190 23,423 
End of period1,614,424 1,457,414 
Accumulated other comprehensive loss
Beginning of period(36,028)(2,984)
Other comprehensive income (loss)22,216 (306)
End of period(13,812)(3,290)
Total stockholders' equity, end of period$1,150,259 $1,044,095 


The accompanying notes are an integral part of these condensed consolidated financial statements.
5
PLEXUS CORP. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
Unaudited
Three Months Ended
December 31, 2022January 1, 2022
Cash flows from operating activities
Net income$42,190 $23,423 
Adjustments to reconcile net income to net cash flows from operating activities:
Depreciation and amortization16,290 15,489 
Share-based compensation expense and related charges5,683 6,357 
Other, net502 602 
Changes in operating assets and liabilities, excluding impacts of currency:
Accounts receivable10,506 (70,159)
Contract assets19,745 9,904 
Inventories(31,409)(214,416)
Other current and non-current assets(7,270)(9,436)
Accrued income taxes payable(2,655)1,121 
Accounts payable(52,702)76,222 
Customer deposits27,170 60,743 
Other current and non-current liabilities(76,844)11,171 
Cash flows used in operating activities(48,794)(88,979)
Cash flows from investing activities
Payments for property, plant and equipment(23,085)(33,246)
Other, net1,503 (124)
Cash flows used in investing activities(21,582)(33,370)
Cash flows from financing activities
Borrowings under debt agreements197,000 181,134 
Payments on debt and finance lease obligations(142,001)(97,565)
Repurchases of common stock(11,470)(10,131)
Proceeds from exercise of stock options— 307 
Payments related to tax withholding for share-based compensation(4,091)(3,702)
Cash flows provided by financing activities39,438 70,043 
Effect of exchange rate changes on cash and cash equivalents3,379 184 
Net decrease in cash and cash equivalents and restricted cash(27,559)(52,122)
Cash and cash equivalents and restricted cash:
Beginning of period275,470 270,513 
End of period$247,911 $218,391 
The accompanying notes are an integral part of these condensed consolidated financial statements.
6
PLEXUS CORP. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR THE THREE MONTHS ENDED DECEMBER 31, 2022 AND JANUARY 1, 2022
Unaudited

1.Basis of Presentation

Basis of Presentation:

The accompanying Condensed Consolidated Financial Statements included herein have been prepared by Plexus Corp. and its subsidiaries (together “Plexus” or the “Company”) without audit and pursuant to the rules and regulations of the United States (“U.S.”) Securities and Exchange Commission (“SEC”). The accompanying Condensed Consolidated Financial Statements reflect all adjustments, which include normal recurring adjustments necessary for the fair statement of the consolidated financial position of the Company as of December 31, 2022 and October 1, 2022, the results of operations and shareholders' equity for the three months ended December 31, 2022 and January 1, 2022, and the cash flows for the same three month periods.

The Company’s fiscal year ends on the Saturday closest to September 30. The Company uses a “4-4-5” weekly accounting system for the interim periods in each quarter. Each quarter, therefore, ends on a Saturday at the end of the 4-4-5 period. Periodically, an additional week must be added to the fiscal year to re-align with the Saturday closest to September 30. All fiscal quarters presented herein included 13 weeks.
Certain information and footnote disclosures, normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP"), have been condensed or omitted pursuant to the SEC’s rules and regulations dealing with interim financial statements. However, the Company believes that the disclosures made in the Condensed Consolidated Financial Statements included herein are adequate to make the information presented not misleading. It is suggested that these Condensed Consolidated Financial Statements be read in conjunction with the Consolidated Financial Statements and notes thereto included in the Company’s 2022 Annual Report on Form 10-K.
The preparation of financial statements requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and notes thereto. The Company has considered information available as of the date of issuance of these financial statements and is not aware of any specific events or circumstances that would require an update to its estimates or judgments, or a revision of the carrying value of its assets or liabilities. These estimates may change as new events occur and additional information becomes available. Actual results could differ materially from these estimates.
Recently Issued Accounting Pronouncements Not Yet Adopted:
In September 2022, the FASB issued ASU 2022-04, which requires enhanced disclosures about supplier finance programs. The guidance is effective for the Company beginning in the first quarter of fiscal 2024. Early adoption is permitted. The Company is currently in the process of assessing the impacts of the guidance.
The Company does not believe that any other recently issued accounting standards will have a material impact on its Consolidated Financial Statements, or apply to its operations.

2.    Inventories
Inventories as of December 31, 2022 and October 1, 2022 consisted of the following (in thousands):
December 31, 2022October 1, 2022
Raw materials$1,468,942 $1,433,353 
Work-in-process81,822 81,207 
Finished goods94,247 88,223 
Total inventories, net$1,645,011 $1,602,783 
In certain circumstances, per contractual terms, customer deposits are received by the Company to offset inventory risks. The total amount of customer deposits related to inventory and included within current liabilities on the accompanying Condensed
7
Consolidated Balance Sheets as of December 31, 2022 and October 1, 2022 was $483.1 million and $463.2 million, respectively.

3.    Debt, Finance Lease and Other Financing Obligations
Debt, finance lease and other financing obligations as of December 31, 2022 and October 1, 2022 consisted of the following (in thousands):
December 31, 2022October 1, 2022
4.05% Senior Notes, due June 15, 2025
$100,000 $100,000 
4.22% Senior Notes, due June 15, 2028
50,000 50,000 
Borrowings under Credit Facility320,000 263,000 
Finance lease and other financing obligations47,786 50,269 
Unamortized deferred financing fees(1,438)(1,522)
Total obligations516,348 461,747 
Less: current portion(329,076)(273,971)
Long-term debt, finance lease and other financing obligations, net of current portion$187,272 $187,776 
As of December 31, 2022, the Company was in compliance with covenants for all debt agreements.
During the three months ended December 31, 2022, the highest daily borrowing under the Company's 5-year senior unsecured revolving credit facility (referred to as the "Credit Facility") was $394.0 million; the average daily borrowings were $320.9 million.
The fair value of the Company’s debt, excluding finance lease and other financing obligations, was $461.5 million and $401.6 million as of December 31, 2022 and October 1, 2022, respectively. The carrying value of the Company's debt, excluding finance lease and other financing obligations, was $470.0 million and $413.0 million as of December 31, 2022 and October 1, 2022, respectively. If measured at fair value in the financial statements, the Company's debt would be classified as Level 2 in the fair value hierarchy. Refer to Note 4, "Derivatives and Fair Value Measurements," for further information regarding the Company's fair value calculations and classifications.

4.    Derivatives and Fair Value Measurements
All derivatives are recognized in the accompanying Condensed Consolidated Balance Sheets at their estimated fair value. The Company uses derivatives to manage the variability of foreign currency obligations. The Company has cash flow hedges related to forecasted foreign currency obligations, in addition to non-designated hedges to manage foreign currency exposures associated with certain foreign currency denominated assets and liabilities. The Company does not enter into derivatives for speculative purposes.
The Company designates some foreign currency exchange contracts as cash flow hedges of forecasted foreign currency expenses. Changes in the fair value of the derivatives that qualify as cash flow hedges are recorded in "Accumulated other comprehensive loss" in the accompanying Condensed Consolidated Balance Sheets until earnings are affected by the variability of the cash flows. In the next twelve months, the Company estimates that $2.4 million of unrealized gains, net of tax, related to cash flow hedges will be reclassified from other comprehensive income (loss) into earnings. Changes in the fair value of the non-designated derivatives related to recognized foreign currency denominated assets and liabilities are recorded in "Miscellaneous, net" in the accompanying Condensed Consolidated Statements of Comprehensive Income.
The Company enters into forward currency exchange contracts for its operations in certain jurisdictions in the AMER and APAC segments on a rolling basis. The Company had cash flow hedges outstanding with a notional value of $148.7 million as of December 31, 2022, and a notional value of $143.2 million as of October 1, 2022. These forward currency contracts fix the exchange rates for the settlement of future foreign currency obligations that have yet to be realized. The total fair value of the forward currency exchange contracts was a $2.4 million asset as of December 31, 2022, and a $6.0 million liability as of October 1, 2022.
8
The Company had additional forward currency exchange contracts outstanding as of December 31, 2022, with a notional value of $113.5 million; there were $60.1 million such contracts outstanding as of October 1, 2022. The Company did not designate these derivative instruments as hedging instruments. The net settlement amount (fair value) related to these contracts is recorded on the Condensed Consolidated Balance Sheets as either a current or long-term asset or liability, depending on the term, and as an element of "Miscellaneous, net" in the Condensed Consolidated Statements of Comprehensive Income. The total fair value of these derivatives was a $1.0 million asset as of December 31, 2022, and a $0.3 million asset as of October 1, 2022.
The tables below present information regarding the fair values of derivative instruments (as defined in Note 1, "Description of Business and Significant Accounting Policies") and the effects of derivative instruments on the Company’s Condensed Consolidated Financial Statements:
Fair Values of Derivative Instruments (in thousands)
  Derivative AssetsDerivative Liabilities
    December 31,
2022		October 1,
2022		  December 31,
2022		October 1,
2022
Derivatives designated as hedging instrumentsBalance sheet
classification		Fair ValueFair ValueBalance sheet
classification		Fair ValueFair Value
Foreign currency forward contractsPrepaid expenses and other$2,451 $715 Other accrued liabilities$44 $6,747 
Fair Values of Derivative Instruments (in thousands)
  Derivative AssetsDerivative Liabilities
    December 31,
2022		October 1,
2022		  December 31,
2022		October 1,
2022
Derivatives not designated as hedging instrumentsBalance sheet
classification		Fair ValueFair ValueBalance sheet
classification		Fair ValueFair Value
Foreign currency forward contractsPrepaid expenses and other$2,487 $1,555 Other accrued liabilities$1,486 $1,249 
The Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Loss ("OCL") (in thousands)
for the Three Months Ended
Derivatives in cash flow hedging relationshipsAmount of Gain Recognized in OCL on Derivatives
December 31, 2022January 1, 2022
Foreign currency forward contracts$6,150 $470 
Derivative Impact on Loss Recognized in Condensed Consolidated Statements of Comprehensive Income (in thousands)
for the Three Months Ended
Derivatives in cash flow hedging relationshipsClassification of Loss Reclassified from Accumulated OCL into IncomeAmount of Loss Reclassified from Accumulated OCL into Income 
December 31, 2022January 1, 2022
Foreign currency forward contractsCost of sales$(2,132)$(743)
Foreign currency forward contractsSelling and administrative expenses$(157)$(59)
Derivatives not designated as hedging instrumentsLocation of Gain (Loss) Recognized on Derivatives in IncomeAmount of Gain (Loss) on Derivatives Recognized in Income
December 31, 2022January 1, 2022
Foreign currency forward contractsMiscellaneous, net$747 $(43)
Fair Value Measurements:
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (or exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses quoted market prices when available or discounted cash flows to calculate
9
fair value. The accounting guidance establishes a fair value hierarchy based on three levels of inputs that may be used to measure fair value. The input levels are:
Level 1: Quoted (observable) market prices in active markets for identical assets or liabilities.
Level 2: Inputs other than Level 1 that are observable, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.
Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the asset or liability.
The following table lists the fair values of assets of the Company’s derivatives as of December 31, 2022 and October 1, 2022, by input level:
Fair Value Measurements Using Input Levels Asset/(Liability) (in thousands)
Fiscal period ended December 31, 2022
Level 1Level 2Level 3Total
Derivatives    
Foreign currency forward contracts$— $3,408 $— $3,408 
Fiscal period ended October 1, 2022
Derivatives
Foreign currency forward contracts$— $(5,726)$— $(5,726)
The fair value of foreign currency forward contracts is determined using a market approach, which includes obtaining directly or indirectly observable values from third parties active in the relevant markets. Inputs in the fair value of the foreign currency forward contracts include prevailing forward and spot prices for currency.

5.    Income Taxes
Income tax expense for the three months ended December 31, 2022 was $7.2 million compared to $3.4 million for the three months ended January 1, 2022.
The effective tax rates for the three months ended December 31, 2022 and January 1, 2022 were 14.7% and 12.5%, respectively. The effective tax rate for the three months ended December 31, 2022 increased from the effective tax rate for the three months ended January 1, 2022 primarily due to a change in the geographic distribution of pre-tax book income.
The amount of unrecognized tax benefits recorded for uncertain tax positions increased by $0.9 million for the three months ended December 31, 2022. The Company recognizes accrued interest and penalties on uncertain tax positions as a component of income tax expense. The amount of interest and penalties recorded for the three months ended December 31, 2022 was not material.
One or more uncertain tax positions may be settled within the next 12 months. Settlement of these matters is not expected to have a material effect on the Company's consolidated results of operations, financial position and cash flows. The Company is not currently under examination by taxing authorities in the U.S. The Company is under audit in a foreign jurisdiction but a settlement is not expected to have a material impact.
The Company maintains valuation allowances when it is more likely than not that all or a portion of a net deferred tax asset will not be realized. During the three months ended December 31, 2022, the Company continued to record a full valuation allowance against its net deferred tax assets in certain jurisdictions within the EMEA segment and a partial valuation against its net deferred tax assets in certain jurisdictions within the AMER segment, as it was more likely than not that these assets would not be fully realized based primarily on historical performance. The Company will continue to provide a valuation allowance against its net deferred tax assets in each of the applicable jurisdictions going forward until it determines it is more likely than not that the deferred tax assets will be realized.

10

6.    Earnings Per Share
The following is a reconciliation of the amounts utilized in the computation of basic and diluted earnings per share for the three months ended December 31, 2022 and January 1, 2022 (in thousands, except per share amounts):
Three Months Ended
 December 31, 2022January 1, 2022
Net income$42,190 $23,423 
Basic weighted average common shares outstanding27,639 28,018 
Dilutive effect of share-based awards and options outstanding666 691 
Diluted weighted average shares outstanding28,305 28,709 
Earnings per share:
Basic$1.53 $0.84 
Diluted$1.49 $0.82 
For the three months ended December 31, 2022 and January 1, 2022, there were no antidilutive awards.
See also Note 12, "Shareholders' Equity," for information regarding the Company's share repurchase plans.

7.    Leases
The components of lease expense for the three months ended December 31, 2022 and January 1, 2022 indicated were as follows (in thousands):
Three Months Ended
December 31, 2022January 1, 2022
Finance lease expense:
   Amortization of right-of-use assets$1,614 $1,693 
   Interest on lease liabilities1,272 1,222 
Operating lease expense2,606 2,857 
Other lease expense1,766 1,404 
Total$7,258 $7,176 
Based on the nature of the right-of use ("ROU") asset, amortization of finance lease ROU assets, operating lease expense and other lease expense are recorded within either cost of goods sold or selling and administrative expenses and interest on finance lease liabilities is recorded within interest expense on the Condensed Consolidated Statements of Comprehensive Income. Other lease expense includes lease expense for leases with an estimated total term of twelve months or less and variable lease expense related to variations in lease payments as a result of a change in factors or circumstances occurring after the lease possession date.
11
The following tables sets forth the amount of lease assets and lease liabilities included in the Company’s Condensed Consolidated Balance Sheets (in thousands):
Financial Statement Line ItemDecember 31, 2022October 1, 2022
ASSETS
   Finance lease assetsProperty, plant and equipment, net$38,025 $40,063 
   Operating lease assetsOperating lease right-of-use assets64,069 65,134 
      Total lease assets$102,094 $105,197 
LIABILITIES AND SHAREHOLDERS' EQUITY
Current
  Finance lease liabilitiesCurrent portion of long-term debt and finance lease obligations$4,406 $5,087 
Operating lease liabilitiesOther accrued liabilities8,878 7,948 
Non-current
  Finance lease liabilitiesLong-term debt and finance lease obligations, net of current portion38,583 39,257 
  Operating lease liabilitiesLong-term operating lease liabilities32,149 33,628 
        Total lease liabilities$84,016 $85,920 

8.    Share-Based Compensation
The Company recognized $5.8 million and $6.3 million of compensation expense associated with share-based awards for the three months ended December 31, 2022 and January 1, 2022, respectively.

9.    Litigation
The Company is party to lawsuits in the ordinary course of business. Management does not believe that these proceedings, individually or in the aggregate, will have a material positive or adverse effect on the Company’s consolidated financial position, results of operations or cash flows.

10.    Reportable Segments
Reportable segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or group, in assessing performance and allocating resources. The Company uses an internal management reporting system, which provides important financial data to evaluate performance and allocate the Company’s resources on a regional basis. Net sales for the segments are attributed to the region in which the product is manufactured or the service is performed. The services provided, manufacturing processes used, class of customers serviced and order fulfillment processes used are similar and generally interchangeable across the segments. A segment’s performance is evaluated based upon its operating income (loss). A segment’s operating income (loss) includes its net sales less cost of sales and selling and administrative expenses, but excludes corporate and other expenses. Corporate and other expenses primarily represent corporate selling and administrative expenses, and restructuring costs and other charges, if any. These costs are not allocated to the segments, as management excludes such costs when assessing the performance of the segments. Inter-segment transactions are generally recorded at amounts that approximate arm’s length transactions. The accounting policies for the segments are the same as for the Company taken as a whole.

12
Information about the Company’s three reportable segments for three months ended December 31, 2022 and January 1, 2022 is as follows (in thousands):
Three Months Ended
 December 31, 2022January 1, 2022
Net sales:
AMER$389,662 $277,346 
APAC641,904 491,672 
EMEA89,373 72,863 
Elimination of inter-segment sales(27,014)(24,425)
$1,093,925 $817,456 
  
Operating income (loss):
AMER$17,415 $1,790 
APAC78,406 60,688 
EMEA(639)956 
Corporate and other costs(37,841)(32,961)
57,341 30,473 
Other income (expense):
Interest expense(6,894)(3,046)
Interest income934 271 
Miscellaneous, net(1,944)(923)
Income before income taxes$49,437 $26,775 
  
 December 31,
2022		October 1,
2022
Total assets:
AMER$1,171,188 $1,150,605 
APAC1,809,364 1,807,542 
EMEA339,382 302,901 
Corporate and eliminations75,358 132,177 
$3,395,292 $3,393,225 
  

11.    Guarantees
The Company offers certain indemnifications under its customer manufacturing agreements. In the normal course of business, the Company may from time to time be obligated to indemnify its customers or its customers’ customers against damages or liabilities arising out of the Company’s negligence, misconduct, breach of contract, or infringement of third-party intellectual property rights. Certain agreements have extended broader indemnification, and while most agreements have contractual limits, some do not. However, the Company generally does not provide for such indemnities and seeks indemnification from its customers for damages or liabilities arising out of the Company’s adherence to customers’ specifications or designs or use of materials furnished, or directed to be used, by its customers. The Company does not believe its obligations under such indemnities are material.
In the normal course of business, the Company also provides its customers a limited warranty covering workmanship, and in some cases materials, on products manufactured by the Company. Such warranty generally provides that products will be free from defects in the Company’s workmanship and meet mutually agreed-upon specifications for periods generally ranging from 12 months to 24 months. The Company’s obligation is generally limited to correcting, at its expense, any defect by repairing or replacing such defective product. The Company’s warranty generally excludes defects resulting from faulty customer-supplied components, design defects or damage caused by any party or cause other than the Company.
13
The Company provides for an estimate of costs that may be incurred under its limited warranty at the time product revenue is recognized and establishes additional reserves for specifically identified product issues. These costs primarily include labor and materials, as necessary, associated with repair or replacement and are included in the Company's accompanying Condensed Consolidated Balance Sheets in "other accrued liabilities." The primary factors that affect the Company’s warranty liability include the value and the number of shipped units and historical and anticipated rates of warranty claims. As these factors are impacted by actual experience and future expectations, the Company assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.
Below is a table summarizing the activity related to the Company’s limited warranty liability for the three months ended December 31, 2022 and January 1, 2022 (in thousands):
Three Months Ended
December 31, 2022January 1, 2022
Reserve balance, beginning of period$6,925 $6,645 
Accruals for warranties issued during the period727 1,258 
   Settlements (in cash or in kind) during the period(1,131)(741)
Reserve balance, end of period$6,521 $7,162 


12.    Shareholders' Equity
On August 11, 2021, the Board of Directors approved a share repurchase program under which the Company was authorized to repurchase up to $50.0 million of its common stock (the "2022 Program"). The 2022 Program commenced upon completion of the 2021 Program and was completed in fiscal 2022. During the three months ended January 1, 2022, the Company repurchased 110,440 shares under this program for $10.2 million at an average price of $91.74 per share.
On August 18, 2022, the Board of Directors approved a share repurchase program under which the Company is authorized to repurchase up to $50.0 million of its common stock (the "2023 Program"). The 2023 Program became effective immediately and has no expiration. During the three months ended December 31, 2022, the Company repurchased 115,723 shares under this program for $11.5 million at an average price of $99.12 per share. As of December 31, 2022, $35.0 million of authority remained under the 2023 Program.
All shares repurchased under the aforementioned programs were recorded as treasury stock.

13.    Trade Accounts Receivable Sale Programs
The Company has Master Accounts Receivable Purchase Agreements with MUFG Bank, New York Branch (formerly known as The Bank of Tokyo-Mitsubishi UFJ, Ltd.) (the "MUFG RPA"), HSBC Bank (China) Company Limited, Xiamen branch (the "HSBC RPA") and other unaffiliated financial institutions, under which the Company may elect to sell receivables; at a discount. All facilities are uncommitted facilities. The maximum facility amount under the MUFG RPA is $340.0 million. The maximum facility amount under the HSBC RPA is $60.0 million. The MUFG RPA will be automatically extended each year unless any party gives no less than 10 days prior notice that the agreement should not be extended. The terms of the HSBC RPA are generally consistent with the terms of the MUFG RPA previously discussed.
Transfers of receivables under the programs are accounted for as sales and, accordingly, receivables sold under the programs are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows. Proceeds from the transfer reflect the face value of the receivables less a discount. The sale discount is recorded within "Miscellaneous, net" in the Condensed Consolidated Statements of Comprehensive Income in the period of the sale. The Company continues servicing receivables sold and performing all accounts receivable administrative functions, and in exchange receives a servicing fee, under both the MUFG RPA and HSBC RPA. Servicing fees related to trade accounts receivable programs recognized during the three months ended December 31, 2022 and January 1, 2022 were not material.

The Company sold $185.6 million and $148.0 million of trade accounts receivable under these programs, or their predecessors, during three months ended December 31, 2022 and January 1, 2022, respectively, in exchange for cash proceeds of $183.6 million and $147.5 million, respectively. As of December 31, 2022 and January 1, 2022, $196.8 million and $151.0 million,
14
respectively, of accounts receivables sold under trade accounts receivable programs and subject to servicing by the Company remained outstanding and had not yet been collected.

14.    Revenue from Contracts with Customers
Revenue is recognized over time for arrangements with customers for which: (i) the Company's performance does not create an asset with an alternative use to the Company, and (ii) the Company has an enforceable right to payment, including reasonable profit margin, for performance completed to date. Revenue recognized over time is estimated based on costs incurred to date plus a reasonable profit margin. If either of the two conditions noted above are not met to recognize revenue over time, revenue is recognized following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying arrangement.
The Company recognizes revenue when a contract exists and when, or as, it satisfies a performance obligation by transferring control of a product or service to a customer. Contracts are accounted for when they have approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer.
The Company generally enters into a master services arrangement that establishes the framework under which business will be conducted. These arrangements represent the master terms and conditions of the Company's services that apply to individual orders, but they do not commit the customer to work with, or to continue to work with, the Company nor do they obligate the customer to any specific volume or pricing of purchases. Moreover, these terms can be amended in appropriate situations.
Customer purchase orders are received for specific quantities with predominantly fixed pricing and delivery requirements. Thus, for the majority of our contracts, there is no guarantee of any revenue to the Company until a customer submits a purchase order. As a result, the Company generally considers its arrangement with a customer to be the combination of the master services arrangement and the purchase order. Most of the Company's arrangements with customers create a single performance obligation as the promise to transfer the individual manufactured product or service is capable of being distinct.
The Company’s performance obligations are satisfied over time as work progresses or at a point in time. A performance obligation is satisfied over time if the Company has an enforceable right to payment, including a reasonable profit margin. Determining if an enforceable right to payment includes a reasonable profit margin requires judgment and is assessed on a contract by contract basis.
Generally, there are no subjective customer acceptance requirements or further obligations related to goods or services provided; if such requirements or obligations exist, then a sale is recognized at the time when such requirements are completed and such obligations are fulfilled.
The Company does not allow for a general right of return. Net sales include amounts billed to customers for shipping and handling and out-of-pocket expenses. The corresponding shipping and handling costs and out-of-pocket expenses are included in cost of sales. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from net sales.
Contract Costs
For contracts requiring over time revenue recognition, the selection of the method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. The Company uses a cost-based input measurement of progress because it best depicts the transfer of assets to the customer, which occurs as costs are incurred during the manufacturing process or as services are rendered. Under the cost-based measure of progress, the extent of progress towards completion is measured based on the costs incurred to date.
There were no other costs to obtain or fulfill customer contracts.

15
Disaggregated Revenue
The table below includes the Company’s revenue for the three months ended December 31, 2022 and January 1, 2022 indicated disaggregated by geographic reportable segment and market sector (in thousands):
Three Months Ended
December 31, 2022
Reportable Segment:
AMERAPACEMEATotal
Market Sector:
Industrial$103,027 $350,584 $18,471 $472,082 
Healthcare/Life Sciences215,381 223,290 49,196 487,867 
Aerospace/Defense68,022 45,654 20,300 133,976 
     External revenue386,430 619,528 87,967 1,093,925 
Inter-segment sales3,232 22,376 1,406 27,014 
    Segment revenue$389,662 $641,904 $89,373 $1,120,939 

Three Months Ended
January 1, 2022
Reportable Segment:
AMERAPACEMEATotal
Market Sector:
Industrial$83,245 $265,275 $15,307 $363,827 
Healthcare/Life Sciences135,962 169,237 39,266 344,465 
Aerospace/Defense55,750 35,743 17,671 109,164 
     External revenue274,957 470,255 72,244 817,456 
Inter-segment sales2,389 21,417 619 24,425 
    Segment revenue$277,346 $491,672 $72,863 $841,881 

For each of the three months ended December 31, 2022 and January 1, 2022, approximately 81% and 87% of the Company's revenue, respectively, was recognized as products and services were transferred over time.
Contract Balances
The timing of revenue recognition, billings and cash collections results in billed accounts receivable, contract assets and deferred revenue on the Company’s accompanying Condensed Consolidated Balance Sheets.
Contract Assets: For performance obligations satisfied at a point in time, billing occurs subsequent to revenue recognition, at which point the customer has been billed and the resulting asset is recorded within accounts receivable. For performance obligations satisfied over time as work progresses, the Company has an unconditional right to payment, which results in the recognition of contract assets. The following table summarizes the activity in the Company's contract assets during the three months ended December 31, 2022 and January 1, 2022 (in thousands):
Three Months Ended
December 31, 2022January 1, 2022
Contract assets, beginning of period$138,540 $115,283 
Revenue recognized during the period884,099 709,723 
Amounts collected or invoiced during the period(903,623)(719,556)
Contract assets, end of period$119,016 $105,450 
Deferred Revenue: Deferred revenue is recorded when consideration is received from a customer prior to transferring goods or services to the customer under the terms of the contract, which is included in other accrued liabilities on Condensed
16
Consolidated Balance Sheets. As of December 31, 2022 and October 1, 2022 the balance of advance payments from customers was $247.1 million and $298.8 million, respectively. The advance payment is not considered a significant financing component because it is used to meet working capital demands that can be higher in the early stages of a contract and to protect the company from the other party failing to adequately complete some or all of its obligations under the contract. Deferred revenue is recognized into revenue when all revenue recognition criteria are met. For performance obligations satisfied over time, recognition will occur as work progresses; otherwise deferred revenue will be recognized based upon shipping terms.

15.    Restructuring and Impairment Charges
Restructuring and impairment charges are recorded within restructuring and impairment charges on the Condensed Consolidated Statements of Comprehensive Income. Restructuring liabilities are recorded within other accrued liabilities on the Condensed Consolidated Balance Sheets.

During the first quarter of fiscal 2023, the Company did not incur any restructuring and impairment charges. During the first quarter of fiscal 2022, the Company recorded $2.0 million of restructuring and impairment charges primarily due to employee severance costs associated with a facility transition in the Company's APAC segment.

The Company recognized a tax benefit of $0.2 million related to restructuring and impairment charges for the three months ended January 1, 2022.

The Company's restructuring accrual activity for the three months ended January 1, 2022 is included in the tables below (in thousands):    
Fixed Asset and Operating ROU Asset ImpairmentEmployee Termination and Severance Costs    Total
Accrual balance, as of October 2, 2021
$— $71 $71 
Restructuring and impairment costs255 1,766 2,021 
Amounts utilized(255)(75)(330)
Accrual balance, as of January 1, 2022
$— $1,762 $1,762 
17
ITEM 2.    MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

"SAFE HARBOR" CAUTIONARY STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995:

The statements contained in this Form 10-Q that are guidance or which are not historical facts (such as statements in the future tense and statements including believe, expect, intend, plan, anticipate, goal, target and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. These risks and uncertainties include the effect of inflationary pressures on our costs of production, profitability, and on the economic outlook of our markets; the effects of shortages and delays in obtaining components as a result of economic cycles, natural disasters or otherwise; the risk of customer delays, changes, cancellations or forecast inaccuracies in both ongoing and new programs; the lack of visibility of future orders, particularly in view of changing economic conditions; the economic performance of the industries, sectors and customers we serve; the effects of tariffs, trade disputes, trade agreements and other trade protection measures; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; our ability to secure new customers, maintain our current customer base and deliver product on a timely basis; the risks of concentration of work for certain customers; the particular risks relative to new or recent customers, programs or services, which risks include customer and other delays, start-up costs, potential inability to execute, the establishment of appropriate terms of agreements, and the lack of a track record of order volume and timing; the effects of start-up costs of new programs and facilities or the costs associated with the closure or consolidation of facilities; possible unexpected costs and operating disruption in transitioning programs, including transitions between Company facilities; the risk that new program wins and/or customer demand may not result in the expected revenue or profitability; the fact that customer orders may not lead to long-term relationships; our ability to manage successfully and execute a complex business model characterized by high product mix and demanding quality, regulatory, and other requirements; the risks associated with excess and obsolete inventory, including the risk that inventory purchased on behalf of our customers may not be consumed or otherwise paid for by the customer, resulting in an inventory write-off; risks related to information technology systems and data security; the ability to realize anticipated savings from restructuring or similar actions, as well as the adequacy of related charges as compared to actual expenses; increasing regulatory and compliance requirements; any tax law changes and related foreign jurisdiction tax developments; current or potential future barriers to the repatriation of funds that are currently held outside of the United States as a result of actions taken by other countries or otherwise; the potential effects of jurisdictional results on our taxes, tax rates, and our ability to use deferred tax assets and net operating losses; the weakness of areas of the global economy; the effect of changes in the pricing and margins of products; raw materials and component cost fluctuations; the potential effect of fluctuations in the value of the currencies in which we transact business; the effects of changes in economic conditions, political conditions and tax matters in the United States and in the other countries in which we do business; the potential effect of other world or local events or other events outside our control (such as the conflict between Russia and Ukraine, escalating tensions between China and Taiwan or China and the United States, changes in energy prices, terrorism, global health epidemics and weather events); the impact of increased competition; an inability to successfully manage human capital; changes in financial accounting standards; and other risks detailed herein and in our other Securities and Exchange Commission filings, particularly in Risk Factors contained in our fiscal 2022 Form 10-K.


*    *    *

18

OVERVIEW
Plexus Corp. and its subsidiaries (together "Plexus," the "Company", "our", or "we") participate in the Electronic Manufacturing Services ("EMS") industry. Since 1979, we have been partnering with companies to create the products that build a better world. We are a global leader with a team of nearly 25,000 individuals who are dedicated to providing Design and Development, Supply Chain Solutions, New Product Introduction, Manufacturing and Sustaining Services. We specialize in serving customers in industries with highly complex products and demanding regulatory environments. We deliver customer service excellence to leading global companies in the Industrial, Healthcare/Life Sciences and Aerospace/Defense market sectors by providing innovative, comprehensive solutions throughout the product's lifecycle. We provide these innovative solutions to customers in the Americas ("AMER"), Asia-Pacific ("APAC") and Europe, Middle East and Africa ("EMEA") regions.

The following Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is intended to provide an analysis of both short-term results and future prospects from management’s perspective, including an assessment of the financial condition and results of operations, events and uncertainties that are not indicative of future operations and any other financial or statistical data that we believe will enhance the understanding of our company’s financial condition, cash flows and other changes in financial condition and results of operations.

The following information should be read in conjunction with our condensed consolidated financial statements included herein and "Risk Factors" included in Part II, Item 1A included herein as well as Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended October 1, 2022, and our "Safe Harbor" Cautionary Statement included above.

Market Pressures Update
We have experienced an inability to procure certain components on a timely basis due to global supply chain constraints. These constraints have impacted our ability to meet customer demand and may inhibit our ability to capture the demand from our customers. The extended lead-times have required us to make additional investments in inventory to satisfy customer demand, which we expect to persist.

Over the past few quarters, the global supply chain constraints have led to inflation in some of the components we acquire, as well as labor and operating costs. We expect the increase in costs, including labor-related issues which have become more pronounced, to continue in the near future. We have been, and expect to continue to be, subject to such inflationary and general labor cost increases. While we have been largely able to mitigate the impacts of inflation through our contractual rights with customers on pricing, the pricing recoveries received may be dilutive to our operating margin. The inability to offset these costs in future periods or the impacts of continued inflation on end markets and our customers may affect our operating results, cash flows and inventory levels, which could increase as a result of higher component prices or the negative effects of inflation on customer end-market demand.

Customers within certain segments are working to better understand the impact of the Department of Commerce’s export controls restricting the People’s Republic of China’s access to advanced semiconductors, supercomputers, and semiconductor manufacturing equipment. We could continue to see demand volatility as they adjust their forecasts as a result of these restrictions.

Changes in tax laws or tax rates in the jurisdictions where we operate, including the potential passage of tax regulation changes such as the establishment of a global minimum tax could result in adverse tax consequences. During the first quarter of fiscal 2023, certain jurisdictions consented to implement a global minimum tax. We will continue to monitor these developments as each jurisdiction incorporates such changes into tax laws.

We believe our balance sheet is positioned to support the potential future challenges presented by the macro-economic pressures we are facing. As of the first quarter of fiscal 2023, cash and cash equivalents and restricted cash were $248 million, while debt, finance lease obligations and other financing were $516 million. Borrowings under our Credit Facility as of December 31, 2022 were $320 million, leaving $180 million of our revolving commitment of $500 million available for use as well as the ability to expand our revolving commitment to $750 million upon mutual agreement with the bank. Interest expense could increase above current levels due to increased borrowing under our Credit Facility associated with working capital investments along with the impact of rising interest rates. Refer to Note 3, "Debt, Finance Lease and Other Financing Obligations," in Notes to Consolidated Financial Statements and "Management’s Discussion and Analysis Liquidity and Capital Resources" in Part I, Item 2 for further information.

19
RESULTS OF OPERATIONS
Consolidated Performance Summary. The following table presents selected consolidated financial data (dollars in millions, except per share data):
Three Months Ended
December 31, 2022January 1, 2022
Net sales$1,093.9 $817.5 
Cost of sales992.7 747.5 
Gross profit101.2 70.0 
Gross margin9.3 %8.6 %
Operating income57.3 30.5 
Operating margin5.2 %3.7 %
Other expense7.9 3.7 
Income tax expense7.2 3.4 
Net income 42.2 23.4 
Diluted earnings per share$1.49 $0.82 
Return on invested capital*13.8 %10.0 %
Economic return*4.8 %0.7 %
*Non-GAAP metric; refer to "Return on Invested Capital ("ROIC") and economic return" below and Exhibit 99.1 for more information.
Net sales. For the three months ended December 31, 2022, net sales increased $276.4 million, or 33.8%, as compared to the three months ended January 1, 2022.
Net sales are analyzed by management by geographic segment, which reflects our reportable segments, and by market sector. Management measures operational performance and allocates resources on a geographic segment basis. Our global business development strategy is based on our targeted market sectors.
A discussion of net sales by reportable segment is presented below (in millions):
Three Months Ended
December 31, 2022January 1, 2022
Net sales:
AMER$389.7 $277.3 
APAC641.9 491.7 
EMEA89.4 72.9 
Elimination of inter-segment sales(27.1)(24.4)
Total net sales$1,093.9 $817.5 
AMER. Net sales for the three months ended December 31, 2022 in the AMER segment increased $112.4 million, or 40.5%, as compared to the three months ended January 1, 2022. The increase in net sales was driven by a $68.2 million increase in production ramps of new products for existing customers and overall net increased customer end-market demand, inclusive of a partial easing of supply chain constraints that had previously created limitations with meeting available customer demand. The increase was also driven by higher pricing associated with inflated component prices and an $11.0 million increase in production ramps for new customers.
APAC. Net sales for the three months ended December 31, 2022 in the APAC segment increased $150.2 million, or 30.5%, as compared to the three months ended January 1, 2022. The increase in net sales was driven by overall net increased customer end-market demand inclusive of a partial easing of supply chain constraints that had previously created limitations with meeting available customer demand. The increase was also driven by higher pricing associated with inflated component prices and a $5.0 million increase in production ramps of new products for existing customers.
20
EMEA. Net sales for the three months ended December 31, 2022 in the EMEA segment increased $16.5 million, or 22.6%, as compared to the three months ended January 1, 2022. The increase in net sales was driven by overall net increased customer end-market demand and increased pricing associated with inflated component prices.
Our net sales by market sector were as follows (in millions):
Three Months Ended
December 31, 2022January 1, 2022
Net sales:
Industrial$472.1 $363.8 
Healthcare/Life Sciences487.9 344.5 
Aerospace/Defense133.9 109.2 
Total net sales$1,093.9 $817.5 
Industrial. Net sales for the three months ended December 31, 2022 in the Industrial sector increased $108.3 million, or 29.8%, as compared to the three months ended January 1, 2022. The increase in net sales was driven by overall net increased customer end-market demand inclusive of a partial easing of supply chain constraints that had previously created limitations with meeting available customer demand. The increase was also driven by higher pricing associated with inflated component prices, a $7.7 million increase in production ramps for new customers and a $7.6 million increase due to production ramps of new products for existing customers.
Healthcare/Life Sciences. Net sales for the three months ended December 31, 2022 in the Healthcare/Life Sciences sector increased $143.4 million, or 41.6%, as compared to the three months ended January 1, 2022. The increase in net sales was driven by overall net increased customer end-market demand inclusive of a partial easing of supply chain constraints that had previously created limitations with meeting available customer demand. The increase was also driven by higher pricing associated with inflated component prices and a $58.5 million increase due to production ramps of new products for existing customers.
Aerospace/Defense. Net sales for the three months ended December 31, 2022 in the Aerospace/Defense sector increased $24.7 million, or 22.6%, as compared to the three months ended January 1, 2022. The increase was driven by overall net increased customer end-market demand and increased pricing associated with inflated component prices, a $7.8 million increase due to production ramps of new products for existing customers and a $7.6 million increase in production ramps for a new customer.
Cost of sales. Cost of sales for the three months ended December 31, 2022 increased $245.2 million, or 32.8%, as compared to the three months ended January 1, 2022. Cost of sales is comprised primarily of material and component costs, labor costs and overhead. For the three months ended December 31, 2022 and January 1, 2022, approximately 89% to 91% of the total cost of sales was variable in nature and fluctuated with sales volumes. Approximately 87% to 88% of these costs were related to material and component costs.
As compared to the three months ended January 1, 2022, the increase in cost of sales for the three months ended December 31, 2022 was primarily driven by the increase in net sales, inflated component costs and an increase in fixed costs, partially offset by improvements in operational efficiencies.
Gross profit. Gross profit for the three months ended December 31, 2022 increased $31.2 million, or 44.6%, as compared to the three months ended January 1, 2022. Gross margin of 9.3% for the three months ended December 31, 2022 increased 70 basis points compared to the three months ended January 1, 2022. The primary driver of the increase in gross profit and gross margin was the increase in net sales and improvements in operational efficiencies, partially offset by inflated component costs and increased fixed costs.
Operating income. Operating income for the three months ended December 31, 2022 increased $26.8 million, or 87.9%, as compared to the three months ended January 1, 2022. Operating margin of 5.2% for the three months ended December 31, 2022 increased 150 basis points compared to the three months ended January 1, 2022. The primary driver of the increase in operating income and operating margin was the result of the increase in gross profit and gross margin along with a $2.0 million decrease in restructuring and impairment charges, partially offset by a $6.4 million increase in selling and administrative expenses ("S&A"). The increase in S&A was primarily due to an increase in compensation costs.

21
A discussion of operating income by reportable segment presented below (in millions):
Three Months Ended
December 31, 2022January 1, 2022
Operating income (loss):
AMER$17.4 $1.8 
APAC78.4 60.7 
EMEA(0.6)1.0 
Corporate and other costs(37.9)(33.0)
Total operating income$57.3 $30.5 
AMER. Operating income increased $15.6 million for the three months ended December 31, 2022 as compared to the three months ended January 1, 2022, primarily as a result of an increase in net sales and improvements in operational efficiencies, partially offset by inflated component costs and increased fixed costs.
APAC. Operating income increased $17.7 million for the three months ended December 31, 2022 as compared to the three months ended January 1, 2022, primarily as a result of an increase in net sales and improvements in operational efficiencies, partially offset by inflated component costs, increased fixed costs and an increase in S&A.
EMEA. Operating income decreased $1.6 million for the three months ended December 31, 2022 as compared to the three months ended January 1, 2022 primarily as a result of inflated component costs and a negative shift in customer mix, partially offset by an increase in net sales.
Other expense. Other expense for the three months ended December 31, 2022 increased $4.2 million as compared to the three months ended January 1, 2022. The increase in other expense for the three months ended December 31, 2022 was primarily due to the increase in interest expense of $3.8 million and factoring fees of $1.5 million.
Income taxes. Income tax expense for the three months ended December 31, 2022 was $7.2 million compared to $3.4 million for the three months ended January 1, 2022. The increase is primarily due to an increase in pre-tax book income and change in the geographic distribution of pre-tax book income.
Our annual effective tax rate varies from the U.S. statutory rate of 21.0% primarily due to the geographic distribution of worldwide earnings as well as a tax holiday granted to a subsidiary located in the APAC segment where we derive a significant portion of our earnings. Our effective tax rate may also be impacted by disputes with taxing authorities, tax planning activities, adjustments to uncertain tax positions and changes in valuation allowances.
The annual effective tax rate for fiscal 2023 is expected to be approximately 14.0% to 16.0% assuming no changes to tax laws.
Net Income. Net income for the three months ended December 31, 2022 increased $18.8 million, or 80.3%, from the three months ended January 1, 2022 to $42.2 million. Net income increased primarily as a result of operating income, partially offset by an increase in tax expense and other expense, as previously discussed.
Diluted earnings per share. Diluted earnings per share increased to $1.49 for the three months ended December 31, 2022 from $0.82 for the three months ended January 1, 2022, primarily as a result of increased net income due to the factors previously discussed as well as a reduction in diluted shares outstanding due to repurchase activity under our share repurchase plans.
Return on Invested Capital ("ROIC") and economic return. We use a financial model that is aligned with our business strategy and includes an ROIC goal of 15% which would exceed our weighted average cost of capital ("WACC") and represent positive economic return. Economic return is the amount our ROIC exceeds our WACC.
Non-GAAP financial measures, including ROIC and economic return, are used for internal management goals and decision making because such measures provide management and investors additional insight into financial performance. In particular, we provide ROIC and economic return because we believe they offer insight into the metrics that are driving management decisions. We view ROIC and economic return as important measures in evaluating the efficiency and effectiveness of our long-term capital investments. We also use ROIC as a performance criteria in determining certain elements of compensation as well as economic return performance.
We define ROIC as tax-effected operating income before restructuring and other special items divided by average invested capital over a rolling two-quarter period for the first quarter. Invested capital is defined as equity plus debt and operating lease
22
liabilities, less cash and cash equivalents. Other companies may not define or calculate ROIC in the same way. ROIC and other non-GAAP financial measures should be considered in addition to, not as a substitute for, measures of our financial performance prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP").
We review our internal calculation of WACC annually. Our WACC is 9.0% for fiscal 2023 as compared to 9.3% for fiscal 2022. By exercising discipline to generate ROIC in excess of our WACC, our goal is to create value for our shareholders. For the three months ended December 31, 2022, ROIC of 13.8% reflects an economic return of 4.8%, based on our weighted average cost of capital of 9.0%. For the three months ended January 1, 2022, ROIC of 10.0% reflects an economic return of 0.7%, based on our weighted average cost of capital of 9.3% for that fiscal year.
For a reconciliation of ROIC, economic return and adjusted operating income (tax-effected) to our financial statements that were prepared using U.S. GAAP, see Exhibit 99.1 to this quarterly report on Form 10-Q, which exhibit is incorporated herein by reference.
Refer to the table below, which includes the calculation of ROIC and economic return for the indicated fiscal period (dollars in millions):
Three Months Ended
 December 31, 2022January 1, 2022
Adjusted operating income (tax-effected)$192.7 $113.1 
Average invested capital1,392.0 1,135.3 
After-tax ROIC13.8 %10.0 %
WACC9.0 %9.3 %
Economic return4.8 %0.7 %

LIQUIDITY AND CAPITAL RESOURCES
Cash and cash equivalents and restricted cash were $247.9 million as of December 31, 2022, as compared to $275.5 million as of October 1, 2022.
As of December 31, 2022, 87% of our cash and cash equivalents balance was held outside of the U.S. by our foreign subsidiaries. Currently, we believe that our cash balance, together with cash available under our Credit Facility, will be sufficient to meet our liquidity needs and potential share repurchases, if any, for the next twelve months and for the foreseeable future.
Our future cash flows from operating activities will be reduced by $47.7 million due to cash payments for U.S. federal taxes on the deemed repatriation of undistributed foreign earnings that are payable over an eight-year period that began in fiscal 2019 with the first payment. The table below provides the expected timing of these future cash outflows, in accordance with the following installment schedule for the remaining four years (in millions):
Remaining 2023$5.7 
202410.6 
202514.1 
202617.3 
Total$47.7 
Cash Flows. The following table provides a summary of cash flows (in millions):
Three Months Ended
December 31, 2022January 1, 2022
Cash used in operating activities$(48.8)$(89.0)
Cash used in investing activities(21.6)(33.4)
Cash provided by financing activities39.4 70.0 
23

Operating Activities. Cash flows used in operating activities were $48.8 million for the three months ended December 31, 2022, as compared to cash flows used in operating activities of $89.0 million for the three months ended January 1, 2022. The change was primarily due to cash flow improvements (reductions) of:

•$18.8 million increase in net income.
•$183.0 million in inventory cash flows driven by inventory levels increasing at a slower rate in the first quarter of fiscal 2023 as compared to the first quarter of fiscal 2022. In the first quarter of fiscal 2023, inventory levels have primarily increased to support the ramp of customer programs, as well as supply chain constraints have led to inflation in some of the components we acquire, increasing inventory.
•$80.7 million in accounts receivable cash flows driven by timing of shipments, mix of customer payment terms and increased factoring of receivables.
•$9.8 million in contract assets cash flows driven by increases in advance payments received from customers who recognize revenue over time.
•$(128.9) million in accounts payables cash flows primarily driven by the timing of materials procurement and payments to suppliers.
•$(88.0) million in other current and non-current liabilities cash flows driven by a release of advance payments to customers as we sold products that contained inflated component prices.
•$(33.6) million in customer deposit cash flows driven by deposits increasing at a slower rate in the first quarter of fiscal 2023 as compared to the first quarter of fiscal 2022, consistent with inventory cash flows. Deposit increases in both periods were primarily to cover certain inventory balances.
The following table provides a summary of cash cycle days for the periods indicated (in days):
Three Months Ended
December 31,
2022		January 1, 2022
Days in accounts receivable6166
Days in contract assets1012
Days in inventory151145
Days in accounts payable(69)(87)
Days in cash deposits(47)(33)
Annualized cash cycle106103
We calculate days in accounts receivable and contract assets as each balance sheet item for the respective quarter divided by annualized sales for the respective quarter by day. We calculate days in inventory, accounts payable and cash deposits as each balance sheet line item for the respective quarter divided by annualized cost of sales for the respective quarter by day. We calculate annualized cash cycle as the sum of days in accounts receivable, days in contract assets and days in inventory, less days in accounts payable and days in cash deposits.
As of December 31, 2022, annualized cash cycle days increased three days compared to January 1, 2022 due to the following:
Days in accounts receivable for the three months ended December 31, 2022 decreased five days compared to the three months ended January 1, 2022. The decrease is primarily attributable to an increase in factored receivables.
Days in contract assets for the three months ended December 31, 2022 decreased two days compared to the three months ended January 1, 2022. The decrease is primarily attributable to increased net sales and an increase in advance payments received from customers with arrangements requiring revenue to be recognized over time as products are produced.
Days in inventory for the three months ended December 31, 2022 increased six days compared to the three months ended January 1, 2022. The increase is primarily attributable to increased inventory levels to support the ramp of customer programs. Inventory levels also increased due to customer demand volatility as well as supply chain constraints which have led to inflation in some of the components we acquire.
Days in accounts payable for the three months ended December 31, 2022 decreased eighteen days compared to the three months ended January 1, 2022. The decrease is primarily attributable to timing of materials procurement and payments to suppliers as well as increased net sales.
24
Days in cash deposits for the three months ended December 31, 2022 increased fourteen days compared to the three months ended January 1, 2022. The increase was primarily attributable to significant deposits received from customers to cover certain increasing inventory balances.
Free Cash Flow. We define free cash flow ("FCF"), a non-GAAP financial measure, as cash flow used in operations less capital expenditures. FCF was $(71.9) million for the three months ended December 31, 2022 compared to $(122.2) million for the three months ended January 1, 2022, an improvement of $50.3 million. The improvement in FCF was primarily due to less of a working capital investment in inventory to support our customers in the first quarter of fiscal 2023 as compared to the first quarter of fiscal 2022.
Non-GAAP financial measures, including FCF, are used for internal management assessments because such measures provide additional insight to investors into ongoing financial performance. In particular, we provide FCF because we believe it offers insight into the metrics that are driving management decisions. We view FCF as an important financial metric as it demonstrates our ability to generate cash and can allow us to pursue opportunities that enhance shareholder value. FCF is a non-GAAP financial measure that should be considered in addition to, not as a substitute for, measures of our financial performance prepared in accordance with U.S. GAAP.
A reconciliation of FCF to our financial statements that were prepared using U.S. GAAP as follows (in millions):
Three Months Ended
December 31,
2022		January 1, 2022
Cash flows used in operating activities$(48.8)$(89.0)
Payments for property, plant and equipment(23.1)(33.2)
Free cash flow$(71.9)$(122.2)
Investing Activities. Cash flows used in investing activities were $21.6 million for the three months ended December 31, 2022 compared to $33.4 million for the three months ended January 1, 2022. The decrease in cash used in investing activities was due to a $10.2 million decrease in capital expenditures, as the manufacturing footprint expansion in Bangkok, Thailand has been substantially completed.
We estimate capital expenditures for fiscal 2023 will be approximately $110.0 million to $130.0 million to support new program ramps and replace older equipment. This estimate does not contemplate any site expansions.
Financing Activities. Cash flows provided by financing activities were $39.4 million for the three months ended December 31, 2022 compared to cash flows provided by financing activities of $70.0 million for the three months ended January 1, 2022. The decrease was primarily attributable to lower borrowings on the credit facility in the first quarter of fiscal 2023 of $57.0 million as compared to the first quarter of fiscal 2022 of $85.0 million.
On August 11, 2021, the Board of Directors approved a share repurchase program under which we were authorized to repurchase up to $50.0 million of our common stock (the "2022 Program"). The 2022 Program commenced upon completion of the 2021 Program and was completed in fiscal 2022. During the three months ended January 1, 2022, we repurchased 110,440 shares under this program for $10.2 million at an average price of $91.74 per share.
On August 18, 2022, the Board of Directors approved a share repurchase program under which we are authorized to repurchase up to $50.0 million of our common stock (the "2023 Program"). The 2023 Program became effective immediately and has no expiration. During the three months ended December 31, 2022, we repurchased 115,723 shares under this program for $11.5 million at an average price of $99.12 per share. As of December 31, 2022, $35.0 million of authority remained under the 2023 Program.
All shares repurchased under the aforementioned programs were recorded as treasury stock.
We have Master Accounts Receivable Purchase Agreements with MUFG Bank, New York Branch (formerly known as The Bank of Tokyo-Mitsubishi UFJ, Ltd.) (the "MUFG RPA"), HSBC Bank (China) Company Limited, Xiamen branch (the "HSBC RPA") and other unaffiliated financial institutions, under which we may elect to sell receivables, at a discount. These facilities are uncommitted facilities. The maximum facility amount under the MUFG RPA as of December 31, 2022 was $340.0 million. The maximum facility amount under the HSBC RPA as of December 31, 2022 was $60.0 million. The MUFG RPA will be automatically extended each year unless any party gives no less than 10 days prior notice that the agreement should not be extended. The terms of the HSBC RPA are generally consistent with the terms of the MUFG RPA previously discussed.
25
We sold $185.6 million and $148.0 million of trade accounts receivable under these programs, or their predecessors, during the three months ended December 31, 2022 and January 1, 2022, respectively, in exchange for cash proceeds of $183.6 million and $147.5 million, respectively. As of December 31, 2022 and January 1, 2022, $196.8 million and $151.0 million, respectively, of accounts receivables sold under trade accounts receivable programs and subject to servicing by us remained outstanding and had not yet been collected.
In all cases, the sale discount was recorded within "Miscellaneous, net" in the Condensed Consolidated Statements of Comprehensive Income in the period of the sale. For further information regarding the receivable sale programs, see Note 13, "Trade Accounts Receivable Sale Programs," in Notes to Condensed Consolidated Financial Statements.
Based on current expectations, we believe that our projected cash flows provided by operations, available cash and cash equivalents, our leasing capabilities and potential borrowings under our 5-year senior unsecured revolving credit facility (referred to as the "Credit Facility"), including our ability to expand our revolving commitment, should be sufficient to meet our working capital and fixed capital requirements, as well as execution upon our share repurchase authorizations as management deems appropriate, for the next twelve months. We believe our balance sheet is positioned to support the potential future challenges presented by macro-economic factors including increased working capital requirements associated with longer lead-times for components, increased component and labor costs, and operating inefficiencies due to supply chain constraints. As of the end of the first quarter of fiscal 2023, cash and cash equivalents and restricted cash were $247.9 million, while debt, finance lease obligations and other financing were $516.3 million. If our future financing needs increase, including to support additional capital expenditures or investments in the growth of our business, then we may need to arrange additional debt or equity financing. Accordingly, we evaluate and consider from time to time various financing alternatives to supplement our financial resources. However, we cannot be assured that we will be able to make any such arrangements on acceptable terms or at all.
26
DISCLOSURE ABOUT CRITICAL ACCOUNTING ESTIMATES
Our critical accounting policies are disclosed in our 2022 Annual Report on Form 10-K. During the first quarter of fiscal 2023, there were no material changes.

NEW ACCOUNTING PRONOUNCEMENTS
See Note 1, "Basis of Presentation," in Notes to Condensed Consolidated Financial Statements regarding recent accounting pronouncements. 

ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There were no material changes in our exposure to market risk from changes in foreign exchange and interest rates from those disclosed in our 2022 Annual Report on Form 10-K.
Foreign Currency Risk
Our international operations create potential foreign exchange risk. Our policy is to selectively hedge our foreign currency denominated transactions in a manner that partially offsets the effects of changes in foreign currency exchange rates. We typically use foreign currency contracts to hedge only those currency exposures associated with certain assets and liabilities denominated in non-functional currencies. Corresponding gains and losses on the underlying transaction generally offset the gains and losses on these foreign currency hedges. We cannot predict changes in currency rates, nor the degree to which we will be able to manage the impacts of currency exchange rate changes. Such changes could have a material effect on our business, results of operations and financial condition.
Our percentages of transactions denominated in currencies other than the U.S. dollar for the indicated periods were as follows: 
Three Months Ended
 December 31, 2022January 1, 2022
Net Sales7%10%
Total Costs15%18%
We have evaluated the potential foreign currency exchange rate risk on transactions denominated in currencies other than the U.S. dollar for the periods presented above. Based on our overall currency exposure, as of December 31, 2022, a 10.0% change in the value of the U.S. dollar relative to our other transactional currencies would not have a material effect on our financial position, results of operations, or cash flows.
Interest Rate Risk
We have financial instruments, including cash equivalents and debt, which are sensitive to changes in interest rates. The primary objective of our investment activities is to preserve principal, while maximizing yields without significantly increasing market risk. To achieve this, we limit the amount of principal exposure to any one issuer.
As of December 31, 2022, our only material interest rate risk was associated with our Credit Facility. Borrowings under the Credit Facility bear interest, at the Company's option, at (a)(1) for borrowings denominated in U.S. dollars, the Term Secured Overnight Financing Rate ("SOFR"), (2) for borrowings denominated in pounds sterling, the Daily Simple Risk-Free Rate, plus, in each case of (a)(1) and (2), 10 basis points, (b) for borrowings denominated in euros, the EURIBOR Rate plus a statutory reserve rate, or (c) an Alternate Base Rate equal to the highest of (i) 100 basis points per annum, (ii) the prime rate last quoted by The Wall Street Journal (or, if not quoted, as otherwise provided in the Credit Facility), (iii) the greater of the federal funds effective rate and the overnight bank funding rate in effect on such day plus, in each case, 50 basis points per annum (or, if neither are available, as otherwise provided in the Credit Facility), and (iv) Term SOFR for a one month interest period on such day plus 110 basis points, plus, in each case of (a), (b), and (c), an applicable interest rate margin based on the Company's then current consolidated total indebtedness (minus certain unrestricted cash and cash equivalents in an amount not to exceed $100 million) to consolidated EBITDA. As of December 31, 2022, the borrowing rate under the Credit Facility was SOFR plus 1.10%. Borrowings under the 2018 NPA are based on a fixed interest rate, thus mitigating much of our interest rate risk. Based on our overall interest rate exposure, as of December 31, 2022, a 10.0% change in interest rates would not have a material effect on our financial position, results of operations, or cash flows.
27
ITEM 4.    CONTROLS AND PROCEDURES
Disclosure Controls and Procedures
The Company maintains disclosure controls and procedures designed to ensure that the information the Company must disclose in its filings with the Securities and Exchange Commission ("SEC") is recorded, processed, summarized and reported on a timely basis. The Company’s Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO") have reviewed and evaluated, with the participation of the Company’s management, the Company’s disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act") as of the end of the period covered by this report. Based on such evaluation, the CEO and CFO have concluded that, as of the Evaluation Date, the Company’s disclosure controls and procedures are effective, at the reasonable assurance level, (a) in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by the Company in the reports the Company files or submits under the Exchange Act, and (b) in assuring that information is accumulated and communicated to the Company’s management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
During the first quarter of fiscal 2023, there have been no changes in the Company’s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II.    OTHER INFORMATION

ITEM 1A.    Risk Factors
In addition to the risks and uncertainties discussed herein, particularly those discussed in the “Safe Harbor” Cautionary Statement and "Management’s Discussion and Analysis of Financial Condition and Results of Operations" in Part I, Item 2, see the risk factors set forth in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended October 1, 2022 that have had no material changes.

ITEM 2.    Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides the specified information about the repurchases of shares by us during the three months ended December 31, 2022:
PeriodTotal number of shares purchasedAverage price paid per shareTotal number of shares purchased as part of publicly announced plans or programsMaximum approximate dollar value of shares that may yet be purchased under the plans or programs (1)
October 2, 2022 -
October 29, 2022		47,769 $91.16 47,769 $42,165,377 
October 30, 2022 -
November 26, 2022		30,306 102.60 30,306 39,055,994 
November 27, 2022 -
December 31, 2022		37,648 106.41 37,648 35,049,821 
115,723 $99.12 115,723 
(1) On August 18, 2022, the Board of Directors approved a new share repurchase program that authorizes the Company to repurchase up to $50.0 million of its common stock (the "2023 Program"). The 2023 Program became effective immediately and has no expiration. The table above reflects the maximum dollar amount remaining available for purchase under the 2023 Program as of December 31, 2022.
28
ITEM 6.    EXHIBITS
The list of exhibits is included below.
Exhibit 
No.		  Exhibit
10.1
10.2
31.1
31.2
32.1
32.2
99.1
101
The following materials from Plexus Corp.’s Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2022, formatted in Inline Extensible Business Reporting Language ("XBRL"): (i) the Condensed Consolidated Statements of Comprehensive Income, (ii) the Condensed Consolidated Balance Sheets, (iii) the Condensed Consolidated Statements of Shareholders’ Equity, (iv) the Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements.
101.INSInline XBRL Instance Document (the instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document).
101.SCHInline XBRL Taxonomy Extension Schema Document.
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.
104
The cover page from the Company’s Quarterly Report on Form 10-Q for the fiscal first quarter ended December 31, 2022, formatted in Inline XBRL and contained in Exhibit 101.

29
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 Plexus Corp.
Registrant
Date:February 3, 2023/s/ Todd P. Kelsey
 Todd P. Kelsey
Chief Executive Officer
Date:February 3, 2023/s/ Patrick J. Jermain
Patrick J. Jermain
Executive Vice President and Chief Financial Officer
30
 EX-10.1 2 erformofperformancestockun.htm EX-10.1 Document

PLEXUS CORP.
PERFORMANCE STOCK UNIT AGREEMENT
(ECONOMIC RETURN)
TO:        %%FIRST_NAME_MIDDLE_NAME_LAST_NAME%-%
DATE:        %%OPTION_DATE,'Month DD, YYYY'%-%
In order to provide additional incentive through stock ownership for certain officers and key employees of Plexus Corp. (the “Corporation”) and its subsidiaries, you (the “Grantee”) are hereby granted a performance stock unit award (“Award”) effective as of _______, 20__ (the “Grant Date”). This Award is subject to the terms and conditions set forth in this Agreement and in the Plexus Corp. 2016 Omnibus Incentive Plan (the “Plan”), the terms of which are incorporated herein by reference.
1.Target Number of Performance Stock Units.
This Award applies to performance stock units that are based upon shares of the Corporation’s Common Stock (the “Performance Stock Units”). The Performance Stock Units granted under this Agreement are units that will be reflected in a book account maintained by the Corporation until they become earned or have been forfeited. The number of Performance Stock Units at target is as follows:
Number of Performance Stock Units (at target): %%TOTAL_SHARES_GRANTED%-%
2.Performance Terms.
(a)The terms of this Section 2 will apply to your Performance Stock Units except in so far as Section 3 ("Treatment Upon Termination") or Section 5 ("Change in Control") apply.
(b)The performance period (the “Performance Period”) for your Performance Stock Units will be the three-year period commencing ______ 20__ and ending on or near _________, 20__. The performance period end date is an estimate based on the projected date of the last day of Fiscal 20__ and may be subject to change. Following the conclusion of the Performance Period, the Committee shall certify in writing the number of Performance Stock Units which are payable (your “Final Performance Stock Units”). The Committee will calculate your Final Performance Stock Units by multiplying your Performance Stock Units (at target) by the “Performance Factor.” The Performance Factor means a percentage (from zero to 200%) which is based on the Corporation’s Economic Return during the Performance Period, determined according to Table 1 of this Agreement.
(c)All determinations made by the Committee shall be binding and conclusive on all parties.
3.Treatment Upon Termination. If your employment with the Corporation terminates prior to the end of the Performance Period, your Final Performance Stock Units will be calculated as follows:
(a)Death, Disability. In the event your employment terminates during the Performance Period as a result of your death or Disability, your Final Performance Stock Units will be based upon a prorated number of Performance Stock Units (at target). Your Final


Performance Stock Units will be determined by multiplying your Performance Stock Units (at target) by a fraction, the numerator of which is the number of days elapsed between the beginning of the Performance Period and the date of your death or Disability, and the denominator of which is the number of days in the Performance Period.
(b)Termination for Cause. In the event your employment is terminated during the Performance Period for Cause, your Performance Stock Units will be forfeited immediately.
(c)Other Termination (Without Cause, Retirement or Resignation). In the event your employment terminates during the Performance Period for any other reason, your Performance Stock Units will be forfeited immediately unless otherwise determined by the Committee.
4.Payment of Awards.
Except for payments pursuant to Section 5 ("Change in Control"), your Final Performance Stock Units shall be paid in the form of Common Stock and all payments will be made to you within two and a half months after the end of the Performance Period (or earlier termination of employment pursuant to Section 3).
5.Change in Control. In the event of a Change in Control:
(a)The Performance Factor shall be calculated as of the date of the Change in Control. The Performance Factor shall be calculated using achieved performance for any completed fiscal year in the three year measurement period prior to the Change in Control and the Target level of performance for the fiscal year of the Change in Control and any future fiscal year(s). Your Final Performance Share Units will be equal to the number of Performance Stock Units (at target) times the calculated Performance Factor.
(b)Within 15 days following the Change in Control, your Final Performance Stock Units will be paid in the form of Common Stock or common stock of any successor corporation; provided that the Corporation may elect to pay an amount of cash equal to the value of the Common Stock that would otherwise be issued. The value shall be equal to the number of shares of Common Stock that would be issued times the Fair Market Value of the Common Stock at the time of the Change in Control.
6.Rights Prior to Payment.
Prior to any payment of the Award, you will not have any right to vote the Performance Stock Units or to receive credit for cash dividends. You will not be deemed a stockholder of the Corporation with respect to any of the Performance Stock Units. The Performance Stock Units may not be sold, assigned, transferred, pledged, encumbered or otherwise disposed of prior to payment.
7.Tax Withholding.
The Corporation shall have the power and right to deduct or withhold, or require you to remit to the Corporation, an amount sufficient to satisfy Federal, state and local taxes required by law to be withheld with respect to issuance of shares under this Agreement. You may make a written election to satisfy this withholding requirement, in whole or in part, by having the Corporation withhold shares having a Fair Market Value on the date the tax is to be determined equal to the minimum marginal total tax which could be imposed on the transaction.
8.Transfer Restrictions After Issuance.
2


Under applicable securities laws, you may not be able to sell any shares for a period of time after issuance, and you must comply with the Corporation’s Insider Trading Restrictions and Policies. The Corporation’s counsel should be consulted on your ability to sell your shares under the 1934 Act.
9.No Employment Agreement Intended.
Neither the establishment of, nor the awarding of Awards under this Plan shall be construed to create a contract of employment between you and the Corporation or its subsidiaries; nor does it give you the right to continue in the employment of the Corporation or its subsidiaries or limit in any way the right of the Corporation or its subsidiaries to discharge you at any time and without notice, with or without cause, or to any benefits not specifically provided by this Plan, or in any manner modify the Corporation’s right to establish, modify, amend or terminate any profit sharing, retirement or other benefit plans.
10.Section 409A Compliance.
This Award is intended to comply with the requirements of Section 409A, and shall be interpreted and administered in accordance with that intent. If any provision of the Plan or this Agreement would otherwise conflict with or frustrate this intent, the Committee may adopt such amendments to the Plan and the Agreement as the Committee deems necessary.

11.Wisconsin Contract.
This Agreement reflects an Award made in Wisconsin and shall be construed under the laws of that state without regard to the conflict of laws provision of any jurisdiction.

3


To accept this grant, logon to your E*TRADE account (www.etrade.com). By accepting this grant online you acknowledge and accept this grant and the terms and conditions. You also acknowledge receipt of this Performance Stock Unit Agreement, a copy of the 2016 Omnibus Incentive Plan, and a copy of the Insider Trading Restrictions and Policies. If this grant is not accepted online within thirty (30) days from the grant date of this Agreement, this Award will be deemed refused and may be withdrawn.
PLEXUS CORP.

By: /s/___________________________
    
4


Table 1
Determination of Performance Factor

The Performance Factor shall be determined according to the following table:


Economic Return*
Measurement Period Average
Payout
Performance Factor
0.0%0%
0.5%20%
1.0%40%
1.5%60%
2.0%80%
2.5%100%
3.0%120%
3.5%140%
4.0%160%
4.5%180%
5.0%200%


* The Economic Return of Plexus shall be measured, on an absolute basis, from 0 – 500 basis points above the weighted average cost of capital ("WACC") as calculated for the annual operating plan of the Corporation for each year of the Measurement Period. The average Economic Return over the Measurement Period will determine the Economic Return for calculation of the number of shares delivered, with payout ranging from 0% - 200% of the targeted shares on a linear scale with payout results interpolated for performance between the percentages listed above.

For purposes of the foregoing calculation:

1.    “Economic Return” means Return on Invested Capital (“ROIC”) minus Weighted Average Cost of Capital (“WACC”).

2.    “Return on Invested Capital” means (i) Adjusted Operating Income (tax effected) divided by (ii) the five (5) quarter average invested capital ending with the fourth quarter of each fiscal year of the Performance Period.

3.    "Weighted Average Cost of Capital" means the weighted average cost of the Company’s capital as calculated for the annual operating plan during each year of the performance period. For fiscal 20__, the Company’s WACC has been established as ___%.



4.    "Performance Period" means the three fiscal year period beginning with the fiscal year of grant and ending after the conclusion of the third fiscal year.

5.     Economic Return for any fiscal year during the Performance Period will be a minimum of 0% and a maximum of 5% for purposes of calculating ER-PSU vesting.



 EX-10.2 3 tsrformofperformancestocku.htm EX-10.2 Document

PLEXUS CORP.
PERFORMANCE STOCK UNIT AGREEMENT
(TOTAL SHAREHOLDER RETURN)
TO:        %%FIRST_NAME_MIDDLE_NAME_LAST_NAME%-%
DATE:        %%OPTION_DATE,'Month DD, YYYY'%-%
In order to provide additional incentive through stock ownership for certain officers and key employees of Plexus Corp. (the “Corporation”) and its subsidiaries, you (the “Grantee”) are hereby granted a performance stock unit award (“Award”) effective as of _______, 20__ (the “Grant Date”). This Award is subject to the terms and conditions set forth in this Agreement and in the Plexus Corp. 2016 Omnibus Incentive Plan (the “Plan”), the terms of which are incorporated herein by reference.
1.Target Number of Performance Stock Units.
This Award applies to performance stock units that are based upon shares of the Corporation’s Common Stock (the “Performance Stock Units”). The Performance Stock Units granted under this Agreement are units that will be reflected in a book account maintained by the Corporation until they become earned or have been forfeited. The number of Performance Stock Units at target is as follows:
Number of Performance Stock Units (at target): %%TOTAL_SHARES_GRANTED%-%
2.Performance Terms.
(a)The terms of this Section 2 will apply to your Performance Stock Units except in so far as Section 3 ("Treatment Upon Termination") or Section 5 ("Change in Control") apply.
(b)The performance period (the “Performance Period”) for your Performance Stock Units will be the three-year period commencing ________, 20__ and ending ________, 20__. Following the conclusion of the Performance Period, the Committee shall certify in writing the number of Performance Stock Units which are payable (your “Final Performance Stock Units”). The Committee will calculate your Final Performance Stock Units by multiplying your Performance Stock Units (at target) by the “Performance Factor.” The Performance Factor means a percentage (from zero to 150%) which is based on the Corporation’s Total Shareholder Return during the Performance Period compared to the companies in the S&P 400 MidCap Index, determined according to Table 1 of this Agreement.
(c)All determinations made by the Committee shall be binding and conclusive on all parties.
3.Treatment Upon Termination. If your employment with the Corporation terminates prior to the end of the Performance Period, your Final Performance Stock Units will be calculated as follows:
(a)Death, Disability. In the event your employment terminates during the Performance Period as a result of your death or Disability, your Final Performance Stock Units will be based upon a prorated number of Performance Stock Units (at target). Your Final Performance Stock Units will be determined by multiplying your Performance Stock Units (at


target) by a fraction, the numerator of which is the number of days elapsed between the beginning of the Performance Period and the date of your death or Disability, and the denominator of which is the number of days in the Performance Period.
(b)Termination for Cause. In the event your employment is terminated during the Performance Period for Cause, your Performance Stock Units will be forfeited immediately.
(c)Other Termination (Without Cause, Retirement or Resignation). In the event your employment terminates during the Performance Period for any other reason, your Performance Stock Units will be forfeited immediately unless otherwise determined by the Committee.
4.Payment of Awards.
Except for payments pursuant to Section 5 ("Change in Control"), your Final Performance Stock Units shall be paid in the form of Common Stock and all payments will be made to you within two and a half months after the end of the Performance Period (or earlier termination of employment pursuant to Section 3).
5.Change in Control. In the event of a Change in Control:
(a)The Performance Factor shall be calculated as if the date of the Change in Control is the last day of the Performance Period. Your Final Performance Share Units will be equal to the number of Performance Stock Units (at target) times the calculated Performance Factor.
(b)Within 15 days following the Change in Control, your Final Performance Stock Units will be paid in the form of Common Stock or common stock of any successor corporation; provided that the Corporation may elect to pay an amount of cash equal to the value of the Common Stock that would otherwise be issued. The value shall be equal to the number of shares of Common Stock that would be issued times the Fair Market Value of the Common Stock at the time of the Change in Control.
6.Rights Prior to Payment.
Prior to any payment of the Award, you will not have any right to vote the Performance Stock Units or to receive credit for cash dividends. You will not be deemed a stockholder of the Corporation with respect to any of the Performance Stock Units. The Performance Stock Units may not be sold, assigned, transferred, pledged, encumbered or otherwise disposed of prior to payment.
7.Tax Withholding.
The Corporation shall have the power and right to deduct or withhold, or require you to remit to the Corporation, an amount sufficient to satisfy Federal, state and local taxes required by law to be withheld with respect to issuance of shares under this Agreement. You may make a written election to satisfy this withholding requirement, in whole or in part, by having the Corporation withhold shares having a Fair Market Value on the date the tax is to be determined equal to the minimum marginal total tax which could be imposed on the transaction.
8.Transfer Restrictions After Issuance.
2

Under applicable securities laws, you may not be able to sell any shares for a period of time after issuance, and you must comply with the Corporation’s Insider Trading Restrictions and Policies. The Corporation’s counsel should be consulted on your ability to sell your shares under the 1934 Act.
9.No Employment Agreement Intended.
Neither the establishment of, nor the awarding of Awards under this Plan shall be construed to create a contract of employment between you and the Corporation or its subsidiaries; nor does it give you the right to continue in the employment of the Corporation or its subsidiaries or limit in any way the right of the Corporation or its subsidiaries to discharge you at any time and without notice, with or without cause, or to any benefits not specifically provided by this Plan, or in any manner modify the Corporation’s right to establish, modify, amend or terminate any profit sharing, retirement or other benefit plans.
10.Section 409A Compliance.
This Award is intended to comply with the requirements of Section 409A, and shall be interpreted and administered in accordance with that intent. If any provision of the Plan or this Agreement would otherwise conflict with or frustrate this intent, the Committee may adopt such amendments to the Plan and the Agreement as the Committee deems necessary.
11.Wisconsin Contract.
This Agreement reflects an Award made in Wisconsin and shall be construed under the laws of that state without regard to the conflict of laws provision of any jurisdiction.

3

To accept this grant, logon to your E*TRADE account (www.etrade.com). By accepting this grant online you acknowledge and accept this grant and the terms and conditions. You also acknowledge receipt of this Performance Stock Unit Agreement, a copy of the 2016 Omnibus Incentive Plan, and a copy of the Insider Trading Restrictions and Policies. If this grant is not accepted online within thirty (30) days from the grant date of this Agreement, this Award will be deemed refused and may be withdrawn.
PLEXUS CORP.

By: /s/___________________________
    
    
4

Table 1
Determination of Performance Factor

The Performance Factor shall be determined according to the following table:
 
Relative TSR Payout
Percentile Rank* Performance Factor
Below 25 0%
25 50%
30 60%
40 80%
50 100%
60 120%
70 140%
75 and above 150%

*TSR shall be based on the percentage increase/decrease from the Initial Price to the Final Price, and shall reflect the reinvestment of dividends paid (if any) to Common Shareholders during the measurement period of the Initial Price and Final Price. Payouts for performance between the percentages listed above will be interpolated.

For purposes of the foregoing calculation:

1.    “Total Shareholder Return” means the quotient (expressed as a percentage) obtained by dividing (i)(A) the Final Price, plus (B) the aggregate amount of dividends paid in respect of a share of Common Stock during the measurement periods (assuming reinvestment of the dividends), minus (C) the Initial Price, by (ii) the Initial Price. The calculation of Total Shareholder Return shall be adjusted to reflect stock splits, recapitalizations and similar events.

2.    “Initial Price” means the average closing price of Common Stock over the thirty calendar day measurement period ending on the trading day immediately preceding the first day of the Performance Period.

3.    “Final Price” means the average closing price of Common Stock over the thirty calendar day measurement period ending on the last day of the Performance Period.

4.    "Performance Period" means three years from the date of PSU grant; provided that in the event of the Grantee's termination of employment during the Performance Period due to the Grantee's death or disability, the final TSR-PSUs will be based upon a prorated number of Performance Stock Units (at target) and, in the event of a Change in Control, Total Shareholder Return shall be calculated through the date of the Change in Control.



5.    The Total Shareholder Return of Plexus shall be measured against the constituent companies of the S&P 400 MidCap Index (S&P 400). The constituents of the S&P 400 shall be determined as of the date of grant, excluding any companies which were not publicly traded on a major US stock exchange (e.g., NYSE, NASDAQ, or AMEX) during the entirety of the period of time defining the Initial Price (“S&P 400 Peers”).

6.    Treatment of S&P 400 Peers for certain corporate events occurring during the Performance Period.
a.If an S&P 400 Peer is acquired by another S&P 400 Peer, the TSR of the successor entity will be used for TSR calculation purposes.
b.If an S&P 400 Peer is acquired by a company not among the S&P 400 Peers or otherwise ceases to be publicly traded other than for reason of bankruptcy, such company will be removed from the S&P 400 Peers.
c.If an S&P 400 peer becomes bankrupt during the Performance Period, then its TSR will be treated as -100% TSR.
d.If S&P 400 Peers merge and none of the affected companies is the successor entity, the affected companies will be removed from the S&P 400 Peers. The newly formed company will not be added to the S&P 400 Peers.
e.If an S&P 400 Peer remains publicly traded but is not a constituent of the S&P 400 at the end of the Performance Period, (e.g., becomes an S&P 500 or 600 constituent company), such company will continue to be an S&P 400 Peer.
f.If an S&P 400 Peer has multiple issuances of stock listed, the primary issuance (as designated by S&P) shall be included as an S&P 400 Peer.


 EX-31.1 4 plxsf2310-qexhibit311.htm EX-31.1 Document

Exhibit 31.1
CERTIFICATION

I, Todd P. Kelsey, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Plexus Corp.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
 
Date: February 3, 2023
/s/ Todd P. Kelsey
Todd P. Kelsey
Chief Executive Officer


 EX-31.2 5 plxsf2310-qq1exhibit312.htm EX-31.2 Document

Exhibit 31.2
CERTIFICATION

I, Patrick J. Jermain, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Plexus Corp.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 3, 2023
/s/ Patrick J. Jermain
Patrick J. Jermain
Executive Vice President and Chief Financial Officer



 EX-32.1 6 plxsf2310-qq1exhibit321.htm EX-32.1 Document

Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Plexus Corp. (the “Company”) on Form 10-Q for the fiscal quarter ended December 31, 2022, as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), I, Todd P. Kelsey, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ Todd P. Kelsey
Todd P. Kelsey
Chief Executive Officer
February 3, 2023

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Plexus Corp. and will be retained by Plexus Corp. and furnished to the Securities and Exchange Commission or its staff upon request.

 EX-32.2 7 plxsf2310-qq1exhibit322.htm EX-32.2 Document

Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Plexus Corp. (the “Company”) on Form 10-Q for the fiscal quarter ended December 31, 2022, as filed with the Securities and Exchange Commission on or about the date hereof (the “Report”), I, Patrick J. Jermain, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ Patrick J. Jermain
Patrick J. Jermain
Executive Vice President and Chief Financial Officer
February 3, 2023

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Plexus Corp. and will be retained by Plexus Corp. and furnished to the Securities and Exchange Commission or its staff upon request.

 EX-99.1 8 plxsf2310-qq1exhibit991.htm EX-99.1 Document


Exhibit 99.1
Return on Invested Capital ("ROIC") and Economic Return Calculations GAAP to non-GAAP reconciliation (dollars in thousands):
Three Months EndedTwelve Months EndedThree Months Ended
Dec 31,Oct 1,Jan 1,
202220222022
Operating income, as reported$57,341 $178,185 $30,473 
Restructuring and impairment charges+— +2,021 +2,021 
Adjusted operating income57,341 180,206 32,494 
x4 x4 
Adjusted annualized operating income$229,364 $180,206 $129,976 
Adjusted effective tax ratex16 %x13 %x13 %
Tax impact$36,698 $23,427 $16,897 
Adjusted operating income (tax-effected)$192,666 $156,779 $113,079 
Average invested capital$1,392,002 $1,207,357 $1,135,312 
ROIC13.8 %13.0 %10.0 %
WACC9.0 %9.3 %9.3 %
Economic Return4.8 %3.7 %0.7 %
December 31,October 1,July 2,April 2,January 1,October 2,
202220222022202220222021
Equity$1,150,259 $1,095,731 $1,058,190 $1,040,591 $1,044,095 $1,028,232 
Plus:
Debt and finance lease obligations - current329,076 273,971 250,012 222,393 151,417 66,313 
Operating lease obligations - current (1)8,878 7,948 8,640 9,266 9,507 9,877 
Debt and finance lease obligations - long-term
187,272 187,776 184,707 186,069 187,075 187,033 
Operating lease obligations - long-term32,149 33,628 32,270 34,347 36,343 37,970 
Less:
Cash and cash equivalents(247,880)(274,805)(276,608)(307,964)(217,067)$(270,172)
$1,459,754 $1,324,249 $1,257,211 $1,184,702 $1,211,370 $1,059,253 

(1)Included in other accrued liabilities on the Consolidated Balance Sheets.

 EX-101.SCH 9 plxs-20221231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Document And Entity Information link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Consolidated Statements of Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000007 - Disclosure - Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Debt, Finance Lease and Other Financing Obligations link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Derivatives and Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Share-Based Compensation link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Litigation link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Reportable Segments link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Guarantees link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Trade Accounts Receivable Sale Programs link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Revenue from Contracts with Customers link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Restructuring and Impairment Charges link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Basis of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Debt, Finance Lease and Other Financing Obligations (Tables) link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Derivatives and Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 0000026 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 0000027 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 0000028 - Disclosure - Reportable Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 0000029 - Disclosure - Guarantees (Tables) link:presentationLink link:calculationLink link:definitionLink 0000030 - Disclosure - Revenue from Contracts with Customers (Tables) link:presentationLink link:calculationLink link:definitionLink 0000031 - Disclosure - Restructuring and Impairment Charges (Tables) link:presentationLink link:calculationLink link:definitionLink 0000032 - Disclosure - Inventories - Schedule of Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 0000033 - Disclosure - Inventories - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000034 - Disclosure - Debt, Finance Lease and Other Financing Obligations - Schedule of Debt, Finance Lease and Other Financing Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 0000035 - Disclosure - Debt, Finance Lease and Other Financing Obligations - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000036 - Disclosure - Derivatives and Fair Value Measurements - Schedule of Fair Values of Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 0000037 - Disclosure - Derivatives and Fair Value Measurements - Schedule of Derivative Impact on Accumulated Other Comprehensive (Loss) Income (Details) link:presentationLink link:calculationLink link:definitionLink 0000038 - Disclosure - Derivatives and Fair Value Measurements - Schedule of Derivative Impact on (Loss) Gain Recognized in Income (Details) link:presentationLink link:calculationLink link:definitionLink 0000039 - Disclosure - Derivatives and Fair Value Measurements - Schedule of Amount of Gain (Loss) on Derivatives Recognized in Income (Details) link:presentationLink link:calculationLink link:definitionLink 0000040 - Disclosure - Derivatives and Fair Value Measurements - Schedule of Fair Value Measurements Using Input Levels (Details) link:presentationLink link:calculationLink link:definitionLink 0000041 - Disclosure - Derivatives and Fair Value Measurements - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000042 - Disclosure - Income Taxes - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000043 - Disclosure - Earnings Per Share - Reconciliation of Amounts Utilized in Computation of Basic and Diluted Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 0000044 - Disclosure - Earnings Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000045 - Disclosure - Leases Schedule of Lease Expense and Other Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000046 - Disclosure - Leases Schedule of Lease Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 0000047 - Disclosure - Benefit Plans - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000048 - Disclosure - Reportable Segments - Schedule of Reportable Segments Information (Details) link:presentationLink link:calculationLink link:definitionLink 0000049 - Disclosure - Reportable Segments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000050 - Disclosure - Guarantees - Schedule of Activity Related to Limited Warranty Liability (Details) link:presentationLink link:calculationLink link:definitionLink 0000051 - Disclosure - Guarantees - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000052 - Disclosure - Shareholders' Equity - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000053 - Disclosure - Trade Accounts Receivable Sale Programs - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000054 - Disclosure - Revenue from Contracts with Customers - Schedule of Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 0000055 - Disclosure - Revenue from Contracts with Customers - Schedule of Contract Assets (Details) link:presentationLink link:calculationLink link:definitionLink 0000056 - Disclosure - Revenue from Contracts with Customers - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 0000057 - Disclosure - Restructuring and Impairment Charges Schedule of Restructuring Accrual Activity (Details) link:presentationLink link:calculationLink link:definitionLink 0000058 - Disclosure - Restructuring and Impairment Charges (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 plxs-20221231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 plxs-20221231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 plxs-20221231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Adjustments to reconcile net income to net cash flows from operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Limited warranty liability, beginning balance Limited warranty liability, ending balance Standard Product Warranty Accrual Income tax expense Income tax expense Income Tax Expense (Benefit) Deferred income taxes payable Deferred Income Tax Liabilities, Net Deferred income taxes Deferred Income Tax Assets, Net Long-term debt, gross Long-term debt, gross Long-Term Debt, Gross Schedule of Activity Related to Limited Warranty Liability Schedule of Product Warranty Liability [Table Text Block] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share $4.05% Senior Notes, due June 15, 2025 4.05% Senior Notes [Member] 4.05% Senior Notes [Member] Income Statement [Abstract] Income Statement [Abstract] Hedging Relationship [Axis] Hedging Relationship [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Additional paid-in capital Additional Paid-in Capital [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Document Fiscal Period Focus Document Fiscal Period Focus Finance lease right-of-use assets Finance Lease, Right-of-Use Asset, after Accumulated Amortization Amounts utilized Restructuring Reserve, Accrual Adjustment Cost of sales Cost of Goods and Services Sold Derivative [Line Items] Derivative [Line Items] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Diluted (in shares) Diluted weighted average shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Diluted Derivative Liability Derivative Liability Schedule of Inventories Schedule of Inventory, Current [Table Text Block] Other accrued liabilities Other Accrued Liabilities, Current [Member] Other Accrued Liabilities, Current [Member] Fair value of derivative liability Derivative Liability, Subject to Master Netting Arrangement, before Offset Debt Instrument [Axis] Debt Instrument [Axis] Corporate and eliminations Corporate And Reconciling Items [Member] Corporate And Reconciling Items [Member] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Restructuring Reserve Restructuring Reserve Current portion of long-term debt and finance lease obligations Current portion of long-term debt and finance lease obligations Long-Term Debt and Finance Lease Obligations Current Long-Term Debt and Finance Lease Obligations Current Fair Value of Financial Instruments Fair Value of Financial Instruments, Policy [Policy Text Block] Common stock, $0.01 par value, 200,000 shares authorized, 54,133 and 54,084 shares issued, respectively, and 27,612 and 27,679 shares outstanding, respectively Common Stock, Value, Issued Additional paid-in capital Additional Paid in Capital Restructuring Charges Restructuring Charges [Member] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Revenue recognized Contract with Customer, Performance Obligation Satisfied in Previous Period Senior Notes Senior Notes [Member] Other, net Payments for (Proceeds from) Other Investing Activities Range [Domain] Statistical Measurement [Domain] Underlying Asset Class [Axis] Underlying Asset Class [Axis] Schedule of Derivative Impact on (Loss) Gain Recognized in Income Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Operating Segments Operating Segments [Member] Estimated unrealized gains (losses), net of tax, expected to be reclassified in the next 12 months Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months Interest Rate, Senior Notes Debt Instrument, Interest Rate, Stated Percentage Guarantees Product Warranty Disclosure [Text Block] Litigation Legal Matters and Contingencies [Text Block] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Beginning of period End of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Other, net Other Noncash Income (Expense) Derivative Asset (Liability), Statement of Financial Position [Extensible Enumeration] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Property, plant and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Current liabilities: Liabilities, Current [Abstract] Foreign Exchange Forward [Member] Foreign Exchange Forward [Member] Proceeds from exercise of stock options Proceeds from Stock Options Exercised Common stock, shares issued (in shares) Common Stock, Shares, Issued Amounts collected or invoiced Contract with Customer, Asset, Reclassified to Receivable Treasury shares purchased Amount repurchased Treasury Stock, Value, Acquired, Cost Method Net income Net income Net income Net Income (Loss) Attributable to Parent Antidilutive Securities Excluded from Computation of Diluted Earnings Per Share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Total obligations Long-term Debt and Finance Lease Obligations, Including Current Maturities Long-term Debt and Finance Lease Obligations, Including Current Maturities Interest on lease liabilities Finance Lease, Interest Expense Transferred over Time Transferred over Time [Member] Income Statement Location [Domain] Income Statement Location [Domain] Share Repurchase Program [Domain] Share Repurchase Program [Domain] Current finance lease liabilities Finance Lease, Liability, Current Derivatives in cash flow hedging relationships Cash Flow Hedging [Member] 2023 Stock Repurchase Program 2023 Stock Repurchase Program [Member] 2023 Stock Repurchase Program Equity Component [Domain] Equity Component [Domain] Amendment Flag Amendment Flag Total lease liabilities Lease Liability Lease Liability Cash flows used in investing activities Net Cash Provided by (Used in) Investing Activities Borrowings under debt agreements Proceeds from Long-Term Lines of Credit Total comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Amortization of right-of-use assets Finance Lease, Right-of-Use Asset, Amortization Schedule of Reportable Segments Information Schedule of Segment Reporting Information, by Segment [Table Text Block] Common stock held in treasury, at cost, 26,521 and 26,405 shares, respectively Treasury Stock, Common, Value Entity Current Reporting Status Entity Current Reporting Status Accrued income taxes payable Increase (Decrease) in Accrued Taxes Payable Other assets Other Assets, Noncurrent MUFG RPA MUFG [Member] MUFG [Member] Hedging Designation [Domain] Hedging Designation [Domain] Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Finance lease and other financing obligations Finance Lease Obligations Finance Lease Obligations Derivative Instrument [Axis] Derivative Instrument [Axis] Depreciation and amortization Depreciation, Depletion and Amortization Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Employee Termination and Severance Costs Employee Severance [Member] Total non-current liabilities Liabilities, Noncurrent Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Entity Address, State or Province Entity Address, State or Province Level 1 Fair Value, Inputs, Level 1 [Member] Accruals for warranties issued during the period Standard Product Warranty Accrual, Increase for Warranties Issued Counterparty Name [Axis] Counterparty Name [Axis] Derivative [Table] Derivative [Table] Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] $4.22% Senior Notes, due June 15, 2028 4.22% Senior Notes [Member] 4.22% Senior Notes [Member] Cash flows used in operating activities Net Cash Provided by (Used in) Operating Activities Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Exercise of stock options and vesting of other share-based awards Stock Issued During Period, Shares, Stock Options Exercised and Vesting of Other Stock Awards Stock Issued During Period, Shares, Stock Options Exercised and Vesting of Other Stock Awards Current operating lease liabilities Operating Lease, Liability, Current Derivative Asset Derivative Asset Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Entities [Table] Entities [Table] Receivables [Abstract] Receivables [Abstract] Accounts receivable, allowances Accounts Receivable, Allowance for Credit Loss, Current Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Miscellaneous, net Miscellaneous, net Other Nonoperating Income (Expense) Legal Entity [Axis] Legal Entity [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Trade Accounts Receivable Sale Programs Loans, Notes, Trade and Other Receivables Disclosure [Text Block] Basis of Presentation Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Restructuring and Impairment Charges Restructuring and Related Activities Disclosure [Text Block] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Product Warranty Liability [Line Items] Product Warranty Liability [Line Items] Total liabilities Liabilities EMEA EMEA Segment [Member] EMEA Segment [Member] Maximum Maximum [Member] Cash flows from investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Industry Sector [Domain] Industry Sector [Domain] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Schedule of Amount of Gain (Loss) on Derivatives Recognized in Income Derivatives Not Designated as Hedging Instruments [Table Text Block] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Assets and Liabilities, Leases [Abstract] Assets and Liabilities, Leases [Abstract] Borrowings under Credit Facility Revolving Credit Facility Revolving Credit Facility [Member] Total current assets Assets, Current Derivatives designated as hedging instruments Designated as Hedging Instrument [Member] Inventory Inventories [Member] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Document Type Document Type Customer deposits Increase (Decrease) Customer Deposits Increase (Decrease) Customer Deposits Entity Small Business Entity Small Business Compensation Related Costs [Abstract] Compensation Related Costs [Abstract] Fair Value, Measurement Frequency [Domain] Measurement Frequency [Domain] Shareholders' Equity Stockholders' Equity Note Disclosure [Text Block] Restructuring Type [Axis] Restructuring Type [Axis] Settlements (in cash or in kind) during the period Standard Product Warranty Accrual, Decrease for Payments Segments [Axis] Segments [Axis] Debt, Finance Lease and Other Financing Obligations Debt Disclosure [Text Block] Share-Based Compensation Compensation and Employee Benefit Plans [Text Block] Entity Shell Company Entity Shell Company Notional amount of forward exchange contracts Derivative Asset, Notional Amount Derivative instrument and other fair value adjustments Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges and Other Fair Value Adjustments , Net of Tax, Portion Attributable to Parent Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges and Other Fair Value Adjustments , Net of Tax, Portion Attributable to Parent Guarantees and Product Warranties [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Title of 12(b) Security Title of 12(b) Security Average daily borrowings Line of Credit Facility, Average Outstanding Amount Consolidation Items [Domain] Consolidation Items [Domain] Schedule of Contract Assets Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Document Period End Date Document Period End Date Class of Treasury Stock [Table] Class of Treasury Stock [Table] Debt Instrument [Line Items] Debt Instrument [Line Items] Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Total assets Total assets Assets Amount of Gain Recognized in OCL on Derivatives Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax Reportable Segments Segment Reporting Disclosure [Text Block] Amount Received From Trade Accounts Receivable Sold To Third Party [Line Items] Amount Received From Trade Accounts Receivable Sold To Third Party [Line Items] [Line Items] for Amount Received From Trade Accounts Receivable Sold To Third Party Earnings per share: Earnings Per Share Diluted and Basic [Abstract] Earnings Per Share Diluted and Basic Selling and administrative expenses Selling, General and Administrative Expenses [Member] Earnings per share: Earnings Per Share [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Total lease Assets Lease Assets Lease Assets Schedule of Derivatives Fair Value Measurements Using Input Levels Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] LIABILITIES AND SHAREHOLDERS’ EQUITY Liabilities and Equity [Abstract] Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Trade accounts receivable sold, not yet collected Continuing Involvement with Derecognized Transferred Financial Assets, Amount Outstanding Cash flows provided by financing activities Net Cash Provided by (Used in) Financing Activities Fair value of debt Long-Term Debt, Fair Value Accounting Policies [Abstract] Accounting Policies [Abstract] Weighted average shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Authorized repurchase amount Stock Repurchase Program, Authorized Amount Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Aerospace/Defense Aerospace/Defense [Member] Aerospace/Defense [Member] Inventories, net Total inventories, net Inventory, Net Accrued salaries and wages Employee-related Liabilities, Current Line of Credit Line of Credit [Member] Accounts payable Accounts Payable, Current Comprehensive income: Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Restructuring and impairment charges Restructuring Charges Shareholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Prepaid expenses and other Prepaid Expense and Other Assets, Current Income before income taxes Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Segments [Domain] Segments [Domain] Amount of Gain (Loss) on Derivatives Recognized in Income Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments Other current and non-current assets Increase (Decrease) in Other Operating Assets Cash proceeds Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount Schedule of Lease Assets and Liabilities Assets and Liabilities, Lessee [Table Text Block] Assets and Liabilities, Lessee [Table Text Block] Earnings Per Share Earnings Per Share [Text Block] 2022 Stock Repurchase Program 2022 Stock Repurchase Program [Member] 2022 Stock Repurchase Program Long-term finance lease liabilities Finance Lease, Liability, Noncurrent Hedging Relationship [Domain] Hedging Relationship [Domain] Cash and cash equivalents and restricted cash: Cash Equivalents, at Carrying Value [Abstract] Percentage of Revenue Percentage of Revenue Percentage of Revenue Hedging Designation [Axis] Hedging Designation [Axis] Entity Filer Category Entity Filer Category Schedule of Fair Values of Derivative Instruments Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Basic (in shares) Basic weighted average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Schedule of Derivative Impact on Accumulated Other Comprehensive (Loss) Income Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] Derivative Contract [Domain] Derivative Contract [Domain] Healthcare/Life Sciences Healthcare/Life Sciences [Member] Healthcare/Life Sciences [Member] Share-based compensation expense Share-Based Payment Arrangement, Expense Gross profit Gross Profit Commitments and contingencies Commitments and Contingencies Net sales Revenue from Contract with Customer, Including Assessed Tax Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Other Tax Expense (Benefit) Other Tax Expense (Benefit) Preferred stock, $0.01 par value, 5,000 shares authorized, none issued or outstanding Preferred Stock, Value, Issued Exercise of stock options and vesting of other share-based awards Stock Issued During Period, Value, Stock Options Exercised and Vesting of Other Stock Awards Stock Issued During Period, Value, Stock Options Exercised and Vesting of Other Stock Awards Revenue from Contract with Customer Revenue from Contract with Customer, Excluding Assessed Tax Entity Address, City or Town Entity Address, City or Town Leases [Abstract] Leases [Abstract] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Leases Lessee, Leases [Policy Text Block] Unrecognized Tax Benefits, Period Increase (Decrease) Unrecognized Tax Benefits, Period Increase (Decrease) Level 3 Fair Value, Inputs, Level 3 [Member] Total non-current assets Assets, Noncurrent Elimination of inter-segment sales Intersegment Eliminations [Member] Industry Sector [Axis] Industry Sector [Axis] Restructuring and Related Activities [Abstract] Minimum Minimum [Member] Work-in-process Inventory, Work in Process, Net of Reserves Revenue from Contracts with Customers Revenue from Contract with Customer [Text Block] Segment Reporting [Abstract] Segment Reporting [Abstract] Restricted cash Restricted Cash and Cash Equivalents, Current Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Contract assets Increase (Decrease) in Contract with Customer, Asset Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Raw materials Inventory, Raw Materials, Net of Reserves Unamortized deferred financing fees Debt Issuance Costs, Net Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Payments related to tax withholding for share-based compensation Payment, Tax Withholding, Share-Based Payment Arrangement Total liabilities and shareholders’ equity Liabilities and Equity Trading Symbol Trading Symbol Entity File Number Entity File Number Credit facility, term Debt Instrument, Term Average repurchase price (in dollars per share) Treasury Stock Acquired, Average Cost Per Share Debt and Capital Lease Obligations [Abstract] Debt and Lease Obligation [Abstract] Treasury stock, shares (in shares) Treasury Stock, Common, Shares Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Timing of Transfer of Good or Service [Domain] Timing of Transfer of Good or Service [Domain] Remaining authorized repurchase amount Stock Repurchase Program, Remaining Authorized Repurchase Amount Dilutive effect of share-based awards and options outstanding (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Derivatives not designated as hedging instruments Not Designated as Hedging Instrument [Member] Level 2 Fair Value, Inputs, Level 2 [Member] Entity Information [Line Items] Entity Information [Line Items] Effective Income Tax Rate Reconciliation, Percent Effective Income Tax Rate Reconciliation, Percent Current Fiscal Year End Date Current Fiscal Year End Date Diluted (in dollars per share) Earnings Per Share, Diluted Inventory [Line Items] Inventory [Line Items] Maximum facility amount Transfer of Financial Assets Accounted for as Sales, Maximum Facility Amount Transfer of Financial Assets Accounted for as Sales, Maximum Facility Amount Accounts payable Increase (Decrease) in Accounts Payable Share-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Consolidation Items [Axis] Consolidation Items [Axis] APAC Asia Pacific Segment [Member] Asia Pacific Segment [Member] Total current liabilities Liabilities, Current Inventory, Current [Table] Inventory, Current [Table] Income Taxes Income Tax Disclosure [Text Block] Other lease expense Other Lease Expense Other Lease Expense Long-term accrued income taxes payable Accrued Income Taxes, Noncurrent Finished goods Inventory, Finished Goods, Net of Reserves Credit Facility [Domain] Credit Facility [Domain] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Basic (in dollars per share) Earnings Per Share, Basic Share Repurchase Program [Axis] Share Repurchase Program [Axis] Derivatives and Fair Value Measurements Derivatives and Fair Value [Text Block] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] Highest daily borrowings Line of Credit Facility, Maximum Amount Outstanding During Period Other income (expense): Nonoperating Income (Expense) [Abstract] Equity, Class of Treasury Stock [Line Items] Equity, Class of Treasury Stock [Line Items] Corporate and other costs Corporate, Non-Segment [Member] Fair value of derivative asset Derivative Asset, Subject to Master Netting Arrangement, before Offset Entity Address, Address Line One Entity Address, Address Line One Counterparty Name [Domain] Counterparty Name [Domain] Treasury stock Treasury Stock [Member] Total shareholders’ equity Beginning of period End of period Stockholders' Equity Attributable to Parent Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Payments on debt and finance lease obligations Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security Interest expense Interest expense Interest Expense Entity Interactive Data Current Entity Interactive Data Current Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Amount of Loss Reclassified from Accumulated OCL into Income  Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net Credit Facility [Axis] Credit Facility [Axis] Trade accounts receivable sold Transfer of Financial Assets Accounted for as Sales, Amount Derecognized Prepaid expenses and other Prepaid Expenses and Other Current Assets [Member] Changes in operating assets and liabilities, excluding impacts of currency: Increase (Decrease) in Operating Capital [Abstract] Minimum prior notice required to cancel automatic extension Transfer of Financial Assets Accounted for as Sales, Facility Agreement, Automatic Extension Cancellation, Minimum Notice Period Required Transfer of Financial Assets Accounted for as Sales, Facility Agreement, Automatic Extension Cancellation, Minimum Notice Period Required HSBC RPA HSBC [Member] HSBC [Member] Inventories Inventory Disclosure [Text Block] Schedule of Debt, Finance Lease and Other Financing Obligations Schedule of Long-Term Debt Instruments [Table Text Block] Retained earnings Retained Earnings [Member] Customer deposits Customer Deposit Current Customer Deposit Current Miscellaneous, net Other Nonoperating Income (Expense) [Member] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Entity Tax Identification Number Entity Tax Identification Number Derivatives, Fair Value [Line Items] Derivatives, Fair Value [Line Items] Common stock Common Stock [Member] Other comprehensive income (loss) Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Number of reportable segments Number of Reportable Segments Schedule of Lease Expense and Other Information Lease, Cost [Table Text Block] Repurchases of common stock Payments for Repurchase of Common Stock Statement [Table] Statement [Table] Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Underlying Asset Class [Domain] Underlying Asset Class [Domain] Contract assets Contract with Customer, Asset, after Allowance for Credit Loss, Current Document Quarterly Report Document Quarterly Report Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration] Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration] Document And Entity Information [Abstract] Document And Entity Information [Abstract] Document and Entity Information [Abstract] Current assets: Assets, Current [Abstract] Long-term operating lease liabilities Operating Lease, Liability, Noncurrent Amount Received From Trade Accounts Receivable Sold To Third Party [Table] Amount Received From Trade Accounts Receivable Sold To Third Party [Table] Amount Received From Trade Accounts Receivable Sold To Third Party Range [Axis] Statistical Measurement [Axis] Nature of Expense [Axis] Nature of Expense [Axis] Net decrease in cash and cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Treasury shares purchased (in shares) Amount repurchased (in shares) Treasury Stock, Shares, Acquired Schedule of Restructuring Accrual Activity Restructuring and Related Costs [Table Text Block] Retained earnings Retained Earnings (Accumulated Deficit) Industrial Industrial [Member] Industrial AMER Americas Segment [Member] Americas Segment [Member] Exercise of stock options and vesting of other share-based awards, including tax withholding Stock Issued During Period, Value, Stock Options Exercised and Vesting of Other Stock Awards, Including Tax Benefits Stock Issued During Period, Value, Stock Options Exercised and Vesting of Other Stock Awards, Including Tax Benefits Fixed Asset and Operating ROU Asset Impairment Impaired Long-Lived Assets Held and Used, Asset Name [Domain] Accounts receivable, net of allowances of $2,531 and $1,961, respectively Accounts Receivable, after Allowance for Credit Loss, Current Entity Central Index Key Entity Central Index Key Equity Components [Axis] Equity Components [Axis] Interest income Interest income Investment Income, Interest Measurement Frequency [Axis] Measurement Frequency [Axis] Recurring Fair Value, Recurring [Member] Timing of Transfer of Good or Service [Axis] Timing of Transfer of Good or Service [Axis] Other accrued liabilities Other Accrued Liabilities, Current Document Fiscal Year Focus Document Fiscal Year Focus Entity [Domain] Entity [Domain] Cash flows from operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] City Area Code City Area Code Statement [Line Items] Statement [Line Items] ASSETS Assets [Abstract] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Selling and administrative expenses Selling, General and Administrative Expense Deferred Revenue Deferred Revenue Long-term debt and finance lease obligations, net of current portion Long-term debt, finance lease and other financing obligations, net of current portion Long-Term Debt And Finance Lease Obligations Long-Term Debt And Finance Lease Obligations Product warranty specification period Standard Product Warranty, Term Standard Product Warranty, Term Cash flows from financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Product Warranty Liability [Table] Product Warranty Liability [Table] Accumulated other comprehensive loss AOCI Attributable to Parent [Member] Share-based compensation expense and related charges Share-Based Payment Arrangement, Noncash Expense Other liabilities Other Liabilities, Noncurrent Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating lease expense Operating Lease, Expense Type of Restructuring [Domain] Type of Restructuring [Domain] Document Transition Report Document Transition Report Other current and non-current liabilities Increase (Decrease) in Other Operating Liabilities Local Phone Number Local Phone Number Payments for property, plant and equipment Payments to Acquire Property, Plant, and Equipment Operating income Operating income (loss): Operating Income (Loss) Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Inventories Increase (Decrease) in Inventories Total lease expense Lease, Expense Lease, Expense Recently Adopted Accounting Pronouncements & Recently Issued Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Reconciliation of Amounts Utilized in Computation of Basic and Diluted Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Cost of sales Cost of Sales [Member] Interim Period, Costs Not Allocable [Domain] Interim Period, Costs Not Allocable [Domain] Common stock, shares outstanding (in shares) Beginning of period (in shares) End of period (in shares) Common Stock, Shares, Outstanding Movement in Standard Product Warranty Accrual [Roll Forward] Movement in Standard Product Warranty Accrual [Roll Forward] EX-101.PRE 13 plxs-20221231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 14 plxs-20221231_g1.gif GRAPHIC begin 644 plxs-20221231_g1.gif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Ҵ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end XML 15 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document And Entity Information - shares
 3 Months Ended
Dec. 31, 2022
Jan. 31, 2023
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Dec. 31, 2022  
Document Transition Report false  
Entity File Number 001-14423  
Entity Registrant Name PLEXUS CORP.  
Entity Incorporation, State or Country Code WI  
Entity Tax Identification Number 39-1344447  
Entity Address, Address Line One One Plexus Way  
Entity Address, City or Town Neenah  
Entity Address, State or Province WI  
Entity Address, Postal Zip Code 54957  
City Area Code 920  
Local Phone Number 969-6000  
Title of 12(b) Security Common Stock, $0.01 par value  
Trading Symbol PLXS  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   27,702,483
Entity Central Index Key 0000785786  
Current Fiscal Year End Date --09-30  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
Amendment Flag false  

XML 16 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Comprehensive Income - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Income Statement [Abstract]    
Net sales $ 1,093,925 $ 817,456
Cost of sales 992,726 747,460
Gross profit 101,199 69,996
Selling and administrative expenses 43,858 37,502
Restructuring and impairment charges 0 2,021
Operating income 57,341 30,473
Other income (expense):    
Interest expense (6,894) (3,046)
Interest income 934 271
Miscellaneous, net (1,944) (923)
Income before income taxes 49,437 26,775
Income tax expense 7,247 3,352
Net income $ 42,190 $ 23,423
Earnings per share:    
Basic (in dollars per share) $ 1.53 $ 0.84
Diluted (in dollars per share) $ 1.49 $ 0.82
Weighted average shares outstanding:    
Basic (in shares) 27,639 28,018
Diluted (in shares) 28,305 28,709
Other comprehensive income (loss):    
Derivative instrument and other fair value adjustments $ 8,439 $ 1,272
Foreign currency translation adjustments 13,777 (1,578)
Other comprehensive income (loss) 22,216 (306)
Total comprehensive income $ 64,406 $ 23,117
XML 17 R3.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Oct. 01, 2022
Current assets:    
Cash and cash equivalents $ 247,880 $ 274,805
Restricted cash 31 665
Accounts receivable, net of allowances of $2,531 and $1,961, respectively 733,962 737,696
Contract assets 119,016 138,540
Inventories, net 1,645,011 1,602,783
Prepaid expenses and other 68,401 61,633
Total current assets 2,814,301 2,816,122
Property, plant and equipment, net 448,325 444,705
Operating lease right-of-use assets 64,069 65,134
Deferred income taxes 39,337 39,075
Other assets 29,260 28,189
Total non-current assets 580,991 577,103
Total assets 3,395,292 3,393,225
Current liabilities:    
Current portion of long-term debt and finance lease obligations 329,076 273,971
Accounts payable 753,755 805,583
Customer deposits 511,037 480,486
Accrued salaries and wages 64,126 88,876
Other accrued liabilities 296,466 357,273
Total current liabilities 1,954,460 2,006,189
Long-term debt and finance lease obligations, net of current portion 187,272 187,776
Long-term accrued income taxes payable 42,019 42,019
Long-term operating lease liabilities 32,149 33,628
Deferred income taxes payable 5,616 6,327
Other liabilities 23,517 21,555
Total non-current liabilities 290,573 291,305
Total liabilities 2,245,033 2,297,494
Commitments and contingencies
Shareholders’ equity:    
Preferred stock, $0.01 par value, 5,000 shares authorized, none issued or outstanding 0 0
Common stock, $0.01 par value, 200,000 shares authorized, 54,133 and 54,084 shares issued, respectively, and 27,612 and 27,679 shares outstanding, respectively 541 541
Additional paid-in capital 654,059 652,467
Common stock held in treasury, at cost, 26,521 and 26,405 shares, respectively (1,104,953) (1,093,483)
Retained earnings 1,614,424 1,572,234
Accumulated other comprehensive loss (13,812) (36,028)
Total shareholders’ equity 1,150,259 1,095,731
Total liabilities and shareholders’ equity $ 3,395,292 $ 3,393,225
XML 18 R4.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2022
Oct. 01, 2022
Statement of Financial Position [Abstract]    
Accounts receivable, allowances $ 2,531 $ 1,961
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 5,000,000 5,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 200,000,000 200,000,000
Common stock, shares issued (in shares) 54,133,000 54,084,000
Common stock, shares outstanding (in shares) 27,612,000 27,679,000
Treasury stock, shares (in shares) 26,521,000 26,405,000
XML 19 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Treasury stock
Retained earnings
Accumulated other comprehensive loss
Beginning of period (in shares) at Oct. 02, 2021   28,047,000        
Exercise of stock options and vesting of other share-based awards   60,000        
Treasury shares purchased (in shares)   (110,000)        
End of period (in shares) at Jan. 01, 2022   27,997,000        
Beginning of period at Oct. 02, 2021 $ 1,028,232 $ 538 $ 639,778 $ (1,043,091) $ 1,433,991 $ (2,984)
Exercise of stock options and vesting of other share-based awards   1        
Share-based compensation expense     6,270      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (3,394)      
Treasury shares purchased       (10,131)    
Net income 23,423       23,423  
Other comprehensive income (loss) (306)         (306)
End of period at Jan. 01, 2022 $ 1,044,095 $ 539 642,654 (1,053,222) 1,457,414 (3,290)
Beginning of period (in shares) at Oct. 01, 2022 27,679,000 27,679,000        
Exercise of stock options and vesting of other share-based awards   49,000        
Treasury shares purchased (in shares)   (116,000)        
End of period (in shares) at Dec. 31, 2022 27,612,000 27,612,000        
Beginning of period at Oct. 01, 2022 $ 1,095,731 $ 541 652,467 (1,093,483) 1,572,234 (36,028)
Exercise of stock options and vesting of other share-based awards   0        
Share-based compensation expense     5,683      
Exercise of stock options and vesting of other share-based awards, including tax withholding     (4,091)      
Treasury shares purchased       (11,470)    
Net income 42,190       42,190  
Other comprehensive income (loss) 22,216         22,216
End of period at Dec. 31, 2022 $ 1,150,259 $ 541 $ 654,059 $ (1,104,953) $ 1,614,424 $ (13,812)
XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Cash flows from operating activities    
Net income $ 42,190 $ 23,423
Adjustments to reconcile net income to net cash flows from operating activities:    
Depreciation and amortization 16,290 15,489
Share-based compensation expense and related charges 5,683 6,357
Other, net 502 602
Changes in operating assets and liabilities, excluding impacts of currency:    
Accounts receivable 10,506 (70,159)
Contract assets 19,745 9,904
Inventories (31,409) (214,416)
Other current and non-current assets (7,270) (9,436)
Accrued income taxes payable (2,655) 1,121
Accounts payable (52,702) 76,222
Customer deposits 27,170 60,743
Other current and non-current liabilities (76,844) 11,171
Cash flows used in operating activities (48,794) (88,979)
Cash flows from investing activities    
Payments for property, plant and equipment (23,085) (33,246)
Other, net 1,503 (124)
Cash flows used in investing activities (21,582) (33,370)
Cash flows from financing activities    
Borrowings under debt agreements 197,000 181,134
Payments on debt and finance lease obligations (142,001) (97,565)
Repurchases of common stock (11,470) (10,131)
Proceeds from exercise of stock options 0 307
Payments related to tax withholding for share-based compensation (4,091) (3,702)
Cash flows provided by financing activities 39,438 70,043
Effect of exchange rate changes on cash and cash equivalents 3,379 184
Net decrease in cash and cash equivalents and restricted cash (27,559) (52,122)
Cash and cash equivalents and restricted cash:    
Beginning of period 275,470 270,513
End of period $ 247,911 $ 218,391
XML 21 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Basis of Presentation
 3 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Basis of Presentation Basis of Presentation
Basis of Presentation:

The accompanying Condensed Consolidated Financial Statements included herein have been prepared by Plexus Corp. and its subsidiaries (together “Plexus” or the “Company”) without audit and pursuant to the rules and regulations of the United States (“U.S.”) Securities and Exchange Commission (“SEC”). The accompanying Condensed Consolidated Financial Statements reflect all adjustments, which include normal recurring adjustments necessary for the fair statement of the consolidated financial position of the Company as of December 31, 2022 and October 1, 2022, the results of operations and shareholders' equity for the three months ended December 31, 2022 and January 1, 2022, and the cash flows for the same three month periods.

The Company’s fiscal year ends on the Saturday closest to September 30. The Company uses a “4-4-5” weekly accounting system for the interim periods in each quarter. Each quarter, therefore, ends on a Saturday at the end of the 4-4-5 period. Periodically, an additional week must be added to the fiscal year to re-align with the Saturday closest to September 30. All fiscal quarters presented herein included 13 weeks.
Certain information and footnote disclosures, normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP"), have been condensed or omitted pursuant to the SEC’s rules and regulations dealing with interim financial statements. However, the Company believes that the disclosures made in the Condensed Consolidated Financial Statements included herein are adequate to make the information presented not misleading. It is suggested that these Condensed Consolidated Financial Statements be read in conjunction with the Consolidated Financial Statements and notes thereto included in the Company’s 2022 Annual Report on Form 10-K.
The preparation of financial statements requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and notes thereto. The Company has considered information available as of the date of issuance of these financial statements and is not aware of any specific events or circumstances that would require an update to its estimates or judgments, or a revision of the carrying value of its assets or liabilities. These estimates may change as new events occur and additional information becomes available. Actual results could differ materially from these estimates.
Recently Issued Accounting Pronouncements Not Yet Adopted:
In September 2022, the FASB issued ASU 2022-04, which requires enhanced disclosures about supplier finance programs. The guidance is effective for the Company beginning in the first quarter of fiscal 2024. Early adoption is permitted. The Company is currently in the process of assessing the impacts of the guidance.
The Company does not believe that any other recently issued accounting standards will have a material impact on its Consolidated Financial Statements, or apply to its operations.
XML 22 R8.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories
 3 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Inventories Inventories
Inventories as of December 31, 2022 and October 1, 2022 consisted of the following (in thousands):
December 31, 2022October 1, 2022
Raw materials$1,468,942 $1,433,353 
Work-in-process81,822 81,207 
Finished goods94,247 88,223 
Total inventories, net$1,645,011 $1,602,783 
In certain circumstances, per contractual terms, customer deposits are received by the Company to offset inventory risks. The total amount of customer deposits related to inventory and included within current liabilities on the accompanying Condensed
Consolidated Balance Sheets as of December 31, 2022 and October 1, 2022 was $483.1 million and $463.2 million, respectively.
XML 23 R9.htm IDEA: XBRL DOCUMENT v3.22.4
Debt, Finance Lease and Other Financing Obligations
 3 Months Ended
Dec. 31, 2022
Debt and Lease Obligation [Abstract]  
Debt, Finance Lease and Other Financing Obligations Debt, Finance Lease and Other Financing Obligations
Debt, finance lease and other financing obligations as of December 31, 2022 and October 1, 2022 consisted of the following (in thousands):
December 31, 2022October 1, 2022
4.05% Senior Notes, due June 15, 2025
$100,000 $100,000 
4.22% Senior Notes, due June 15, 2028
50,000 50,000 
Borrowings under Credit Facility320,000 263,000 
Finance lease and other financing obligations47,786 50,269 
Unamortized deferred financing fees(1,438)(1,522)
Total obligations516,348 461,747 
Less: current portion(329,076)(273,971)
Long-term debt, finance lease and other financing obligations, net of current portion$187,272 $187,776 
As of December 31, 2022, the Company was in compliance with covenants for all debt agreements.
During the three months ended December 31, 2022, the highest daily borrowing under the Company's 5-year senior unsecured revolving credit facility (referred to as the "Credit Facility") was $394.0 million; the average daily borrowings were $320.9 million.
The fair value of the Company’s debt, excluding finance lease and other financing obligations, was $461.5 million and $401.6 million as of December 31, 2022 and October 1, 2022, respectively. The carrying value of the Company's debt, excluding finance lease and other financing obligations, was $470.0 million and $413.0 million as of December 31, 2022 and October 1, 2022, respectively. If measured at fair value in the financial statements, the Company's debt would be classified as Level 2 in the fair value hierarchy. Refer to Note 4, "Derivatives and Fair Value Measurements," for further information regarding the Company's fair value calculations and classifications.
XML 24 R10.htm IDEA: XBRL DOCUMENT v3.22.4
Derivatives and Fair Value Measurements
 3 Months Ended
Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivatives and Fair Value Measurements Derivatives and Fair Value Measurements
All derivatives are recognized in the accompanying Condensed Consolidated Balance Sheets at their estimated fair value. The Company uses derivatives to manage the variability of foreign currency obligations. The Company has cash flow hedges related to forecasted foreign currency obligations, in addition to non-designated hedges to manage foreign currency exposures associated with certain foreign currency denominated assets and liabilities. The Company does not enter into derivatives for speculative purposes.
The Company designates some foreign currency exchange contracts as cash flow hedges of forecasted foreign currency expenses. Changes in the fair value of the derivatives that qualify as cash flow hedges are recorded in "Accumulated other comprehensive loss" in the accompanying Condensed Consolidated Balance Sheets until earnings are affected by the variability of the cash flows. In the next twelve months, the Company estimates that $2.4 million of unrealized gains, net of tax, related to cash flow hedges will be reclassified from other comprehensive income (loss) into earnings. Changes in the fair value of the non-designated derivatives related to recognized foreign currency denominated assets and liabilities are recorded in "Miscellaneous, net" in the accompanying Condensed Consolidated Statements of Comprehensive Income.
The Company enters into forward currency exchange contracts for its operations in certain jurisdictions in the AMER and APAC segments on a rolling basis. The Company had cash flow hedges outstanding with a notional value of $148.7 million as of December 31, 2022, and a notional value of $143.2 million as of October 1, 2022. These forward currency contracts fix the exchange rates for the settlement of future foreign currency obligations that have yet to be realized. The total fair value of the forward currency exchange contracts was a $2.4 million asset as of December 31, 2022, and a $6.0 million liability as of October 1, 2022.
The Company had additional forward currency exchange contracts outstanding as of December 31, 2022, with a notional value of $113.5 million; there were $60.1 million such contracts outstanding as of October 1, 2022. The Company did not designate these derivative instruments as hedging instruments. The net settlement amount (fair value) related to these contracts is recorded on the Condensed Consolidated Balance Sheets as either a current or long-term asset or liability, depending on the term, and as an element of "Miscellaneous, net" in the Condensed Consolidated Statements of Comprehensive Income. The total fair value of these derivatives was a $1.0 million asset as of December 31, 2022, and a $0.3 million asset as of October 1, 2022.
The tables below present information regarding the fair values of derivative instruments (as defined in Note 1, "Description of Business and Significant Accounting Policies") and the effects of derivative instruments on the Company’s Condensed Consolidated Financial Statements:
Fair Values of Derivative Instruments (in thousands)
  Derivative AssetsDerivative Liabilities
    December 31,
2022		October 1,
2022		  December 31,
2022		October 1,
2022
Derivatives designated as hedging instrumentsBalance sheet
classification		Fair ValueFair ValueBalance sheet
classification		Fair ValueFair Value
Foreign currency forward contractsPrepaid expenses and other$2,451 $715 Other accrued liabilities$44 $6,747 
Fair Values of Derivative Instruments (in thousands)
  Derivative AssetsDerivative Liabilities
    December 31,
2022		October 1,
2022		  December 31,
2022		October 1,
2022
Derivatives not designated as hedging instrumentsBalance sheet
classification		Fair ValueFair ValueBalance sheet
classification		Fair ValueFair Value
Foreign currency forward contractsPrepaid expenses and other$2,487 $1,555 Other accrued liabilities$1,486 $1,249 
The Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Loss ("OCL") (in thousands)
for the Three Months Ended
Derivatives in cash flow hedging relationshipsAmount of Gain Recognized in OCL on Derivatives
December 31, 2022January 1, 2022
Foreign currency forward contracts$6,150 $470 
Derivative Impact on Loss Recognized in Condensed Consolidated Statements of Comprehensive Income (in thousands)
for the Three Months Ended
Derivatives in cash flow hedging relationshipsClassification of Loss Reclassified from Accumulated OCL into IncomeAmount of Loss Reclassified from Accumulated OCL into Income 
December 31, 2022January 1, 2022
Foreign currency forward contractsCost of sales$(2,132)$(743)
Foreign currency forward contractsSelling and administrative expenses$(157)$(59)
Derivatives not designated as hedging instrumentsLocation of Gain (Loss) Recognized on Derivatives in IncomeAmount of Gain (Loss) on Derivatives Recognized in Income
December 31, 2022January 1, 2022
Foreign currency forward contractsMiscellaneous, net$747 $(43)
Fair Value Measurements:
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (or exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses quoted market prices when available or discounted cash flows to calculate
fair value. The accounting guidance establishes a fair value hierarchy based on three levels of inputs that may be used to measure fair value. The input levels are:
Level 1: Quoted (observable) market prices in active markets for identical assets or liabilities.
Level 2: Inputs other than Level 1 that are observable, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.
Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the asset or liability.
The following table lists the fair values of assets of the Company’s derivatives as of December 31, 2022 and October 1, 2022, by input level:
Fair Value Measurements Using Input Levels Asset/(Liability) (in thousands)
Fiscal period ended December 31, 2022
Level 1Level 2Level 3Total
Derivatives    
Foreign currency forward contracts$— $3,408 $— $3,408 
Fiscal period ended October 1, 2022
Derivatives
Foreign currency forward contracts$— $(5,726)$— $(5,726)
The fair value of foreign currency forward contracts is determined using a market approach, which includes obtaining directly or indirectly observable values from third parties active in the relevant markets. Inputs in the fair value of the foreign currency forward contracts include prevailing forward and spot prices for currency.
XML 25 R11.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes
 3 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Income tax expense for the three months ended December 31, 2022 was $7.2 million compared to $3.4 million for the three months ended January 1, 2022.
The effective tax rates for the three months ended December 31, 2022 and January 1, 2022 were 14.7% and 12.5%, respectively. The effective tax rate for the three months ended December 31, 2022 increased from the effective tax rate for the three months ended January 1, 2022 primarily due to a change in the geographic distribution of pre-tax book income.
The amount of unrecognized tax benefits recorded for uncertain tax positions increased by $0.9 million for the three months ended December 31, 2022. The Company recognizes accrued interest and penalties on uncertain tax positions as a component of income tax expense. The amount of interest and penalties recorded for the three months ended December 31, 2022 was not material.
One or more uncertain tax positions may be settled within the next 12 months. Settlement of these matters is not expected to have a material effect on the Company's consolidated results of operations, financial position and cash flows. The Company is not currently under examination by taxing authorities in the U.S. The Company is under audit in a foreign jurisdiction but a settlement is not expected to have a material impact.
The Company maintains valuation allowances when it is more likely than not that all or a portion of a net deferred tax asset will not be realized. During the three months ended December 31, 2022, the Company continued to record a full valuation allowance against its net deferred tax assets in certain jurisdictions within the EMEA segment and a partial valuation against its net deferred tax assets in certain jurisdictions within the AMER segment, as it was more likely than not that these assets would not be fully realized based primarily on historical performance. The Company will continue to provide a valuation allowance against its net deferred tax assets in each of the applicable jurisdictions going forward until it determines it is more likely than not that the deferred tax assets will be realized.
XML 26 R12.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings Per Share
 3 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
The following is a reconciliation of the amounts utilized in the computation of basic and diluted earnings per share for the three months ended December 31, 2022 and January 1, 2022 (in thousands, except per share amounts):
Three Months Ended
 December 31, 2022January 1, 2022
Net income$42,190 $23,423 
Basic weighted average common shares outstanding27,639 28,018 
Dilutive effect of share-based awards and options outstanding666 691 
Diluted weighted average shares outstanding28,305 28,709 
Earnings per share:
Basic$1.53 $0.84 
Diluted$1.49 $0.82 
For the three months ended December 31, 2022 and January 1, 2022, there were no antidilutive awards.
See also Note 12, "Shareholders' Equity," for information regarding the Company's share repurchase plans.
XML 27 R13.htm IDEA: XBRL DOCUMENT v3.22.4
Leases
 3 Months Ended
Dec. 31, 2022
Leases [Abstract]  
Leases Leases
The components of lease expense for the three months ended December 31, 2022 and January 1, 2022 indicated were as follows (in thousands):
Three Months Ended
December 31, 2022January 1, 2022
Finance lease expense:
   Amortization of right-of-use assets$1,614 $1,693 
   Interest on lease liabilities1,272 1,222 
Operating lease expense2,606 2,857 
Other lease expense1,766 1,404 
Total$7,258 $7,176 
Based on the nature of the right-of use ("ROU") asset, amortization of finance lease ROU assets, operating lease expense and other lease expense are recorded within either cost of goods sold or selling and administrative expenses and interest on finance lease liabilities is recorded within interest expense on the Condensed Consolidated Statements of Comprehensive Income. Other lease expense includes lease expense for leases with an estimated total term of twelve months or less and variable lease expense related to variations in lease payments as a result of a change in factors or circumstances occurring after the lease possession date.
The following tables sets forth the amount of lease assets and lease liabilities included in the Company’s Condensed Consolidated Balance Sheets (in thousands):
Financial Statement Line ItemDecember 31, 2022October 1, 2022
ASSETS
   Finance lease assetsProperty, plant and equipment, net$38,025 $40,063 
   Operating lease assetsOperating lease right-of-use assets64,069 65,134 
      Total lease assets$102,094 $105,197 
LIABILITIES AND SHAREHOLDERS' EQUITY
Current
  Finance lease liabilitiesCurrent portion of long-term debt and finance lease obligations$4,406 $5,087 
Operating lease liabilitiesOther accrued liabilities8,878 7,948 
Non-current
  Finance lease liabilitiesLong-term debt and finance lease obligations, net of current portion38,583 39,257 
  Operating lease liabilitiesLong-term operating lease liabilities32,149 33,628 
        Total lease liabilities$84,016 $85,920 
XML 28 R14.htm IDEA: XBRL DOCUMENT v3.22.4
Share-Based Compensation
 3 Months Ended
Dec. 31, 2022
Compensation Related Costs [Abstract]  
Share-Based Compensation Share-Based CompensationThe Company recognized $5.8 million and $6.3 million of compensation expense associated with share-based awards for the three months ended December 31, 2022 and January 1, 2022, respectively.
XML 29 R15.htm IDEA: XBRL DOCUMENT v3.22.4
Litigation
 3 Months Ended
Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
Litigation LitigationThe Company is party to lawsuits in the ordinary course of business. Management does not believe that these proceedings, individually or in the aggregate, will have a material positive or adverse effect on the Company’s consolidated financial position, results of operations or cash flows.
XML 30 R16.htm IDEA: XBRL DOCUMENT v3.22.4
Reportable Segments
 3 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Reportable Segments Reportable SegmentsReportable segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or group, in assessing performance and allocating resources. The Company uses an internal management reporting system, which provides important financial data to evaluate performance and allocate the Company’s resources on a regional basis. Net sales for the segments are attributed to the region in which the product is manufactured or the service is performed. The services provided, manufacturing processes used, class of customers serviced and order fulfillment processes used are similar and generally interchangeable across the segments. A segment’s performance is evaluated based upon its operating income (loss). A segment’s operating income (loss) includes its net sales less cost of sales and selling and administrative expenses, but excludes corporate and other expenses. Corporate and other expenses primarily represent corporate selling and administrative expenses, and restructuring costs and other charges, if any. These costs are not allocated to the segments, as management excludes such costs when assessing the performance of the segments. Inter-segment transactions are generally recorded at amounts that approximate arm’s length transactions. The accounting policies for the segments are the same as for the Company taken as a whole.
Information about the Company’s three reportable segments for three months ended December 31, 2022 and January 1, 2022 is as follows (in thousands):
Three Months Ended
 December 31, 2022January 1, 2022
Net sales:
AMER$389,662 $277,346 
APAC641,904 491,672 
EMEA89,373 72,863 
Elimination of inter-segment sales(27,014)(24,425)
$1,093,925 $817,456 
  
Operating income (loss):
AMER$17,415 $1,790 
APAC78,406 60,688 
EMEA(639)956 
Corporate and other costs(37,841)(32,961)
57,341 30,473 
Other income (expense):
Interest expense(6,894)(3,046)
Interest income934 271 
Miscellaneous, net(1,944)(923)
Income before income taxes$49,437 $26,775 
  
 December 31,
2022		October 1,
2022
Total assets:
AMER$1,171,188 $1,150,605 
APAC1,809,364 1,807,542 
EMEA339,382 302,901 
Corporate and eliminations75,358 132,177 
$3,395,292 $3,393,225 
  
XML 31 R17.htm IDEA: XBRL DOCUMENT v3.22.4
Guarantees
 3 Months Ended
Dec. 31, 2022
Guarantees and Product Warranties [Abstract]  
Guarantees Guarantees
The Company offers certain indemnifications under its customer manufacturing agreements. In the normal course of business, the Company may from time to time be obligated to indemnify its customers or its customers’ customers against damages or liabilities arising out of the Company’s negligence, misconduct, breach of contract, or infringement of third-party intellectual property rights. Certain agreements have extended broader indemnification, and while most agreements have contractual limits, some do not. However, the Company generally does not provide for such indemnities and seeks indemnification from its customers for damages or liabilities arising out of the Company’s adherence to customers’ specifications or designs or use of materials furnished, or directed to be used, by its customers. The Company does not believe its obligations under such indemnities are material.
In the normal course of business, the Company also provides its customers a limited warranty covering workmanship, and in some cases materials, on products manufactured by the Company. Such warranty generally provides that products will be free from defects in the Company’s workmanship and meet mutually agreed-upon specifications for periods generally ranging from 12 months to 24 months. The Company’s obligation is generally limited to correcting, at its expense, any defect by repairing or replacing such defective product. The Company’s warranty generally excludes defects resulting from faulty customer-supplied components, design defects or damage caused by any party or cause other than the Company.
The Company provides for an estimate of costs that may be incurred under its limited warranty at the time product revenue is recognized and establishes additional reserves for specifically identified product issues. These costs primarily include labor and materials, as necessary, associated with repair or replacement and are included in the Company's accompanying Condensed Consolidated Balance Sheets in "other accrued liabilities." The primary factors that affect the Company’s warranty liability include the value and the number of shipped units and historical and anticipated rates of warranty claims. As these factors are impacted by actual experience and future expectations, the Company assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.
Below is a table summarizing the activity related to the Company’s limited warranty liability for the three months ended December 31, 2022 and January 1, 2022 (in thousands):
Three Months Ended
December 31, 2022January 1, 2022
Reserve balance, beginning of period$6,925 $6,645 
Accruals for warranties issued during the period727 1,258 
   Settlements (in cash or in kind) during the period(1,131)(741)
Reserve balance, end of period$6,521 $7,162 
XML 32 R18.htm IDEA: XBRL DOCUMENT v3.22.4
Shareholders' Equity
 3 Months Ended
Dec. 31, 2022
Stockholders' Equity Note [Abstract]  
Shareholders' Equity Shareholders' Equity
On August 11, 2021, the Board of Directors approved a share repurchase program under which the Company was authorized to repurchase up to $50.0 million of its common stock (the "2022 Program"). The 2022 Program commenced upon completion of the 2021 Program and was completed in fiscal 2022. During the three months ended January 1, 2022, the Company repurchased 110,440 shares under this program for $10.2 million at an average price of $91.74 per share.
On August 18, 2022, the Board of Directors approved a share repurchase program under which the Company is authorized to repurchase up to $50.0 million of its common stock (the "2023 Program"). The 2023 Program became effective immediately and has no expiration. During the three months ended December 31, 2022, the Company repurchased 115,723 shares under this program for $11.5 million at an average price of $99.12 per share. As of December 31, 2022, $35.0 million of authority remained under the 2023 Program.
All shares repurchased under the aforementioned programs were recorded as treasury stock.
XML 33 R19.htm IDEA: XBRL DOCUMENT v3.22.4
Trade Accounts Receivable Sale Programs
 3 Months Ended
Dec. 31, 2022
Receivables [Abstract]  
Trade Accounts Receivable Sale Programs Trade Accounts Receivable Sale Programs
The Company has Master Accounts Receivable Purchase Agreements with MUFG Bank, New York Branch (formerly known as The Bank of Tokyo-Mitsubishi UFJ, Ltd.) (the "MUFG RPA"), HSBC Bank (China) Company Limited, Xiamen branch (the "HSBC RPA") and other unaffiliated financial institutions, under which the Company may elect to sell receivables; at a discount. All facilities are uncommitted facilities. The maximum facility amount under the MUFG RPA is $340.0 million. The maximum facility amount under the HSBC RPA is $60.0 million. The MUFG RPA will be automatically extended each year unless any party gives no less than 10 days prior notice that the agreement should not be extended. The terms of the HSBC RPA are generally consistent with the terms of the MUFG RPA previously discussed.
Transfers of receivables under the programs are accounted for as sales and, accordingly, receivables sold under the programs are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows. Proceeds from the transfer reflect the face value of the receivables less a discount. The sale discount is recorded within "Miscellaneous, net" in the Condensed Consolidated Statements of Comprehensive Income in the period of the sale. The Company continues servicing receivables sold and performing all accounts receivable administrative functions, and in exchange receives a servicing fee, under both the MUFG RPA and HSBC RPA. Servicing fees related to trade accounts receivable programs recognized during the three months ended December 31, 2022 and January 1, 2022 were not material.

The Company sold $185.6 million and $148.0 million of trade accounts receivable under these programs, or their predecessors, during three months ended December 31, 2022 and January 1, 2022, respectively, in exchange for cash proceeds of $183.6 million and $147.5 million, respectively. As of December 31, 2022 and January 1, 2022, $196.8 million and $151.0 million,
respectively, of accounts receivables sold under trade accounts receivable programs and subject to servicing by the Company remained outstanding and had not yet been collected.
XML 34 R20.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue from Contracts with Customers
 3 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
Revenue from Contracts with Customers Revenue from Contracts with Customers
Revenue is recognized over time for arrangements with customers for which: (i) the Company's performance does not create an asset with an alternative use to the Company, and (ii) the Company has an enforceable right to payment, including reasonable profit margin, for performance completed to date. Revenue recognized over time is estimated based on costs incurred to date plus a reasonable profit margin. If either of the two conditions noted above are not met to recognize revenue over time, revenue is recognized following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying arrangement.
The Company recognizes revenue when a contract exists and when, or as, it satisfies a performance obligation by transferring control of a product or service to a customer. Contracts are accounted for when they have approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer.
The Company generally enters into a master services arrangement that establishes the framework under which business will be conducted. These arrangements represent the master terms and conditions of the Company's services that apply to individual orders, but they do not commit the customer to work with, or to continue to work with, the Company nor do they obligate the customer to any specific volume or pricing of purchases. Moreover, these terms can be amended in appropriate situations.
Customer purchase orders are received for specific quantities with predominantly fixed pricing and delivery requirements. Thus, for the majority of our contracts, there is no guarantee of any revenue to the Company until a customer submits a purchase order. As a result, the Company generally considers its arrangement with a customer to be the combination of the master services arrangement and the purchase order. Most of the Company's arrangements with customers create a single performance obligation as the promise to transfer the individual manufactured product or service is capable of being distinct.
The Company’s performance obligations are satisfied over time as work progresses or at a point in time. A performance obligation is satisfied over time if the Company has an enforceable right to payment, including a reasonable profit margin. Determining if an enforceable right to payment includes a reasonable profit margin requires judgment and is assessed on a contract by contract basis.
Generally, there are no subjective customer acceptance requirements or further obligations related to goods or services provided; if such requirements or obligations exist, then a sale is recognized at the time when such requirements are completed and such obligations are fulfilled.
The Company does not allow for a general right of return. Net sales include amounts billed to customers for shipping and handling and out-of-pocket expenses. The corresponding shipping and handling costs and out-of-pocket expenses are included in cost of sales. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from net sales.
Contract Costs
For contracts requiring over time revenue recognition, the selection of the method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. The Company uses a cost-based input measurement of progress because it best depicts the transfer of assets to the customer, which occurs as costs are incurred during the manufacturing process or as services are rendered. Under the cost-based measure of progress, the extent of progress towards completion is measured based on the costs incurred to date.
There were no other costs to obtain or fulfill customer contracts.
Disaggregated Revenue
The table below includes the Company’s revenue for the three months ended December 31, 2022 and January 1, 2022 indicated disaggregated by geographic reportable segment and market sector (in thousands):
Three Months Ended
December 31, 2022
Reportable Segment:
AMERAPACEMEATotal
Market Sector:
Industrial$103,027 $350,584 $18,471 $472,082 
Healthcare/Life Sciences215,381 223,290 49,196 487,867 
Aerospace/Defense68,022 45,654 20,300 133,976 
     External revenue386,430 619,528 87,967 1,093,925 
Inter-segment sales3,232 22,376 1,406 27,014 
    Segment revenue$389,662 $641,904 $89,373 $1,120,939 

Three Months Ended
January 1, 2022
Reportable Segment:
AMERAPACEMEATotal
Market Sector:
Industrial$83,245 $265,275 $15,307 $363,827 
Healthcare/Life Sciences135,962 169,237 39,266 344,465 
Aerospace/Defense55,750 35,743 17,671 109,164 
     External revenue274,957 470,255 72,244 817,456 
Inter-segment sales2,389 21,417 619 24,425 
    Segment revenue$277,346 $491,672 $72,863 $841,881 

For each of the three months ended December 31, 2022 and January 1, 2022, approximately 81% and 87% of the Company's revenue, respectively, was recognized as products and services were transferred over time.
Contract Balances
The timing of revenue recognition, billings and cash collections results in billed accounts receivable, contract assets and deferred revenue on the Company’s accompanying Condensed Consolidated Balance Sheets.
Contract Assets: For performance obligations satisfied at a point in time, billing occurs subsequent to revenue recognition, at which point the customer has been billed and the resulting asset is recorded within accounts receivable. For performance obligations satisfied over time as work progresses, the Company has an unconditional right to payment, which results in the recognition of contract assets. The following table summarizes the activity in the Company's contract assets during the three months ended December 31, 2022 and January 1, 2022 (in thousands):
Three Months Ended
December 31, 2022January 1, 2022
Contract assets, beginning of period$138,540 $115,283 
Revenue recognized during the period884,099 709,723 
Amounts collected or invoiced during the period(903,623)(719,556)
Contract assets, end of period$119,016 $105,450 
Deferred Revenue: Deferred revenue is recorded when consideration is received from a customer prior to transferring goods or services to the customer under the terms of the contract, which is included in other accrued liabilities on Condensed
Consolidated Balance Sheets. As of December 31, 2022 and October 1, 2022 the balance of advance payments from customers was $247.1 million and $298.8 million, respectively. The advance payment is not considered a significant financing component because it is used to meet working capital demands that can be higher in the early stages of a contract and to protect the company from the other party failing to adequately complete some or all of its obligations under the contract. Deferred revenue is recognized into revenue when all revenue recognition criteria are met. For performance obligations satisfied over time, recognition will occur as work progresses; otherwise deferred revenue will be recognized based upon shipping terms.
XML 35 R21.htm IDEA: XBRL DOCUMENT v3.22.4
Restructuring and Impairment Charges
 3 Months Ended
Dec. 31, 2022
Restructuring and Related Activities [Abstract]  
Restructuring and Impairment Charges Restructuring and Impairment Charges
Restructuring and impairment charges are recorded within restructuring and impairment charges on the Condensed Consolidated Statements of Comprehensive Income. Restructuring liabilities are recorded within other accrued liabilities on the Condensed Consolidated Balance Sheets.

During the first quarter of fiscal 2023, the Company did not incur any restructuring and impairment charges. During the first quarter of fiscal 2022, the Company recorded $2.0 million of restructuring and impairment charges primarily due to employee severance costs associated with a facility transition in the Company's APAC segment.

The Company recognized a tax benefit of $0.2 million related to restructuring and impairment charges for the three months ended January 1, 2022.

The Company's restructuring accrual activity for the three months ended January 1, 2022 is included in the tables below (in thousands):    
Fixed Asset and Operating ROU Asset ImpairmentEmployee Termination and Severance Costs    Total
Accrual balance, as of October 2, 2021
$— $71 $71 
Restructuring and impairment costs255 1,766 2,021 
Amounts utilized(255)(75)(330)
Accrual balance, as of January 1, 2022
$— $1,762 $1,762 
XML 36 R22.htm IDEA: XBRL DOCUMENT v3.22.4
Basis of Presentation (Policies)
 3 Months Ended
Dec. 31, 2022
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation:

The accompanying Condensed Consolidated Financial Statements included herein have been prepared by Plexus Corp. and its subsidiaries (together “Plexus” or the “Company”) without audit and pursuant to the rules and regulations of the United States (“U.S.”) Securities and Exchange Commission (“SEC”). The accompanying Condensed Consolidated Financial Statements reflect all adjustments, which include normal recurring adjustments necessary for the fair statement of the consolidated financial position of the Company as of December 31, 2022 and October 1, 2022, the results of operations and shareholders' equity for the three months ended December 31, 2022 and January 1, 2022, and the cash flows for the same three month periods.

The Company’s fiscal year ends on the Saturday closest to September 30. The Company uses a “4-4-5” weekly accounting system for the interim periods in each quarter. Each quarter, therefore, ends on a Saturday at the end of the 4-4-5 period. Periodically, an additional week must be added to the fiscal year to re-align with the Saturday closest to September 30. All fiscal quarters presented herein included 13 weeks.
Certain information and footnote disclosures, normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP"), have been condensed or omitted pursuant to the SEC’s rules and regulations dealing with interim financial statements. However, the Company believes that the disclosures made in the Condensed Consolidated Financial Statements included herein are adequate to make the information presented not misleading. It is suggested that these Condensed Consolidated Financial Statements be read in conjunction with the Consolidated Financial Statements and notes thereto included in the Company’s 2022 Annual Report on Form 10-K.
The preparation of financial statements requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and notes thereto. The Company has considered information available as of the date of issuance of these financial statements and is not aware of any specific events or circumstances that would require an update to its estimates or judgments, or a revision of the carrying value of its assets or liabilities. These estimates may change as new events occur and additional information becomes available. Actual results could differ materially from these estimates.
Recently Adopted Accounting Pronouncements & Recently Issued Accounting Pronouncements Not Yet Adopted
Recently Issued Accounting Pronouncements Not Yet Adopted:
In September 2022, the FASB issued ASU 2022-04, which requires enhanced disclosures about supplier finance programs. The guidance is effective for the Company beginning in the first quarter of fiscal 2024. Early adoption is permitted. The Company is currently in the process of assessing the impacts of the guidance.
The Company does not believe that any other recently issued accounting standards will have a material impact on its Consolidated Financial Statements, or apply to its operations.
Fair Value of Financial Instruments
Fair Value Measurements:
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (or exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses quoted market prices when available or discounted cash flows to calculate
fair value. The accounting guidance establishes a fair value hierarchy based on three levels of inputs that may be used to measure fair value. The input levels are:
Level 1: Quoted (observable) market prices in active markets for identical assets or liabilities.
Level 2: Inputs other than Level 1 that are observable, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.
Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the asset or liability.
XML 37 R23.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories (Tables)
 3 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Schedule of Inventories
Inventories as of December 31, 2022 and October 1, 2022 consisted of the following (in thousands):
December 31, 2022October 1, 2022
Raw materials$1,468,942 $1,433,353 
Work-in-process81,822 81,207 
Finished goods94,247 88,223 
Total inventories, net$1,645,011 $1,602,783 
XML 38 R24.htm IDEA: XBRL DOCUMENT v3.22.4
Debt, Finance Lease and Other Financing Obligations (Tables)
 3 Months Ended
Dec. 31, 2022
Debt and Lease Obligation [Abstract]  
Schedule of Debt, Finance Lease and Other Financing Obligations
Debt, finance lease and other financing obligations as of December 31, 2022 and October 1, 2022 consisted of the following (in thousands):
December 31, 2022October 1, 2022
4.05% Senior Notes, due June 15, 2025
$100,000 $100,000 
4.22% Senior Notes, due June 15, 2028
50,000 50,000 
Borrowings under Credit Facility320,000 263,000 
Finance lease and other financing obligations47,786 50,269 
Unamortized deferred financing fees(1,438)(1,522)
Total obligations516,348 461,747 
Less: current portion(329,076)(273,971)
Long-term debt, finance lease and other financing obligations, net of current portion$187,272 $187,776 
XML 39 R25.htm IDEA: XBRL DOCUMENT v3.22.4
Derivatives and Fair Value Measurements (Tables)
 3 Months Ended
Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Fair Values of Derivative Instruments
The tables below present information regarding the fair values of derivative instruments (as defined in Note 1, "Description of Business and Significant Accounting Policies") and the effects of derivative instruments on the Company’s Condensed Consolidated Financial Statements:
Fair Values of Derivative Instruments (in thousands)
  Derivative AssetsDerivative Liabilities
    December 31,
2022		October 1,
2022		  December 31,
2022		October 1,
2022
Derivatives designated as hedging instrumentsBalance sheet
classification		Fair ValueFair ValueBalance sheet
classification		Fair ValueFair Value
Foreign currency forward contractsPrepaid expenses and other$2,451 $715 Other accrued liabilities$44 $6,747 
Fair Values of Derivative Instruments (in thousands)
  Derivative AssetsDerivative Liabilities
    December 31,
2022		October 1,
2022		  December 31,
2022		October 1,
2022
Derivatives not designated as hedging instrumentsBalance sheet
classification		Fair ValueFair ValueBalance sheet
classification		Fair ValueFair Value
Foreign currency forward contractsPrepaid expenses and other$2,487 $1,555 Other accrued liabilities$1,486 $1,249 
Schedule of Derivative Impact on Accumulated Other Comprehensive (Loss) Income
The Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Loss ("OCL") (in thousands)
for the Three Months Ended
Derivatives in cash flow hedging relationshipsAmount of Gain Recognized in OCL on Derivatives
December 31, 2022January 1, 2022
Foreign currency forward contracts$6,150 $470 
Schedule of Derivative Impact on (Loss) Gain Recognized in Income
Derivative Impact on Loss Recognized in Condensed Consolidated Statements of Comprehensive Income (in thousands)
for the Three Months Ended
Derivatives in cash flow hedging relationshipsClassification of Loss Reclassified from Accumulated OCL into IncomeAmount of Loss Reclassified from Accumulated OCL into Income 
December 31, 2022January 1, 2022
Foreign currency forward contractsCost of sales$(2,132)$(743)
Foreign currency forward contractsSelling and administrative expenses$(157)$(59)
Schedule of Amount of Gain (Loss) on Derivatives Recognized in Income
Derivatives not designated as hedging instrumentsLocation of Gain (Loss) Recognized on Derivatives in IncomeAmount of Gain (Loss) on Derivatives Recognized in Income
December 31, 2022January 1, 2022
Foreign currency forward contractsMiscellaneous, net$747 $(43)
Schedule of Derivatives Fair Value Measurements Using Input Levels
The following table lists the fair values of assets of the Company’s derivatives as of December 31, 2022 and October 1, 2022, by input level:
Fair Value Measurements Using Input Levels Asset/(Liability) (in thousands)
Fiscal period ended December 31, 2022
Level 1Level 2Level 3Total
Derivatives    
Foreign currency forward contracts$— $3,408 $— $3,408 
Fiscal period ended October 1, 2022
Derivatives
Foreign currency forward contracts$— $(5,726)$— $(5,726)
XML 40 R26.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings Per Share (Tables)
 3 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Reconciliation of Amounts Utilized in Computation of Basic and Diluted Earnings Per Share
The following is a reconciliation of the amounts utilized in the computation of basic and diluted earnings per share for the three months ended December 31, 2022 and January 1, 2022 (in thousands, except per share amounts):
Three Months Ended
 December 31, 2022January 1, 2022
Net income$42,190 $23,423 
Basic weighted average common shares outstanding27,639 28,018 
Dilutive effect of share-based awards and options outstanding666 691 
Diluted weighted average shares outstanding28,305 28,709 
Earnings per share:
Basic$1.53 $0.84 
Diluted$1.49 $0.82 
XML 41 R27.htm IDEA: XBRL DOCUMENT v3.22.4
Leases (Tables)
 3 Months Ended
Dec. 31, 2022
Leases [Abstract]  
Schedule of Lease Expense and Other Information
The components of lease expense for the three months ended December 31, 2022 and January 1, 2022 indicated were as follows (in thousands):
Three Months Ended
December 31, 2022January 1, 2022
Finance lease expense:
   Amortization of right-of-use assets$1,614 $1,693 
   Interest on lease liabilities1,272 1,222 
Operating lease expense2,606 2,857 
Other lease expense1,766 1,404 
Total$7,258 $7,176 
Schedule of Lease Assets and Liabilities
The following tables sets forth the amount of lease assets and lease liabilities included in the Company’s Condensed Consolidated Balance Sheets (in thousands):
Financial Statement Line ItemDecember 31, 2022October 1, 2022
ASSETS
   Finance lease assetsProperty, plant and equipment, net$38,025 $40,063 
   Operating lease assetsOperating lease right-of-use assets64,069 65,134 
      Total lease assets$102,094 $105,197 
LIABILITIES AND SHAREHOLDERS' EQUITY
Current
  Finance lease liabilitiesCurrent portion of long-term debt and finance lease obligations$4,406 $5,087 
Operating lease liabilitiesOther accrued liabilities8,878 7,948 
Non-current
  Finance lease liabilitiesLong-term debt and finance lease obligations, net of current portion38,583 39,257 
  Operating lease liabilitiesLong-term operating lease liabilities32,149 33,628 
        Total lease liabilities$84,016 $85,920 
XML 42 R28.htm IDEA: XBRL DOCUMENT v3.22.4
Reportable Segments (Tables)
 3 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Schedule of Reportable Segments Information
Information about the Company’s three reportable segments for three months ended December 31, 2022 and January 1, 2022 is as follows (in thousands):
Three Months Ended
 December 31, 2022January 1, 2022
Net sales:
AMER$389,662 $277,346 
APAC641,904 491,672 
EMEA89,373 72,863 
Elimination of inter-segment sales(27,014)(24,425)
$1,093,925 $817,456 
  
Operating income (loss):
AMER$17,415 $1,790 
APAC78,406 60,688 
EMEA(639)956 
Corporate and other costs(37,841)(32,961)
57,341 30,473 
Other income (expense):
Interest expense(6,894)(3,046)
Interest income934 271 
Miscellaneous, net(1,944)(923)
Income before income taxes$49,437 $26,775 
  
 December 31,
2022		October 1,
2022
Total assets:
AMER$1,171,188 $1,150,605 
APAC1,809,364 1,807,542 
EMEA339,382 302,901 
Corporate and eliminations75,358 132,177 
$3,395,292 $3,393,225 
  
XML 43 R29.htm IDEA: XBRL DOCUMENT v3.22.4
Guarantees (Tables)
 3 Months Ended
Dec. 31, 2022
Guarantees and Product Warranties [Abstract]  
Schedule of Activity Related to Limited Warranty Liability
Below is a table summarizing the activity related to the Company’s limited warranty liability for the three months ended December 31, 2022 and January 1, 2022 (in thousands):
Three Months Ended
December 31, 2022January 1, 2022
Reserve balance, beginning of period$6,925 $6,645 
Accruals for warranties issued during the period727 1,258 
   Settlements (in cash or in kind) during the period(1,131)(741)
Reserve balance, end of period$6,521 $7,162 
XML 44 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue from Contracts with Customers (Tables)
 3 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The table below includes the Company’s revenue for the three months ended December 31, 2022 and January 1, 2022 indicated disaggregated by geographic reportable segment and market sector (in thousands):
Three Months Ended
December 31, 2022
Reportable Segment:
AMERAPACEMEATotal
Market Sector:
Industrial$103,027 $350,584 $18,471 $472,082 
Healthcare/Life Sciences215,381 223,290 49,196 487,867 
Aerospace/Defense68,022 45,654 20,300 133,976 
     External revenue386,430 619,528 87,967 1,093,925 
Inter-segment sales3,232 22,376 1,406 27,014 
    Segment revenue$389,662 $641,904 $89,373 $1,120,939 

Three Months Ended
January 1, 2022
Reportable Segment:
AMERAPACEMEATotal
Market Sector:
Industrial$83,245 $265,275 $15,307 $363,827 
Healthcare/Life Sciences135,962 169,237 39,266 344,465 
Aerospace/Defense55,750 35,743 17,671 109,164 
     External revenue274,957 470,255 72,244 817,456 
Inter-segment sales2,389 21,417 619 24,425 
    Segment revenue$277,346 $491,672 $72,863 $841,881 
Schedule of Contract Assets The following table summarizes the activity in the Company's contract assets during the three months ended December 31, 2022 and January 1, 2022 (in thousands):
Three Months Ended
December 31, 2022January 1, 2022
Contract assets, beginning of period$138,540 $115,283 
Revenue recognized during the period884,099 709,723 
Amounts collected or invoiced during the period(903,623)(719,556)
Contract assets, end of period$119,016 $105,450 
XML 45 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Restructuring and Impairment Charges (Tables)
 3 Months Ended
Dec. 31, 2022
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Accrual Activity
The Company's restructuring accrual activity for the three months ended January 1, 2022 is included in the tables below (in thousands):    
Fixed Asset and Operating ROU Asset ImpairmentEmployee Termination and Severance Costs    Total
Accrual balance, as of October 2, 2021
$— $71 $71 
Restructuring and impairment costs255 1,766 2,021 
Amounts utilized(255)(75)(330)
Accrual balance, as of January 1, 2022
$— $1,762 $1,762 
XML 46 R32.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories - Schedule of Inventories (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Oct. 01, 2022
Inventory Disclosure [Abstract]    
Raw materials $ 1,468,942 $ 1,433,353
Work-in-process 81,822 81,207
Finished goods 94,247 88,223
Total inventories, net $ 1,645,011 $ 1,602,783
XML 47 R33.htm IDEA: XBRL DOCUMENT v3.22.4
Inventories - Narrative (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Oct. 01, 2022
Inventory [Line Items]    
Customer deposits $ 511,037 $ 480,486
Inventory    
Inventory [Line Items]    
Customer deposits $ 483,100 $ 463,200
XML 48 R34.htm IDEA: XBRL DOCUMENT v3.22.4
Debt, Finance Lease and Other Financing Obligations - Schedule of Debt, Finance Lease and Other Financing Obligations (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Oct. 01, 2022
Debt Instrument [Line Items]    
Long-term debt, gross $ 470,000 $ 413,000
Finance lease and other financing obligations 47,786 50,269
Unamortized deferred financing fees (1,438) (1,522)
Total obligations 516,348 461,747
Current portion of long-term debt and finance lease obligations (329,076) (273,971)
Long-term debt, finance lease and other financing obligations, net of current portion 187,272 187,776
Senior Notes | $4.05% Senior Notes, due June 15, 2025    
Debt Instrument [Line Items]    
Long-term debt, gross $ 100,000 $ 100,000
Interest Rate, Senior Notes 4.05% 4.05%
Senior Notes | $4.22% Senior Notes, due June 15, 2028    
Debt Instrument [Line Items]    
Long-term debt, gross $ 50,000 $ 50,000
Interest Rate, Senior Notes 4.22% 4.22%
Line of Credit | Borrowings under Credit Facility    
Debt Instrument [Line Items]    
Long-term debt, gross $ 320,000 $ 263,000
XML 49 R35.htm IDEA: XBRL DOCUMENT v3.22.4
Debt, Finance Lease and Other Financing Obligations - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2022
Oct. 01, 2022
Debt Instrument [Line Items]    
Fair value of debt $ 461,500 $ 401,600
Long-term debt, gross 470,000 $ 413,000
Revolving Credit Facility    
Debt Instrument [Line Items]    
Highest daily borrowings 394,000  
Average daily borrowings $ 320,900  
Credit facility, term 5 years  
XML 50 R36.htm IDEA: XBRL DOCUMENT v3.22.4
Derivatives and Fair Value Measurements - Schedule of Fair Values of Derivative Instruments (Details) - Foreign Exchange Forward [Member] - USD ($)
$ in Thousands
Dec. 31, 2022
Oct. 01, 2022
Derivatives not designated as hedging instruments    
Derivatives, Fair Value [Line Items]    
Fair value of derivative asset $ 1,000 $ 300
Prepaid expenses and other | Derivatives designated as hedging instruments    
Derivatives, Fair Value [Line Items]    
Fair value of derivative asset 2,451 715
Prepaid expenses and other | Derivatives not designated as hedging instruments    
Derivatives, Fair Value [Line Items]    
Fair value of derivative asset 2,487 1,555
Other accrued liabilities | Derivatives designated as hedging instruments    
Derivatives, Fair Value [Line Items]    
Fair value of derivative liability 44 6,747
Other accrued liabilities | Derivatives not designated as hedging instruments    
Derivatives, Fair Value [Line Items]    
Fair value of derivative liability $ 1,486 $ 1,249
XML 51 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Derivatives and Fair Value Measurements - Schedule of Derivative Impact on Accumulated Other Comprehensive (Loss) Income (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Foreign Exchange Forward [Member] | Derivatives designated as hedging instruments | Derivatives in cash flow hedging relationships    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of Gain Recognized in OCL on Derivatives $ 6,150 $ 470
XML 52 R38.htm IDEA: XBRL DOCUMENT v3.22.4
Derivatives and Fair Value Measurements - Schedule of Derivative Impact on (Loss) Gain Recognized in Income (Details) - Derivatives designated as hedging instruments - Derivatives in cash flow hedging relationships - Foreign Exchange Forward [Member] - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Cost of sales    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of Loss Reclassified from Accumulated OCL into Income  $ (2,132) $ (743)
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration] Cost of sales Cost of sales
Selling and administrative expenses    
Derivative Instruments, Gain (Loss) [Line Items]    
Amount of Loss Reclassified from Accumulated OCL into Income  $ (157) $ (59)
Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration] Selling and administrative expenses Selling and administrative expenses
XML 53 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Derivatives and Fair Value Measurements - Schedule of Amount of Gain (Loss) on Derivatives Recognized in Income (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Derivatives not designated as hedging instruments | Miscellaneous, net | Foreign Exchange Forward [Member]    
Derivative [Line Items]    
Amount of Gain (Loss) on Derivatives Recognized in Income $ 747 $ (43)
XML 54 R40.htm IDEA: XBRL DOCUMENT v3.22.4
Derivatives and Fair Value Measurements - Schedule of Fair Value Measurements Using Input Levels (Details) - Recurring - Foreign Exchange Forward [Member] - USD ($)
$ in Thousands
Dec. 31, 2022
Oct. 01, 2022
Derivative Asset $ 3,408  
Derivative Liability   $ 5,726
Derivative Asset (Liability), Statement of Financial Position [Extensible Enumeration] Other accrued liabilities Other accrued liabilities
Level 1    
Derivative Asset $ 0  
Derivative Liability   $ 0
Level 2    
Derivative Asset 3,408  
Derivative Liability   5,726
Level 3    
Derivative Asset $ 0  
Derivative Liability   $ 0
XML 55 R41.htm IDEA: XBRL DOCUMENT v3.22.4
Derivatives and Fair Value Measurements - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2022
Oct. 01, 2022
Estimated unrealized gains (losses), net of tax, expected to be reclassified in the next 12 months $ 2,400  
Derivatives designated as hedging instruments | Derivatives in cash flow hedging relationships | Foreign Exchange Forward [Member]    
Notional amount of forward exchange contracts 148,700 $ 143,200
Fair value of derivative asset 2,400  
Fair value of derivative liability   6,000
Derivatives not designated as hedging instruments | Foreign Exchange Forward [Member]    
Notional amount of forward exchange contracts 113,500 60,100
Fair value of derivative asset $ 1,000 $ 300
XML 56 R42.htm IDEA: XBRL DOCUMENT v3.22.4
Income Taxes - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Income Tax Disclosure [Abstract]    
Income tax expense $ 7,247 $ 3,352
Effective Income Tax Rate Reconciliation, Percent 14.70% 12.50%
Unrecognized Tax Benefits, Period Increase (Decrease) $ 900  
XML 57 R43.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings Per Share - Reconciliation of Amounts Utilized in Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Earnings Per Share [Abstract]    
Net income $ 42,190 $ 23,423
Basic weighted average common shares outstanding (in shares) 27,639 28,018
Dilutive effect of share-based awards and options outstanding (in shares) 666 691
Diluted weighted average shares outstanding (in shares) 28,305 28,709
Earnings per share:    
Basic (in dollars per share) $ 1.53 $ 0.84
Diluted (in dollars per share) $ 1.49 $ 0.82
XML 58 R44.htm IDEA: XBRL DOCUMENT v3.22.4
Earnings Per Share - Narrative (Details) - shares
shares in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Earnings Per Share [Abstract]    
Antidilutive Securities Excluded from Computation of Diluted Earnings Per Share 0 0
XML 59 R45.htm IDEA: XBRL DOCUMENT v3.22.4
Leases Schedule of Lease Expense and Other Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Leases [Abstract]    
Amortization of right-of-use assets $ 1,614 $ 1,693
Interest on lease liabilities 1,272 1,222
Operating lease expense 2,606 2,857
Other lease expense 1,766 1,404
Total lease expense $ 7,258 $ 7,176
XML 60 R46.htm IDEA: XBRL DOCUMENT v3.22.4
Leases Schedule of Lease Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2022
Oct. 01, 2022
Assets and Liabilities, Leases [Abstract]    
Finance lease right-of-use assets $ 38,025 $ 40,063
Operating lease right-of-use assets 64,069 65,134
Total lease Assets 102,094 105,197
Current finance lease liabilities $ 4,406 $ 5,087
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Current portion of long-term debt and finance lease obligations Current portion of long-term debt and finance lease obligations
Current operating lease liabilities $ 8,878 $ 7,948
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Other accrued liabilities Other accrued liabilities
Long-term finance lease liabilities $ 38,583 $ 39,257
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Long-term debt and finance lease obligations, net of current portion Long-term debt and finance lease obligations, net of current portion
Long-term operating lease liabilities $ 32,149 $ 33,628
Total lease liabilities $ 84,016 $ 85,920
XML 61 R47.htm IDEA: XBRL DOCUMENT v3.22.4
Benefit Plans - Narrative (Details) - USD ($)
$ in Millions
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Compensation Related Costs [Abstract]    
Share-based compensation expense $ 5.8 $ 6.3
XML 62 R48.htm IDEA: XBRL DOCUMENT v3.22.4
Reportable Segments - Schedule of Reportable Segments Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Oct. 01, 2022
Net sales $ 1,093,925 $ 817,456  
Operating income (loss): 57,341 30,473  
Total assets 3,395,292   $ 3,393,225
Other income (expense):      
Interest expense (6,894) (3,046)  
Interest income 934 271  
Miscellaneous, net (1,944) (923)  
Income before income taxes 49,437 26,775  
Elimination of inter-segment sales      
Net sales (27,014) (24,425)  
Corporate and other costs      
Operating income (loss): (37,841) (32,961)  
Corporate and eliminations      
Total assets 75,358   132,177
AMER | Operating Segments      
Net sales 389,662 277,346  
Operating income (loss): 17,415 1,790  
Total assets 1,171,188   1,150,605
APAC | Operating Segments      
Net sales 641,904 491,672  
Operating income (loss): 78,406 60,688  
Total assets 1,809,364   1,807,542
EMEA | Operating Segments      
Net sales 89,373 72,863  
Operating income (loss): (639) $ 956  
Total assets $ 339,382   $ 302,901
XML 63 R49.htm IDEA: XBRL DOCUMENT v3.22.4
Reportable Segments - Narrative (Details)
 3 Months Ended
Dec. 31, 2022
segment
Segment Reporting [Abstract]  
Number of reportable segments 3
XML 64 R50.htm IDEA: XBRL DOCUMENT v3.22.4
Guarantees - Schedule of Activity Related to Limited Warranty Liability (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Movement in Standard Product Warranty Accrual [Roll Forward]    
Limited warranty liability, beginning balance $ 6,925 $ 6,645
Accruals for warranties issued during the period 727 1,258
Settlements (in cash or in kind) during the period (1,131) (741)
Limited warranty liability, ending balance $ 6,521 $ 7,162
XML 65 R51.htm IDEA: XBRL DOCUMENT v3.22.4
Guarantees - Narrative (Details)
 3 Months Ended
Dec. 31, 2022
Minimum  
Product Warranty Liability [Line Items]  
Product warranty specification period 12 months
Maximum  
Product Warranty Liability [Line Items]  
Product warranty specification period 24 months
XML 66 R52.htm IDEA: XBRL DOCUMENT v3.22.4
Shareholders' Equity - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Aug. 18, 2022
Aug. 11, 2021
2022 Stock Repurchase Program        
Equity, Class of Treasury Stock [Line Items]        
Authorized repurchase amount       $ 50,000
Amount repurchased (in shares)   110,440    
Amount repurchased   $ 10,200    
Average repurchase price (in dollars per share)   $ 91.74    
2023 Stock Repurchase Program        
Equity, Class of Treasury Stock [Line Items]        
Authorized repurchase amount     $ 50,000  
Amount repurchased (in shares) 115,723      
Amount repurchased $ 11,500      
Average repurchase price (in dollars per share) $ 99.12      
Remaining authorized repurchase amount $ 35,000      
XML 67 R53.htm IDEA: XBRL DOCUMENT v3.22.4
Trade Accounts Receivable Sale Programs - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Amount Received From Trade Accounts Receivable Sold To Third Party [Line Items]    
Trade accounts receivable sold $ 185,600 $ 148,000
Cash proceeds 183,600 147,500
Trade accounts receivable sold, not yet collected 196,800 $ 151,000
MUFG RPA    
Amount Received From Trade Accounts Receivable Sold To Third Party [Line Items]    
Maximum facility amount $ 340,000  
Minimum prior notice required to cancel automatic extension 10 days  
HSBC RPA    
Amount Received From Trade Accounts Receivable Sold To Third Party [Line Items]    
Maximum facility amount $ 60,000  
XML 68 R54.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue from Contracts with Customers - Schedule of Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer $ 1,120,939 $ 841,881
Operating Segments    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 1,093,925 817,456
Elimination of inter-segment sales    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 27,014 24,425
Industrial | Operating Segments    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 472,082 363,827
Healthcare/Life Sciences | Operating Segments    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 487,867 344,465
Aerospace/Defense | Operating Segments    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 133,976 109,164
AMER    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 389,662 277,346
AMER | Operating Segments    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 386,430 274,957
AMER | Elimination of inter-segment sales    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 3,232 2,389
AMER | Industrial | Operating Segments    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 103,027 83,245
AMER | Healthcare/Life Sciences | Operating Segments    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 215,381 135,962
AMER | Aerospace/Defense | Operating Segments    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 68,022 55,750
APAC    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 641,904 491,672
APAC | Operating Segments    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 619,528 470,255
APAC | Elimination of inter-segment sales    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 22,376 21,417
APAC | Industrial | Operating Segments    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 350,584 265,275
APAC | Healthcare/Life Sciences | Operating Segments    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 223,290 169,237
APAC | Aerospace/Defense | Operating Segments    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 45,654 35,743
EMEA    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 89,373 72,863
EMEA | Operating Segments    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 87,967 72,244
EMEA | Elimination of inter-segment sales    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 1,406 619
EMEA | Industrial | Operating Segments    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 18,471 15,307
EMEA | Healthcare/Life Sciences | Operating Segments    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer 49,196 39,266
EMEA | Aerospace/Defense | Operating Segments    
Disaggregation of Revenue [Line Items]    
Revenue from Contract with Customer $ 20,300 $ 17,671
XML 69 R55.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue from Contracts with Customers - Schedule of Contract Assets (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Oct. 01, 2022
Oct. 02, 2021
Revenue from Contract with Customer [Abstract]        
Contract assets $ 119,016 $ 105,450 $ 138,540 $ 115,283
Revenue recognized 884,099 709,723    
Amounts collected or invoiced $ (903,623) $ (719,556)    
XML 70 R56.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue from Contracts with Customers - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Oct. 01, 2022
Disaggregation of Revenue [Line Items]      
Deferred Revenue $ 247,100   $ 298,800
Transferred over Time      
Disaggregation of Revenue [Line Items]      
Percentage of Revenue 81.00% 87.00%  
XML 71 R57.htm IDEA: XBRL DOCUMENT v3.22.4
Restructuring and Impairment Charges Schedule of Restructuring Accrual Activity (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Oct. 02, 2021
Restructuring Cost and Reserve [Line Items]      
Restructuring Reserve   $ 1,762 $ 71
Restructuring and impairment charges $ 0 2,021  
Amounts utilized   (330)  
Fixed Asset and Operating ROU Asset Impairment      
Restructuring Cost and Reserve [Line Items]      
Restructuring Reserve   0 0
Restructuring and impairment charges   255  
Amounts utilized   (255)  
Employee Termination and Severance Costs      
Restructuring Cost and Reserve [Line Items]      
Restructuring Reserve   1,762 $ 71
Restructuring and impairment charges   1,766  
Amounts utilized   $ (75)  
XML 72 R58.htm IDEA: XBRL DOCUMENT v3.22.4
Restructuring and Impairment Charges (Details) - USD ($)
$ in Thousands
 3 Months Ended
Dec. 31, 2022
Jan. 01, 2022
Restructuring Cost and Reserve [Line Items]    
Restructuring and impairment charges $ 0 $ 2,021
Restructuring Charges    
Restructuring Cost and Reserve [Line Items]    
Other Tax Expense (Benefit)   $ (200)
XML 73 plxs-20221231_htm.xml IDEA: XBRL DOCUMENT 0000785786 2022-10-02 2022-12-31 0000785786 2023-01-31 0000785786 2021-10-03 2022-01-01 0000785786 2022-12-31 0000785786 2022-10-01 0000785786 us-gaap:CommonStockMember 2022-10-01 0000785786 us-gaap:CommonStockMember 2021-10-02 0000785786 us-gaap:CommonStockMember 2022-10-02 2022-12-31 0000785786 us-gaap:CommonStockMember 2021-10-03 2022-01-01 0000785786 us-gaap:CommonStockMember 2022-12-31 0000785786 us-gaap:CommonStockMember 2022-01-01 0000785786 2021-10-02 0000785786 us-gaap:AdditionalPaidInCapitalMember 2022-10-01 0000785786 us-gaap:AdditionalPaidInCapitalMember 2021-10-02 0000785786 us-gaap:AdditionalPaidInCapitalMember 2022-10-02 2022-12-31 0000785786 us-gaap:AdditionalPaidInCapitalMember 2021-10-03 2022-01-01 0000785786 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000785786 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 0000785786 us-gaap:TreasuryStockMember 2022-10-01 0000785786 us-gaap:TreasuryStockMember 2021-10-02 0000785786 us-gaap:TreasuryStockMember 2022-10-02 2022-12-31 0000785786 us-gaap:TreasuryStockMember 2021-10-03 2022-01-01 0000785786 us-gaap:TreasuryStockMember 2022-12-31 0000785786 us-gaap:TreasuryStockMember 2022-01-01 0000785786 us-gaap:RetainedEarningsMember 2022-10-01 0000785786 us-gaap:RetainedEarningsMember 2021-10-02 0000785786 us-gaap:RetainedEarningsMember 2022-10-02 2022-12-31 0000785786 us-gaap:RetainedEarningsMember 2021-10-03 2022-01-01 0000785786 us-gaap:RetainedEarningsMember 2022-12-31 0000785786 us-gaap:RetainedEarningsMember 2022-01-01 0000785786 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-01 0000785786 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-02 0000785786 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-10-02 2022-12-31 0000785786 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-10-03 2022-01-01 0000785786 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000785786 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 0000785786 2022-01-01 0000785786 us-gaap:InventoriesMember 2022-12-31 0000785786 us-gaap:InventoriesMember 2022-10-01 0000785786 plxs:A4.05SeniorNotesMember us-gaap:SeniorNotesMember 2022-12-31 0000785786 plxs:A4.05SeniorNotesMember us-gaap:SeniorNotesMember 2022-10-01 0000785786 plxs:A4.22SeniorNotesMember us-gaap:SeniorNotesMember 2022-12-31 0000785786 plxs:A4.22SeniorNotesMember us-gaap:SeniorNotesMember 2022-10-01 0000785786 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2022-12-31 0000785786 us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2022-10-01 0000785786 us-gaap:RevolvingCreditFacilityMember 2022-10-02 2022-12-31 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-10-01 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2022-12-31 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2022-10-01 0000785786 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000785786 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-10-01 0000785786 plxs:OtherAccruedLiabilitiesCurrentMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-12-31 0000785786 plxs:OtherAccruedLiabilitiesCurrentMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-10-01 0000785786 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2022-12-31 0000785786 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2022-10-01 0000785786 plxs:OtherAccruedLiabilitiesCurrentMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2022-12-31 0000785786 plxs:OtherAccruedLiabilitiesCurrentMember us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2022-10-01 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2022-10-02 2022-12-31 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2021-10-03 2022-01-01 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2021-10-03 2022-01-01 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2022-10-02 2022-12-31 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-10-02 2022-12-31 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2021-10-03 2022-01-01 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2022-10-02 2022-12-31 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2021-10-03 2022-01-01 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember 2022-10-01 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-10-01 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-10-01 0000785786 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-10-01 0000785786 us-gaap:OperatingSegmentsMember plxs:AmericasSegmentMember 2022-10-02 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:AmericasSegmentMember 2021-10-03 2022-01-01 0000785786 us-gaap:OperatingSegmentsMember plxs:AsiaPacificSegmentMember 2022-10-02 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:AsiaPacificSegmentMember 2021-10-03 2022-01-01 0000785786 us-gaap:OperatingSegmentsMember plxs:EMEASegmentMember 2022-10-02 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:EMEASegmentMember 2021-10-03 2022-01-01 0000785786 us-gaap:IntersegmentEliminationMember 2022-10-02 2022-12-31 0000785786 us-gaap:IntersegmentEliminationMember 2021-10-03 2022-01-01 0000785786 us-gaap:CorporateNonSegmentMember 2022-10-02 2022-12-31 0000785786 us-gaap:CorporateNonSegmentMember 2021-10-03 2022-01-01 0000785786 us-gaap:OperatingSegmentsMember plxs:AmericasSegmentMember 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:AmericasSegmentMember 2022-10-01 0000785786 us-gaap:OperatingSegmentsMember plxs:AsiaPacificSegmentMember 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:AsiaPacificSegmentMember 2022-10-01 0000785786 us-gaap:OperatingSegmentsMember plxs:EMEASegmentMember 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:EMEASegmentMember 2022-10-01 0000785786 plxs:CorporateAndReconcilingItemsMember 2022-12-31 0000785786 plxs:CorporateAndReconcilingItemsMember 2022-10-01 0000785786 srt:MinimumMember 2022-10-02 2022-12-31 0000785786 srt:MaximumMember 2022-10-02 2022-12-31 0000785786 plxs:A2022StockRepurchaseProgramMember 2021-08-11 0000785786 plxs:A2022StockRepurchaseProgramMember 2021-10-03 2022-01-01 0000785786 plxs:A2023StockRepurchaseProgramMember 2022-08-18 0000785786 plxs:A2023StockRepurchaseProgramMember 2022-10-02 2022-12-31 0000785786 plxs:A2023StockRepurchaseProgramMember 2022-12-31 0000785786 plxs:MUFGMember 2022-12-31 0000785786 plxs:HSBCMember 2022-12-31 0000785786 plxs:MUFGMember 2022-10-02 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:IndustrialMember plxs:AmericasSegmentMember 2022-10-02 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:IndustrialMember plxs:AsiaPacificSegmentMember 2022-10-02 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:IndustrialMember plxs:EMEASegmentMember 2022-10-02 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:IndustrialMember 2022-10-02 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:HealthcareLifeSciencesMember plxs:AmericasSegmentMember 2022-10-02 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:HealthcareLifeSciencesMember plxs:AsiaPacificSegmentMember 2022-10-02 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:HealthcareLifeSciencesMember plxs:EMEASegmentMember 2022-10-02 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:HealthcareLifeSciencesMember 2022-10-02 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:AerospaceDefenseMember plxs:AmericasSegmentMember 2022-10-02 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:AerospaceDefenseMember plxs:AsiaPacificSegmentMember 2022-10-02 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:AerospaceDefenseMember plxs:EMEASegmentMember 2022-10-02 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:AerospaceDefenseMember 2022-10-02 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember 2022-10-02 2022-12-31 0000785786 us-gaap:IntersegmentEliminationMember plxs:AmericasSegmentMember 2022-10-02 2022-12-31 0000785786 us-gaap:IntersegmentEliminationMember plxs:AsiaPacificSegmentMember 2022-10-02 2022-12-31 0000785786 us-gaap:IntersegmentEliminationMember plxs:EMEASegmentMember 2022-10-02 2022-12-31 0000785786 plxs:AmericasSegmentMember 2022-10-02 2022-12-31 0000785786 plxs:AsiaPacificSegmentMember 2022-10-02 2022-12-31 0000785786 plxs:EMEASegmentMember 2022-10-02 2022-12-31 0000785786 us-gaap:OperatingSegmentsMember plxs:IndustrialMember plxs:AmericasSegmentMember 2021-10-03 2022-01-01 0000785786 us-gaap:OperatingSegmentsMember plxs:IndustrialMember plxs:AsiaPacificSegmentMember 2021-10-03 2022-01-01 0000785786 us-gaap:OperatingSegmentsMember plxs:IndustrialMember plxs:EMEASegmentMember 2021-10-03 2022-01-01 0000785786 us-gaap:OperatingSegmentsMember plxs:IndustrialMember 2021-10-03 2022-01-01 0000785786 us-gaap:OperatingSegmentsMember plxs:HealthcareLifeSciencesMember plxs:AmericasSegmentMember 2021-10-03 2022-01-01 0000785786 us-gaap:OperatingSegmentsMember plxs:HealthcareLifeSciencesMember plxs:AsiaPacificSegmentMember 2021-10-03 2022-01-01 0000785786 us-gaap:OperatingSegmentsMember plxs:HealthcareLifeSciencesMember plxs:EMEASegmentMember 2021-10-03 2022-01-01 0000785786 us-gaap:OperatingSegmentsMember plxs:HealthcareLifeSciencesMember 2021-10-03 2022-01-01 0000785786 us-gaap:OperatingSegmentsMember plxs:AerospaceDefenseMember plxs:AmericasSegmentMember 2021-10-03 2022-01-01 0000785786 us-gaap:OperatingSegmentsMember plxs:AerospaceDefenseMember plxs:AsiaPacificSegmentMember 2021-10-03 2022-01-01 0000785786 us-gaap:OperatingSegmentsMember plxs:AerospaceDefenseMember plxs:EMEASegmentMember 2021-10-03 2022-01-01 0000785786 us-gaap:OperatingSegmentsMember plxs:AerospaceDefenseMember 2021-10-03 2022-01-01 0000785786 us-gaap:OperatingSegmentsMember 2021-10-03 2022-01-01 0000785786 us-gaap:IntersegmentEliminationMember plxs:AmericasSegmentMember 2021-10-03 2022-01-01 0000785786 us-gaap:IntersegmentEliminationMember plxs:AsiaPacificSegmentMember 2021-10-03 2022-01-01 0000785786 us-gaap:IntersegmentEliminationMember plxs:EMEASegmentMember 2021-10-03 2022-01-01 0000785786 plxs:AmericasSegmentMember 2021-10-03 2022-01-01 0000785786 plxs:AsiaPacificSegmentMember 2021-10-03 2022-01-01 0000785786 plxs:EMEASegmentMember 2021-10-03 2022-01-01 0000785786 us-gaap:TransferredOverTimeMember 2022-10-02 2022-12-31 0000785786 us-gaap:TransferredOverTimeMember 2021-10-03 2022-01-01 0000785786 us-gaap:RestructuringChargesMember 2021-10-03 2022-01-01 0000785786 us-gaap:ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain 2021-10-02 0000785786 us-gaap:EmployeeSeveranceMember 2021-10-02 0000785786 us-gaap:ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain 2021-10-03 2022-01-01 0000785786 us-gaap:EmployeeSeveranceMember 2021-10-03 2022-01-01 0000785786 us-gaap:ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain 2022-01-01 0000785786 us-gaap:EmployeeSeveranceMember 2022-01-01 shares iso4217:USD iso4217:USD shares pure plxs:segment 0000785786 --09-30 2023 Q1 false http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2022#CostOfGoodsAndServicesSold http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2022#SellingGeneralAndAdministrativeExpense http://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrent http://www.plexus.com/20221231#LongTermDebtAndFinanceLeaseObligationsCurrent http://www.plexus.com/20221231#LongTermDebtAndFinanceLeaseObligationsCurrent http://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrent http://fasb.org/us-gaap/2022#OtherAccruedLiabilitiesCurrent http://www.plexus.com/20221231#LongTermDebtAndFinanceLeaseObligations http://www.plexus.com/20221231#LongTermDebtAndFinanceLeaseObligations 10-Q true 2022-12-31 false 001-14423 PLEXUS CORP. WI 39-1344447 One Plexus Way Neenah WI 54957 920 969-6000 Common Stock, $0.01 par value PLXS NASDAQ Yes Yes Large Accelerated Filer false false false 27702483 1093925000 817456000 992726000 747460000 101199000 69996000 43858000 37502000 0 2021000 57341000 30473000 6894000 3046000 934000 271000 -1944000 -923000 49437000 26775000 7247000 3352000 42190000 23423000 1.53 0.84 1.49 0.82 27639000 28018000 28305000 28709000 42190000 23423000 8439000 1272000 13777000 -1578000 22216000 -306000 64406000 23117000 247880000 274805000 31000 665000 2531000 1961000 733962000 737696000 119016000 138540000 1645011000 1602783000 68401000 61633000 2814301000 2816122000 448325000 444705000 64069000 65134000 39337000 39075000 29260000 28189000 580991000 577103000 3395292000 3393225000 329076000 273971000 753755000 805583000 511037000 480486000 64126000 88876000 296466000 357273000 1954460000 2006189000 187272000 187776000 42019000 42019000 32149000 33628000 5616000 6327000 23517000 21555000 290573000 291305000 2245033000 2297494000 0.01 0.01 5000000 5000000 0 0 0 0 0 0 0.01 0.01 200000000 200000000 54133000 54084000 27612000 27679000 541000 541000 654059000 652467000 26521000 26405000 1104953000 1093483000 1614424000 1572234000 -13812000 -36028000 1150259000 1095731000 3395292000 3393225000 27679000 28047000 49000 60000 116000 110000 27612000 27997000 1095731000 1028232000 541000 538000 0 1000 541000 539000 652467000 639778000 5683000 6270000 -4091000 -3394000 654059000 642654000 -1093483000 -1043091000 11470000 10131000 -1104953000 -1053222000 1572234000 1433991000 42190000 23423000 1614424000 1457414000 -36028000 -2984000 22216000 -306000 -13812000 -3290000 1150259000 1044095000 42190000 23423000 16290000 15489000 5683000 6357000 -502000 -602000 -10506000 70159000 -19745000 -9904000 31409000 214416000 7270000 9436000 -2655000 1121000 -52702000 76222000 27170000 60743000 -76844000 11171000 -48794000 -88979000 23085000 33246000 -1503000 124000 -21582000 -33370000 197000000 181134000 142001000 97565000 11470000 10131000 0 307000 4091000 3702000 39438000 70043000 3379000 184000 -27559000 -52122000 275470000 270513000 247911000 218391000 Basis of Presentation<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation:</span></div><div style="text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements included herein have been prepared by Plexus Corp. and its subsidiaries (together “Plexus” or the “Company”) without audit and pursuant to the rules and regulations of the United States (“U.S.”) Securities and Exchange Commission (“SEC”). The accompanying Condensed Consolidated Financial Statements reflect all adjustments, which include normal recurring adjustments necessary for the fair statement of the consolidated financial position of the Company as of December 31, 2022 and October 1, 2022, the results of operations and shareholders' equity for the three months ended December 31, 2022 and January 1, 2022, and the cash flows for the same three month periods.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year ends on the Saturday closest to September 30. The Company uses a “4-4-5” weekly accounting system for the interim periods in each quarter. Each quarter, therefore, ends on a Saturday at the end of the 4-4-5 period. Periodically, an additional week must be added to the fiscal year to re-align with the Saturday closest to September 30. All fiscal quarters presented herein included 13 weeks. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain information and footnote disclosures, normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP"), have been condensed or omitted pursuant to the SEC’s rules and regulations dealing with interim financial statements. However, the Company believes that the disclosures made in the Condensed Consolidated Financial Statements included herein are adequate to make the information presented not misleading. It is suggested that these Condensed Consolidated Financial Statements be read in conjunction with the Consolidated Financial Statements and notes thereto included in the Company’s 2022 Annual Report on Form 10-K.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of financial statements requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and notes thereto. The Company has considered information available as of the date of issuance of these financial statements and is not aware of any specific events or circumstances that would require an update to its estimates or judgments, or a revision of the carrying value of its assets or liabilities. These estimates may change as new events occur and additional information becomes available. Actual results could differ materially from these estimates. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted: </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the FASB issued ASU 2022-04, which requires enhanced disclosures about supplier finance programs. The guidance is effective for the Company beginning in the first quarter of fiscal 2024. Early adoption is permitted. The Company is currently in the process of assessing the impacts of the guidance. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not believe that any other recently issued accounting standards will have a material impact on its Consolidated Financial Statements, or apply to its operations.</span></div> <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation:</span></div><div style="text-indent:-18pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements included herein have been prepared by Plexus Corp. and its subsidiaries (together “Plexus” or the “Company”) without audit and pursuant to the rules and regulations of the United States (“U.S.”) Securities and Exchange Commission (“SEC”). The accompanying Condensed Consolidated Financial Statements reflect all adjustments, which include normal recurring adjustments necessary for the fair statement of the consolidated financial position of the Company as of December 31, 2022 and October 1, 2022, the results of operations and shareholders' equity for the three months ended December 31, 2022 and January 1, 2022, and the cash flows for the same three month periods.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s fiscal year ends on the Saturday closest to September 30. The Company uses a “4-4-5” weekly accounting system for the interim periods in each quarter. Each quarter, therefore, ends on a Saturday at the end of the 4-4-5 period. Periodically, an additional week must be added to the fiscal year to re-align with the Saturday closest to September 30. All fiscal quarters presented herein included 13 weeks. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certain information and footnote disclosures, normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP"), have been condensed or omitted pursuant to the SEC’s rules and regulations dealing with interim financial statements. However, the Company believes that the disclosures made in the Condensed Consolidated Financial Statements included herein are adequate to make the information presented not misleading. It is suggested that these Condensed Consolidated Financial Statements be read in conjunction with the Consolidated Financial Statements and notes thereto included in the Company’s 2022 Annual Report on Form 10-K.</span></div>The preparation of financial statements requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and notes thereto. The Company has considered information available as of the date of issuance of these financial statements and is not aware of any specific events or circumstances that would require an update to its estimates or judgments, or a revision of the carrying value of its assets or liabilities. These estimates may change as new events occur and additional information becomes available. Actual results could differ materially from these estimates. <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted: </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, the FASB issued ASU 2022-04, which requires enhanced disclosures about supplier finance programs. The guidance is effective for the Company beginning in the first quarter of fiscal 2024. Early adoption is permitted. The Company is currently in the process of assessing the impacts of the guidance. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not believe that any other recently issued accounting standards will have a material impact on its Consolidated Financial Statements, or apply to its operations.</span></div> Inventories<div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories as of December 31, 2022 and October 1, 2022 consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,468,942 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,433,353 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,822 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,207 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,247 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,223 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,645,011 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,602,783 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain circumstances, per contractual terms, customer deposits are received by the Company to offset inventory risks. The total amount of customer deposits related to inventory and included within current liabilities on the accompanying Condensed </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Balance Sheets as of December 31, 2022 and October 1, 2022 w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as $483.1 million a</span>nd $463.2 million, respectively. <div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories as of December 31, 2022 and October 1, 2022 consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,468,942 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,433,353 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,822 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,207 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,247 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,223 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories, net</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,645,011 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,602,783 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1468942000 1433353000 81822000 81207000 94247000 88223000 1645011000 1602783000 483100000 463200000 Debt, Finance Lease and Other Financing Obligations<div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt, finance lease and other financing obligations as of December 31, 2022 and October 1, 2022 consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.05% Senior Notes, due June 15, 2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.22% Senior Notes, due June 15, 2028</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings under Credit Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease and other financing obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,786 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,269 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized deferred financing fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,522)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,348 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461,747 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329,076)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273,971)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, finance lease and other financing obligations, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,272 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,776 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company was in compliance with covenants for all debt agreements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December 31, 2022, the highest daily borrowing under the Company's 5-year senior unsecured revolving credit facility (referred to as the "Credit Facility") was $394.0 million; the average daily borrowings were $320.9 million. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Company’s debt, excluding finance lease</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and other financing obligations, was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$461.5 million </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$401.6 million as of December 31, 2022 and October 1, 2022, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company's debt, excluding finance lease and other financing obligations, was </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$470.0 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$413.0 million as of December 31, 2022 and October 1, 2022, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If measured at fair value in the financial stateme</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nts, the Company's debt would be classified as Level 2 in the fair value hierarchy. Refer to Note 4, "Derivatives and Fair Value Measurements," for further information regarding the Company's fair value calculations and classifications.</span></div> <div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt, finance lease and other financing obligations as of December 31, 2022 and October 1, 2022 consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.05% Senior Notes, due June 15, 2025</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,000 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.22% Senior Notes, due June 15, 2028</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,000 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Borrowings under Credit Facility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,000 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease and other financing obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,786 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,269 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized deferred financing fees</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,438)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,522)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">516,348 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">461,747 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(329,076)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273,971)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, finance lease and other financing obligations, net of current portion</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,272 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,776 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0.0405 0.0405 100000000 100000000 0.0422 0.0422 50000000 50000000 320000000 263000000 47786000 50269000 1438000 1522000 516348000 461747000 329076000 273971000 187272000 187776000 P5Y 394000000 320900000 461500000 401600000 470000000 413000000 Derivatives and Fair Value Measurements<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All derivatives are recognized in the accompanying Condensed Consolidated Balance Sheets at their estimated fair value. The Company uses derivatives to manage the variability of foreign currency obligations. The Company has cash flow hedges related to forecasted foreign currency obligations, in addition to non-designated hedges to manage foreign currency exposures associated with certain foreign currency denominated assets and liabilities. The Company does not enter into derivatives for speculative purposes. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company designates some foreign currency exchange contracts as cash flow hedges of forecasted foreign currency expenses. Changes in the fair value of the derivatives that qualify as cash flow hedges are recorded in "Accumulated other comprehensive loss" in the accompanying Condensed Consolidated Bala</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nce Sheets until earnings are affected by the variability of the cash flows. In the next twelve months, the Company estimates t</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hat $2.4 million of unrealized gains, net of tax, related to cash flow hedges will be reclassified from other comprehensive income (loss) into earnings. Changes in the fair value of the non-designated derivatives related to recognized foreign currency denominated assets and liabilities are recorded in "Miscellaneous, net" in the accompanying Condensed Consolidated Statements of Comprehensive Income.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into forward currency exchange contracts for its operations in certain jurisdictions in the AMER and APAC segments on a rolling basis. The Company had cash flow hedges outstanding with a notional value of $148.7 million as of December 31, 2022, and a notional value of $143.2 million as of October 1, 2022. These forward currency contracts fix the exchange rates for the settlement of future foreign currency obligations that have yet to be realized. The total fair value of the forward currency exchange contracts was a $2.4 million asset as of December 31, 2022, and a $6.0 million liability as of October 1, 2022.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had additional forward currency exchange contracts outstanding as of December 31, 2022, with a notional value of $113.5 million; there were $60.1 million such contracts outstanding as of October 1, 2022. The Company did not designate these derivative instruments as hedging instruments. The net settlement amount (fair value) related to these contracts is recorded on the Condensed Consolidated Balance Sheets as either a current or long-term asset or liability, depending on the term, and as an element of "Miscellaneous, net" in the Condensed Consolidated Statements of Comprehensive Income. The total fair value of these derivatives was a $1.0 million asset as of December 31, 2022, and a $0.3 million asset as of October 1, 2022.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present information regarding the fair values of derivative instruments (as defined in Note 1, "Description of Business and Significant Accounting Policies") and the effects of derivative instruments on the Company’s Condensed Consolidated Financial Statements:</span></div><div style="margin-bottom:9pt;margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:19.837%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.030%"/><td style="width:0.1%"/></tr><tr><td colspan="39" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Values of Derivative Instruments (in thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivative Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivative Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 1,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 1,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet<br/>classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet<br/>classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,451 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,747 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:19.837%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.030%"/><td style="width:0.1%"/></tr><tr><td colspan="39" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Values of Derivative Instruments (in thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivative Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivative Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 1,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 1,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet<br/>classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet<br/>classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,487 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,555 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,486 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,249 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:67.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.982%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">The Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Loss ("OCL") (in thousands)</span></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">for the Three Months Ended</span></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in cash flow hedging relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount of Gain Recognized in OCL on Derivatives</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,150 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">470 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:31.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.725%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.162%"/><td style="width:0.1%"/></tr><tr><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Impact on Loss Recognized in Condensed Consolidated Statements of Comprehensive Income (in thousands)</span></td></tr><tr><td colspan="21" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">for the Three Months Ended</span></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in cash flow hedging relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Classification of Loss Reclassified from Accumulated OCL into Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount of Loss Reclassified from Accumulated OCL into Income </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDAvZnJhZzpkMzFlOGRiMzNlMDU0NWMyYTJjNjM5YjQ0NjQ4NTRhOS90YWJsZTo0OTk2MmI0NTFiMjQ0YzVhOGQ4MTlkYzA0NjFhN2FiNS90YWJsZXJhbmdlOjQ5OTYyYjQ1MWIyNDRjNWE4ZDgxOWRjMDQ2MWE3YWI1XzQtMi0xLTEtNzczNzk_caefd306-ab8e-4ce4-a444-eecc4963e739"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDAvZnJhZzpkMzFlOGRiMzNlMDU0NWMyYTJjNjM5YjQ0NjQ4NTRhOS90YWJsZTo0OTk2MmI0NTFiMjQ0YzVhOGQ4MTlkYzA0NjFhN2FiNS90YWJsZXJhbmdlOjQ5OTYyYjQ1MWIyNDRjNWE4ZDgxOWRjMDQ2MWE3YWI1XzQtMi0xLTEtNzczNzk_f26d5a49-552d-43cd-92e3-67ed570764a3">Cost of sales</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,132)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(743)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDAvZnJhZzpkMzFlOGRiMzNlMDU0NWMyYTJjNjM5YjQ0NjQ4NTRhOS90YWJsZTo0OTk2MmI0NTFiMjQ0YzVhOGQ4MTlkYzA0NjFhN2FiNS90YWJsZXJhbmdlOjQ5OTYyYjQ1MWIyNDRjNWE4ZDgxOWRjMDQ2MWE3YWI1XzUtMi0xLTEtNzczNzk_7253f37d-248c-4c5c-92dd-b93adc385420"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDAvZnJhZzpkMzFlOGRiMzNlMDU0NWMyYTJjNjM5YjQ0NjQ4NTRhOS90YWJsZTo0OTk2MmI0NTFiMjQ0YzVhOGQ4MTlkYzA0NjFhN2FiNS90YWJsZXJhbmdlOjQ5OTYyYjQ1MWIyNDRjNWE4ZDgxOWRjMDQ2MWE3YWI1XzUtMi0xLTEtNzczNzk_879e8979-57ec-403e-a58b-616f141fdbda">Selling and administrative expenses</span></span></span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(157)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.597%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.210%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.006%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of Gain (Loss) Recognized on Derivatives in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount of Gain (Loss) on Derivatives Recognized in Income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Miscellaneous, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">747 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:3pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements:</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (or exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses quoted market prices when available or discounted cash flows to calculate </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fair value. The accounting guidance establishes a fair value hierarchy based on three levels of inputs that may be used to measure fair value. The input levels are:</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted (observable) market prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Inputs other than Level 1 that are observable, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the asset or liability.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table lists the fair values of assets of the Company’s derivatives as of December 31, 2022 and October 1, 2022, by input level:</span></div><div style="margin-bottom:9pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.964%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using Input Levels Asset/(Liability) (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal period ended December 31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDAvZnJhZzpkMzFlOGRiMzNlMDU0NWMyYTJjNjM5YjQ0NjQ4NTRhOS90YWJsZTo5NTc0YTViZWVhMjY0YjI4Yjc5OWNlNzVmNTExY2YzNi90YWJsZXJhbmdlOjk1NzRhNWJlZWEyNjRiMjhiNzk5Y2U3NWY1MTFjZjM2XzMtMC0xLTEtNzczNzk_1909f597-9b80-4375-804e-fa37306ae7ba">Foreign currency forward contracts</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,408 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,408 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal period ended October 1, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDAvZnJhZzpkMzFlOGRiMzNlMDU0NWMyYTJjNjM5YjQ0NjQ4NTRhOS90YWJsZTo5NTc0YTViZWVhMjY0YjI4Yjc5OWNlNzVmNTExY2YzNi90YWJsZXJhbmdlOjk1NzRhNWJlZWEyNjRiMjhiNzk5Y2U3NWY1MTFjZjM2XzctMC0xLTEtNzczNzk_19718e4d-d96a-4960-a855-19b689af6eee">Foreign currency forward contracts</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,726)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,726)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of foreign currency forward contracts is determined using a market approach, which includes obtaining directly or indirectly observable values from third parties active in the relevant markets. Inputs in the fair value of the foreign currency forward contracts include prevailing forward and spot prices for currency.</span></div> 2400000 148700000 143200000 2400000 6000000 113500000 60100000 1000000 300000 <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below present information regarding the fair values of derivative instruments (as defined in Note 1, "Description of Business and Significant Accounting Policies") and the effects of derivative instruments on the Company’s Condensed Consolidated Financial Statements:</span></div><div style="margin-bottom:9pt;margin-top:14pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:19.837%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.030%"/><td style="width:0.1%"/></tr><tr><td colspan="39" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Values of Derivative Instruments (in thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivative Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivative Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 1,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 1,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet<br/>classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet<br/>classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,451 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">715 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">44 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,747 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:19.837%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.030%"/><td style="width:0.1%"/></tr><tr><td colspan="39" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Values of Derivative Instruments (in thousands)</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivative Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivative Liabilities</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 1,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">  </span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">October 1,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet<br/>classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance sheet<br/>classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,487 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,555 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,486 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,249 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div> 2451000 715000 44000 6747000 2487000 1555000 1486000 1249000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:67.274%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.980%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.982%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">The Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Loss ("OCL") (in thousands)</span></td></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">for the Three Months Ended</span></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in cash flow hedging relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount of Gain Recognized in OCL on Derivatives</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,150 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">470 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table> 6150000 470000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:31.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.937%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.725%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.162%"/><td style="width:0.1%"/></tr><tr><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivative Impact on Loss Recognized in Condensed Consolidated Statements of Comprehensive Income (in thousands)</span></td></tr><tr><td colspan="21" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">for the Three Months Ended</span></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives in cash flow hedging relationships</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Classification of Loss Reclassified from Accumulated OCL into Income</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount of Loss Reclassified from Accumulated OCL into Income </span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDAvZnJhZzpkMzFlOGRiMzNlMDU0NWMyYTJjNjM5YjQ0NjQ4NTRhOS90YWJsZTo0OTk2MmI0NTFiMjQ0YzVhOGQ4MTlkYzA0NjFhN2FiNS90YWJsZXJhbmdlOjQ5OTYyYjQ1MWIyNDRjNWE4ZDgxOWRjMDQ2MWE3YWI1XzQtMi0xLTEtNzczNzk_caefd306-ab8e-4ce4-a444-eecc4963e739"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDAvZnJhZzpkMzFlOGRiMzNlMDU0NWMyYTJjNjM5YjQ0NjQ4NTRhOS90YWJsZTo0OTk2MmI0NTFiMjQ0YzVhOGQ4MTlkYzA0NjFhN2FiNS90YWJsZXJhbmdlOjQ5OTYyYjQ1MWIyNDRjNWE4ZDgxOWRjMDQ2MWE3YWI1XzQtMi0xLTEtNzczNzk_f26d5a49-552d-43cd-92e3-67ed570764a3">Cost of sales</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2,132)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(743)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDAvZnJhZzpkMzFlOGRiMzNlMDU0NWMyYTJjNjM5YjQ0NjQ4NTRhOS90YWJsZTo0OTk2MmI0NTFiMjQ0YzVhOGQ4MTlkYzA0NjFhN2FiNS90YWJsZXJhbmdlOjQ5OTYyYjQ1MWIyNDRjNWE4ZDgxOWRjMDQ2MWE3YWI1XzUtMi0xLTEtNzczNzk_7253f37d-248c-4c5c-92dd-b93adc385420"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDAvZnJhZzpkMzFlOGRiMzNlMDU0NWMyYTJjNjM5YjQ0NjQ4NTRhOS90YWJsZTo0OTk2MmI0NTFiMjQ0YzVhOGQ4MTlkYzA0NjFhN2FiNS90YWJsZXJhbmdlOjQ5OTYyYjQ1MWIyNDRjNWE4ZDgxOWRjMDQ2MWE3YWI1XzUtMi0xLTEtNzczNzk_879e8979-57ec-403e-a58b-616f141fdbda">Selling and administrative expenses</span></span></span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(157)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table> -2132000 -743000 -157000 -59000 <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:31.597%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:33.210%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.119%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.006%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Location of Gain (Loss) Recognized on Derivatives in Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amount of Gain (Loss) on Derivatives Recognized in Income</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency forward contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Miscellaneous, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">747 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table> 747000 -43000 <div style="margin-bottom:3pt;margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements:</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (or exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses quoted market prices when available or discounted cash flows to calculate </span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fair value. The accounting guidance establishes a fair value hierarchy based on three levels of inputs that may be used to measure fair value. The input levels are:</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1: Quoted (observable) market prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2: Inputs other than Level 1 that are observable, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3: Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the asset or liability.</span></div> <div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table lists the fair values of assets of the Company’s derivatives as of December 31, 2022 and October 1, 2022, by input level:</span></div><div style="margin-bottom:9pt;margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.964%"/><td style="width:0.1%"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using Input Levels Asset/(Liability) (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal period ended December 31, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 2</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Level 3</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDAvZnJhZzpkMzFlOGRiMzNlMDU0NWMyYTJjNjM5YjQ0NjQ4NTRhOS90YWJsZTo5NTc0YTViZWVhMjY0YjI4Yjc5OWNlNzVmNTExY2YzNi90YWJsZXJhbmdlOjk1NzRhNWJlZWEyNjRiMjhiNzk5Y2U3NWY1MTFjZjM2XzMtMC0xLTEtNzczNzk_1909f597-9b80-4375-804e-fa37306ae7ba">Foreign currency forward contracts</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,408 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,408 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Fiscal period ended October 1, 2022</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Derivatives</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDAvZnJhZzpkMzFlOGRiMzNlMDU0NWMyYTJjNjM5YjQ0NjQ4NTRhOS90YWJsZTo5NTc0YTViZWVhMjY0YjI4Yjc5OWNlNzVmNTExY2YzNi90YWJsZXJhbmdlOjk1NzRhNWJlZWEyNjRiMjhiNzk5Y2U3NWY1MTFjZjM2XzctMC0xLTEtNzczNzk_19718e4d-d96a-4960-a855-19b689af6eee">Foreign currency forward contracts</span></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,726)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5,726)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 3408000 0 3408000 0 5726000 0 5726000 Income Taxes<div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense for the three months ended December 31, 2022 was $7.2 million compared to $3.4 million for the three months ended January 1, 2022. </span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rates for the three months ended December 31, 2022 and January 1, 2022 were 14.7% and 12.5%, respectively. The effective tax rate for the three months ended December 31, 2022 increased from the effective tax rate for the three months ended January 1, 2022 primarily due to a change in the geographic distribution of pre-tax book income. </span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of unrecognized tax benefits recorded for uncertain tax positions increased by $0.9 million for the three months ended December 31, 2022. The Company recognizes accrued interest and penalties on uncertain tax positions as a component of income tax expense. The amount of interest and penalties recorded for the three months ended December 31, 2022 was not material.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One or more uncertain tax positions may be settled within the next 12 months. Settlement of these matters is not expected to have a material effect on the Company's consolidated results of operations, financial position and cash flows. The Company is not currently under examination by taxing authorities in the U.S. The Company is under audit in a foreign jurisdiction but a settlement is not expected to have a material impact.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains valuation allowances when it is more likely than not that all or a portion of a net deferred tax asset will not be realized. During the three months ended December 31, 2022, the Company continued to record a full valuation allowance against its net deferred tax assets in certain jurisdictions within the EMEA segment and a partial valuation against its net deferred tax assets in certain jurisdictions within the AMER segment, as it was more likely than not that these assets would not be fully realized based primarily on historical performance. The Company will continue to provide a valuation allowance against its net deferred tax assets in each of the applicable jurisdictions going forward until it determines it is more likely than not that the deferred tax assets will be realized.</span></div> 7200000 3400000 0.147 0.125 900000 Earnings Per Share<div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the amounts utilized in the computation of basic and diluted earnings per share for the three months ended December 31, 2022 and January 1, 2022 (in thousands, except per share amounts): </span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,190 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,423 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,639 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,018 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of share-based awards and options outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,305 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,709 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.84 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.49 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.82 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended December 31, 2022 and January 1, 2022, there were no antidilutive awards. </span></div><div style="margin-bottom:9pt;margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See also Note 12, "Shareholders' Equity," for information regarding the Company's share repurchase plans.</span></div> <div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the amounts utilized in the computation of basic and diluted earnings per share for the three months ended December 31, 2022 and January 1, 2022 (in thousands, except per share amounts): </span></div><div style="margin-bottom:3pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,190 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,423 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,639 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,018 </span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of share-based awards and options outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,305 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,709 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.53 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.84 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.49 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.82 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 42190000 23423000 27639000 28018000 666000 691000 28305000 28709000 1.53 0.84 1.49 0.82 0 0 Leases<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the three months ended December 31, 2022 and January 1, 2022 indicated were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,693 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Interest on lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,272 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,606 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,258 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,176 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:4pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on the nature of the right-of use ("ROU") asset, amortization of finance lease ROU assets, operating lease expense and other lease expense are recorded within either cost of goods sold or selling and administrative expenses and interest on finance lease liabilities is recorded within interest expense on the Condensed Consolidated Statements of Comprehensive Income. Other lease expense includes lease expense for leases with an estimated total term of twelve months or less and variable lease expense related to variations in lease payments as a result of a change in factors or circumstances occurring after the lease possession date.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables sets forth the amount of lease assets and lease liabilities included in the Company’s Condensed Consolidated Balance Sheets (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.721%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Statement Line Item</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Finance lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,025 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,063 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Operating lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,069 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,134 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">      Total lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,094 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,197 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDkvZnJhZzowZjg3YTIzYzMyOWU0NDY4ODUwNDliYzZiZTE2MjdmMC90YWJsZTo4ZjEyYmQxYTI1MDE0YmYzOGU3OGU1YWE1NzdmZDcwYi90YWJsZXJhbmdlOjhmMTJiZDFhMjUwMTRiZjM4ZTc4ZTVhYTU3N2ZkNzBiXzgtMC0xLTEtNzczNzk_4bfdada2-4fa8-4951-8c87-7f6b359e0a2c"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDkvZnJhZzowZjg3YTIzYzMyOWU0NDY4ODUwNDliYzZiZTE2MjdmMC90YWJsZTo4ZjEyYmQxYTI1MDE0YmYzOGU3OGU1YWE1NzdmZDcwYi90YWJsZXJhbmdlOjhmMTJiZDFhMjUwMTRiZjM4ZTc4ZTVhYTU3N2ZkNzBiXzgtMC0xLTEtNzczNzk_62018924-6db2-4412-a53d-cc1ba6af40f6">Finance lease liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt and finance lease obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,406 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDkvZnJhZzowZjg3YTIzYzMyOWU0NDY4ODUwNDliYzZiZTE2MjdmMC90YWJsZTo4ZjEyYmQxYTI1MDE0YmYzOGU3OGU1YWE1NzdmZDcwYi90YWJsZXJhbmdlOjhmMTJiZDFhMjUwMTRiZjM4ZTc4ZTVhYTU3N2ZkNzBiXzktMC0xLTEtNzczNzk_167ff0db-2535-499b-90ae-2fb05e413a7d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDkvZnJhZzowZjg3YTIzYzMyOWU0NDY4ODUwNDliYzZiZTE2MjdmMC90YWJsZTo4ZjEyYmQxYTI1MDE0YmYzOGU3OGU1YWE1NzdmZDcwYi90YWJsZXJhbmdlOjhmMTJiZDFhMjUwMTRiZjM4ZTc4ZTVhYTU3N2ZkNzBiXzktMC0xLTEtNzczNzk_94ea2426-0588-4a07-b136-874f08ec59f9">Operating lease liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,878 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,948 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDkvZnJhZzowZjg3YTIzYzMyOWU0NDY4ODUwNDliYzZiZTE2MjdmMC90YWJsZTo4ZjEyYmQxYTI1MDE0YmYzOGU3OGU1YWE1NzdmZDcwYi90YWJsZXJhbmdlOjhmMTJiZDFhMjUwMTRiZjM4ZTc4ZTVhYTU3N2ZkNzBiXzExLTAtMS0xLTc3Mzc5_203abb31-4e57-408b-9c4d-d852912ac127"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDkvZnJhZzowZjg3YTIzYzMyOWU0NDY4ODUwNDliYzZiZTE2MjdmMC90YWJsZTo4ZjEyYmQxYTI1MDE0YmYzOGU3OGU1YWE1NzdmZDcwYi90YWJsZXJhbmdlOjhmMTJiZDFhMjUwMTRiZjM4ZTc4ZTVhYTU3N2ZkNzBiXzExLTAtMS0xLTc3Mzc5_8b17675c-973b-44e6-a9de-6a45b06fde88">Finance lease liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,257 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,149 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,628 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">        Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,016 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,920 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the three months ended December 31, 2022 and January 1, 2022 indicated were as follows (in thousands):</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Amortization of right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,693 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Interest on lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,272 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,606 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,857 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other lease expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,258 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,176 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 1614000 1693000 1272000 1222000 2606000 2857000 1766000 1404000 7258000 7176000 <div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables sets forth the amount of lease assets and lease liabilities included in the Company’s Condensed Consolidated Balance Sheets (in thousands):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:53.139%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.721%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Statement Line Item</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Finance lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,025 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,063 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Operating lease assets</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,069 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,134 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">      Total lease assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,094 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,197 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDkvZnJhZzowZjg3YTIzYzMyOWU0NDY4ODUwNDliYzZiZTE2MjdmMC90YWJsZTo4ZjEyYmQxYTI1MDE0YmYzOGU3OGU1YWE1NzdmZDcwYi90YWJsZXJhbmdlOjhmMTJiZDFhMjUwMTRiZjM4ZTc4ZTVhYTU3N2ZkNzBiXzgtMC0xLTEtNzczNzk_4bfdada2-4fa8-4951-8c87-7f6b359e0a2c"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDkvZnJhZzowZjg3YTIzYzMyOWU0NDY4ODUwNDliYzZiZTE2MjdmMC90YWJsZTo4ZjEyYmQxYTI1MDE0YmYzOGU3OGU1YWE1NzdmZDcwYi90YWJsZXJhbmdlOjhmMTJiZDFhMjUwMTRiZjM4ZTc4ZTVhYTU3N2ZkNzBiXzgtMC0xLTEtNzczNzk_62018924-6db2-4412-a53d-cc1ba6af40f6">Finance lease liabilities</span></span></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt and finance lease obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,406 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDkvZnJhZzowZjg3YTIzYzMyOWU0NDY4ODUwNDliYzZiZTE2MjdmMC90YWJsZTo4ZjEyYmQxYTI1MDE0YmYzOGU3OGU1YWE1NzdmZDcwYi90YWJsZXJhbmdlOjhmMTJiZDFhMjUwMTRiZjM4ZTc4ZTVhYTU3N2ZkNzBiXzktMC0xLTEtNzczNzk_167ff0db-2535-499b-90ae-2fb05e413a7d"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDkvZnJhZzowZjg3YTIzYzMyOWU0NDY4ODUwNDliYzZiZTE2MjdmMC90YWJsZTo4ZjEyYmQxYTI1MDE0YmYzOGU3OGU1YWE1NzdmZDcwYi90YWJsZXJhbmdlOjhmMTJiZDFhMjUwMTRiZjM4ZTc4ZTVhYTU3N2ZkNzBiXzktMC0xLTEtNzczNzk_94ea2426-0588-4a07-b136-874f08ec59f9">Operating lease liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,878 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,948 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDkvZnJhZzowZjg3YTIzYzMyOWU0NDY4ODUwNDliYzZiZTE2MjdmMC90YWJsZTo4ZjEyYmQxYTI1MDE0YmYzOGU3OGU1YWE1NzdmZDcwYi90YWJsZXJhbmdlOjhmMTJiZDFhMjUwMTRiZjM4ZTc4ZTVhYTU3N2ZkNzBiXzExLTAtMS0xLTc3Mzc5_203abb31-4e57-408b-9c4d-d852912ac127"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVkM2VmZTkxMzY3NTQyNmE4ZTE4MjIyZDFlMTJkM2UxL3NlYzo1ZDNlZmU5MTM2NzU0MjZhOGUxODIyMmQxZTEyZDNlMV8xMDkvZnJhZzowZjg3YTIzYzMyOWU0NDY4ODUwNDliYzZiZTE2MjdmMC90YWJsZTo4ZjEyYmQxYTI1MDE0YmYzOGU3OGU1YWE1NzdmZDcwYi90YWJsZXJhbmdlOjhmMTJiZDFhMjUwMTRiZjM4ZTc4ZTVhYTU3N2ZkNzBiXzExLTAtMS0xLTc3Mzc5_8b17675c-973b-44e6-a9de-6a45b06fde88">Finance lease liabilities</span></span></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt and finance lease obligations, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,583 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,257 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">  Operating lease liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,149 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,628 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">        Total lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,016 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,920 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 38025000 40063000 64069000 65134000 102094000 105197000 4406000 5087000 8878000 7948000 38583000 39257000 32149000 33628000 84016000 85920000 Share-Based CompensationThe Company recognized $5.8 million and $6.3 million of compensation expense associated with share-based awards for the three months ended December 31, 2022 and January 1, 2022, respectively. 5800000 6300000 LitigationThe Company is party to lawsuits in the ordinary course of business. Management does not believe that these proceedings, individually or in the aggregate, will have a material positive or adverse effect on the Company’s consolidated financial position, results of operations or cash flows. Reportable SegmentsReportable segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or group, in assessing performance and allocating resources. The Company uses an internal management reporting system, which provides important financial data to evaluate performance and allocate the Company’s resources on a regional basis. Net sales for the segments are attributed to the region in which the product is manufactured or the service is performed. The services provided, manufacturing processes used, class of customers serviced and order fulfillment processes used are similar and generally interchangeable across the segments. A segment’s performance is evaluated based upon its operating income (loss). A segment’s operating income (loss) includes its net sales less cost of sales and selling and administrative expenses, but excludes corporate and other expenses. Corporate and other expenses primarily represent corporate selling and administrative expenses, and restructuring costs and other charges, if any. These costs are not allocated to the segments, as management excludes such costs when assessing the performance of the segments. Inter-segment transactions are generally recorded at amounts that approximate arm’s length transactions. The accounting policies for the segments are the same as for the Company taken as a whole.<div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about the Company’s three reportable segments for three months ended December 31, 2022 and January 1, 2022 is as follows (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMER</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,662 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,346 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641,904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,672 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,373 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,863 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of inter-segment sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,014)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,425)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093,925 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817,456 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMER</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,415 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,790 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,688 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">956 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,841)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,961)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,341 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,473 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,894)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,046)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,944)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(923)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,437 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,775 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMER</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171,188 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150,605 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,809,364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,807,542 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,382 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302,901 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and eliminations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,358 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,177 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,395,292 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,393,225 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td></tr></table></div> <div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information about the Company’s three reportable segments for three months ended December 31, 2022 and January 1, 2022 is as follows (in thousands):</span></div><div style="margin-bottom:9pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net sales:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMER</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,662 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,346 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641,904 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,672 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,373 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,863 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of inter-segment sales</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,014)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,425)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093,925 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817,456 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMER</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,415 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,790 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,406 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,688 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(639)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">956 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and other costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,841)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,961)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,341 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,473 </span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,894)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,046)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">934 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Miscellaneous, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,944)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(923)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,437 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,775 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.999%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 1,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMER</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,171,188 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150,605 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,809,364 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,807,542 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339,382 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302,901 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and eliminations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,358 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,177 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,395,292 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,393,225 </span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:1pt;font-weight:400;line-height:100%"> </span></td></tr></table></div> 3 389662000 277346000 641904000 491672000 89373000 72863000 -27014000 -24425000 1093925000 817456000 17415000 1790000 78406000 60688000 -639000 956000 -37841000 -32961000 57341000 30473000 6894000 3046000 934000 271000 -1944000 -923000 49437000 26775000 1171188000 1150605000 1809364000 1807542000 339382000 302901000 75358000 132177000 3395292000 3393225000 Guarantees<div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers certain indemnifications under its customer manufacturing agreements. In the normal course of business, the Company may from time to time be obligated to indemnify its customers or its customers’ customers against damages or liabilities arising out of the Company’s negligence, misconduct, breach of contract, or infringement of third-party intellectual property rights. Certain agreements have extended broader indemnification, and while most agreements have contractual limits, some do not. However, the Company generally does not provide for such indemnities and seeks indemnification from its customers for damages or liabilities arising out of the Company’s adherence to customers’ specifications or designs or use of materials furnished, or directed to be used, by its customers. The Company does not believe its obligations under such indemnities are material.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company also provides its customers a limited warranty covering workmanship, and in some cases materials, on products manufactured by the Company. Such warranty generally provides that products will be free from defects in the Company’s workmanship and meet mutually agreed-upon specifications for periods generally ranging from 12 months to 24 months. The Company’s obligation is generally limited to correcting, at its expense, any defect by repairing or replacing such defective product. The Company’s warranty generally excludes defects resulting from faulty customer-supplied components, design defects or damage caused by any party or cause other than the Company.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides for an estimate of costs that may be incurred under its limited warranty at the time product revenue is recognized and establishes additional reserves for specifically identified product issues. These costs primarily include labor and materials, as necessary, associated with repair or replacement and are included in the Company's accompanying Condensed Consolidated Balance Sheets in "other accrued liabilities." The primary factors that affect the Company’s warranty liability include the value and the number of shipped units and historical and anticipated rates of warranty claims. As these factors are impacted by actual experience and future expectations, the Company assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a table summarizing the activity related to the Company’s limited warranty liability for the three months ended December 31, 2022 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 1, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve balance, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,925 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,645 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties issued during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,258 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Settlements (in cash or in kind) during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(741)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve balance, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,521 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,162 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> P12M P24M <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below is a table summarizing the activity related to the Company’s limited warranty liability for the three months ended December 31, 2022 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 1, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.639%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve balance, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,925 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,645 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals for warranties issued during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,258 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">   Settlements (in cash or in kind) during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,131)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(741)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reserve balance, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,521 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,162 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 6925000 6645000 727000 1258000 1131000 741000 6521000 7162000 Shareholders' Equity<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 11, 2021, the Board of Directors approved a share repurchase program under which the Company was authorized to repurchase up to $50.0 million of its common stock (the "2022 Program"). The 2022 Program commenced upon completion of the 2021 Program and was completed in fiscal 2022. During the three months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">January 1, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company repurchased 110,440 shares under this program for $10.2 million at an average price of $91.74 per share. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 18, 2022, the Board of Directors approved a share repurchase program under which the Company is authorized to repurchase up to $50.0 million of its common stock (the "2023 Program"). The 2023 Program became effective immediately and has no expiration. During the three months ended December 31, 2022, the Company repurchased 115,723 shares under this program for $11.5 million at an average price of $99.12 per share. As of December 31, 2022, $35.0 million of authority remained under the 2023 Program.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All shares repurchased under the aforementioned programs were recorded as treasury stock.</span></div> 50000000 110440 10200000 91.74 50000000 115723 11500000 99.12 35000000 Trade Accounts Receivable Sale Programs<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has Master Accounts Receivable Purchase Agreements with MUFG Bank, New York Branch (formerly known as The Bank of Tokyo-Mitsubishi UFJ, Ltd.) (the "MUFG RPA"), HSBC Bank (China) Company Limited, Xiamen branch (the "HSBC RPA") and other unaffiliated financial institutions, under which the Company may elect to sell receivables; at a discount. All facilities are uncommitted facilities. The maximum facility amount under the MUFG R</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PA is $340.0 million. The maximum facility amount under the HSBC RPA is $60.0 million.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The MUFG RPA will be automatically extended each year unless any party gives no less than 10 days prior notice that the agreement should not be extended. The terms of the HSBC RPA are generally consistent with the terms of the MUFG RPA previously discussed.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Transfers of receivables under the programs are accounted for as sales and, accordingly, receivables sold under the programs are excluded from accounts receivable on the Condensed Consolidated Balance Sheets and are reflected as cash provided by operating activities on the Condensed Consolidated Statements of Cash Flows. Proceeds from the transfer reflect the face value of the receivables less a discount. The sale discount is recorded within "Miscellaneous, net" in the Condensed Consolidated Statements of Comprehensive Income in the period of the sale. The Company continues servicing receivables sold and performing all accounts receivable administrative functions, and in exchange receives a servicing fee, under both the MUFG RPA and HSBC RPA. Servicing fees related to trade accounts receivable programs recognized during the three months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 31, 2022 and January 1, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> were not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company sold $185.6 million and $148.0 million</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of trade accounts receivable under these programs, or their predecessors, during three months ended December 31, 2022 and January 1, 2022, respectively, in exchange for cash proceeds</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> of $183.6 million and</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$147.5 million, respectively. As of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">December 31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">January 1, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, $196.8 million and $151.0 million, </span></div>respectively, of accounts receivables sold under trade accounts receivable programs and subject to servicing by the Company remained outstanding and had not yet been collected. 340000000 60000000 P10D 185600000 148000000 183600000 147500000 196800000 151000000 Revenue from Contracts with Customers<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized over time for arrangements with customers for which: (i) the Company's performance does not create an asset with an alternative use to the Company, and (ii) the Company has an enforceable right to payment, including reasonable profit margin, for performance completed to date. Revenue recognized over time is estimated based on costs incurred to date plus a reasonable profit margin. If either of the two conditions noted above are not met to recognize revenue over time, revenue is recognized following the transfer of control of such products to the customer, which typically occurs upon shipment or delivery depending on the terms of the underlying arrangement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when a contract exists and when, or as, it satisfies a performance obligation by transferring control of a product or service to a customer. Contracts are accounted for when they have approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally enters into a master services arrangement that establishes the framework under which business will be conducted. These arrangements represent the master terms and conditions of the Company's services that apply to individual orders, but they do not commit the customer to work with, or to continue to work with, the Company nor do they obligate the customer to any specific volume or pricing of purchases. Moreover, these terms can be amended in appropriate situations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer purchase orders are received for specific quantities with predominantly fixed pricing and delivery requirements. Thus, for the majority of our contracts, there is no guarantee of any revenue to the Company until a customer submits a purchase order. As a result, the Company generally considers its arrangement with a customer to be the combination of the master services arrangement and the purchase order. Most of the Company's arrangements with customers create a single performance obligation as the promise to transfer the individual manufactured product or service is capable of being distinct.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company’s performance obligations are satisfied over time as work progresses or at a point in time. A performance obligation is satisfied over time if the Company has an enforceable right to payment, including a reasonable profit margin. Determining if an enforceable right to payment includes a reasonable profit margin requires judgment and is assessed on a contract by contract basis.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, there are no subjective customer acceptance requirements or further obligations related to goods or services provided; if such requirements or obligations exist, then a sale is recognized at the time when such requirements are completed and such obligations are fulfilled.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not allow for a general right of return. Net sales include amounts billed to customers for shipping and handling and out-of-pocket expenses. The corresponding shipping and handling costs and out-of-pocket expenses are included in cost of sales. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction, that are collected by the Company from a customer, are excluded from net sales.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Costs</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts requiring over time revenue recognition, the selection of the method to measure progress towards completion requires judgment and is based on the nature of the products or services to be provided. The Company uses a cost-based input measurement of progress because it best depicts the transfer of assets to the customer, which occurs as costs are incurred during the manufacturing process or as services are rendered. Under the cost-based measure of progress, the extent of progress towards completion is measured based on the costs incurred to date. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no other costs to obtain or fulfill customer contracts. </span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregated Revenue</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below includes the Company’s revenue for the three months ended December 31, 2022 and January 1, 2022 indicated disaggregated by geographic reportable segment and market sector (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:38.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.059%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.506%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reportable Segment:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMER</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market Sector:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,027 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,584 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,471 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472,082 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare/Life Sciences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,381 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,290 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487,867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aerospace/Defense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,022 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,654 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,976 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     External revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386,430 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619,528 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,967 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093,925 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter-segment sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,232 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,376 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,014 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Segment revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,662 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641,904 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,373 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,120,939 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:38.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.059%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.506%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reportable Segment:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMER</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market Sector:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,307 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363,827 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare/Life Sciences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,962 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,266 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344,465 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aerospace/Defense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,743 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,671 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,164 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     External revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,957 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,255 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,244 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817,456 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter-segment sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,389 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,417 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,425 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Segment revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,346 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,672 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,863 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841,881 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each of the three months ended December 31, 2022 and January 1, 2022, approximately 81% and 87% of the Company's revenue, respectively, was recognized as products and services were transferred over time.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections results in billed accounts receivable, contract assets and deferred revenue on the Company’s accompanying Condensed Consolidated Balance Sheets.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Contract Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: For performance obligations satisfied at a point in time, billing occurs subsequent to revenue recognition, at which point the customer has been billed and the resulting asset is recorded within accounts receivable. For performance obligations satisfied over time as work progresses, the Company has an unconditional right to payment, which results in the recognition of contract assets. The following table summarizes the activity in the Company's contract assets during the three months ended December 31, 2022 and January 1, 2022 (in thousands):</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:72.793%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.584%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.554%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,540 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,283 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884,099 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709,723 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts collected or invoiced during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903,623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(719,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,016 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,450 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deferred Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Deferred revenue is recorded when consideration is received from a customer prior to transferring goods or services to the customer under the terms of the contract, which is included in other accrued liabilities on Condensed </span></div>Consolidated Balance Sheets. As of December 31, 2022 and October 1, 2022 the balance of advance payments from customers was $247.1 million and $298.8 million, respectively. The advance payment is not considered a significant financing component because it is used to meet working capital demands that can be higher in the early stages of a contract and to protect the company from the other party failing to adequately complete some or all of its obligations under the contract. Deferred revenue is recognized into revenue when all revenue recognition criteria are met. For performance obligations satisfied over time, recognition will occur as work progresses; otherwise deferred revenue will be recognized based upon shipping terms. <div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below includes the Company’s revenue for the three months ended December 31, 2022 and January 1, 2022 indicated disaggregated by geographic reportable segment and market sector (in thousands):</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:38.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.059%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.506%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reportable Segment:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMER</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market Sector:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,027 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350,584 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,471 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472,082 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare/Life Sciences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215,381 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223,290 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487,867 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aerospace/Defense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,022 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,654 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,300 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,976 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     External revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386,430 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619,528 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,967 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093,925 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter-segment sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,232 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,376 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,406 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,014 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Segment revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">389,662 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641,904 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,373 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,120,939 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:38.575%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.059%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.506%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reportable Segment:</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AMER</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">APAC</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMEA</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market Sector:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Industrial</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,245 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,275 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,307 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363,827 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare/Life Sciences</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,962 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,237 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,266 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">344,465 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aerospace/Defense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,750 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,743 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,671 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,164 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">     External revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274,957 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,255 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,244 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817,456 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inter-segment sales</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,389 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,417 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,425 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">    Segment revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277,346 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491,672 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,863 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841,881 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 103027000 350584000 18471000 472082000 215381000 223290000 49196000 487867000 68022000 45654000 20300000 133976000 386430000 619528000 87967000 1093925000 3232000 22376000 1406000 27014000 389662000 641904000 89373000 1120939000 83245000 265275000 15307000 363827000 135962000 169237000 39266000 344465000 55750000 35743000 17671000 109164000 274957000 470255000 72244000 817456000 2389000 21417000 619000 24425000 277346000 491672000 72863000 841881000 0.81 0.87 The following table summarizes the activity in the Company's contract assets during the three months ended December 31, 2022 and January 1, 2022 (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:72.793%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.832%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.584%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.554%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,540 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,283 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue recognized during the period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">884,099 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709,723 </span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts collected or invoiced during the period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(903,623)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(719,556)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets, end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,016 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,450 </span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 138540000 115283000 884099000 709723000 -903623000 -719556000 119016000 105450000 247100000 298800000 Restructuring and Impairment Charges<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and impairment charges are recorded within restructuring and impairment charges on the Condensed Consolidated Statements of Comprehensive Income. Restructuring liabilities are recorded within other accrued liabilities on the Condensed Consolidated Balance Sheets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2023, the Company did not incur any restructuring and impairment charges. During the first quarter of fiscal 2022, the Company recorded $2.0 million of restructuring and impairment charges primarily due to employee severance costs associated with a facility transition in the Company's APAC segment.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized a tax benefit of $0.2 million related to restructuring and impairment charges for the three months ended January 1, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's restructuring accrual activity for the three months ended January 1, 2022 is included in the tables below (in thousands):    </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Asset and Operating ROU Asset Impairment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Termination and Severance Costs    </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrual balance, as of October 2, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and impairment costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,021 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts utilized</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrual balance, as of January 1, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 2000000 -200000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's restructuring accrual activity for the three months ended January 1, 2022 is included in the tables below (in thousands):    </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.092%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.958%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.963%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed Asset and Operating ROU Asset Impairment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Termination and Severance Costs    </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrual balance, as of October 2, 2021</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and impairment costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,021 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amounts utilized</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(255)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(330)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accrual balance, as of January 1, 2022</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0 71000 71000 255000 1766000 2021000 -255000 -75000 -330000 0 1762000 1762000 EXCEL 74 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

U$'0M'T=/G79ZI P%=AOT M[XC[3F,4R> =1LQE5-:?\#B?KKG="NV8A VE9J,WTX39J/EHH&F#SM8&2;5A MV="8!.L#:']C#!X,7V 8O.5O4$L#!!0 ( "]"0U8Q"4_8M0( ,8% 9 M >&PO=V]R:W-H965T MT"8!FG3#!JQ T>[R,.Q!L6E;J"QZHIPL?S_*3KP,:+.]V*+$CA5V4LSZ/2^_HFCCDML5(\I!JMG.3D*N7%=$7,M4.5M:#*Q,EH=!E72MMH M,6OW'MUB1HTWVN*C VZJ2KG=$@UMY]$X.FP\Z:+T82->S&I5X#/Z+_6C$RON M63)=H65-%ASF\^AN?+.70=08:Y:HQ_HNT'W.=S M$?A2,MQ^8=OY7B01I U[JO9@45!IV_W5KWT=C@#7HS< R1Z0M+J[0*W*>^75 M8N9H"RYX"UM8M*FV:!&G;;B49^_D5 O.+SYIKPL5"C2+O?"%W3C=8Y<=-GD# M.X$'LKYD>&HK]'_?SO]C/)4KR5:WL#C1#K9S?@2

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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 76 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 77 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.4 html 149 220 1 false 44 0 false 5 false false R1.htm 0000001 - Document - Document And Entity Information Sheet http://www.plexus.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 0000002 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome Consolidated Statements of Comprehensive Income Statements 2 false false R3.htm 0000003 - Statement - Consolidated Balance Sheets Sheet http://www.plexus.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 3 false false R4.htm 0000004 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.plexus.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 4 false false R5.htm 0000005 - Statement - Consolidated Statements of Shareholders' Equity Sheet http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity Consolidated Statements of Shareholders' Equity Statements 5 false false R6.htm 0000006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.plexus.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 0000007 - Disclosure - Basis of Presentation Sheet http://www.plexus.com/role/BasisofPresentation Basis of Presentation Notes 7 false false R8.htm 0000008 - Disclosure - Inventories Sheet http://www.plexus.com/role/Inventories Inventories Notes 8 false false R9.htm 0000009 - Disclosure - Debt, Finance Lease and Other Financing Obligations Sheet http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligations Debt, Finance Lease and Other Financing Obligations Notes 9 false false R10.htm 0000010 - Disclosure - Derivatives and Fair Value Measurements Sheet http://www.plexus.com/role/DerivativesandFairValueMeasurements Derivatives and Fair Value Measurements Notes 10 false false R11.htm 0000011 - Disclosure - Income Taxes Sheet http://www.plexus.com/role/IncomeTaxes Income Taxes Notes 11 false false R12.htm 0000012 - Disclosure - Earnings Per Share Sheet http://www.plexus.com/role/EarningsPerShare Earnings Per Share Notes 12 false false R13.htm 0000013 - Disclosure - Leases Sheet http://www.plexus.com/role/Leases Leases Notes 13 false false R14.htm 0000014 - Disclosure - Share-Based Compensation Sheet http://www.plexus.com/role/ShareBasedCompensation Share-Based Compensation Notes 14 false false R15.htm 0000015 - Disclosure - Litigation Sheet http://www.plexus.com/role/Litigation Litigation Notes 15 false false R16.htm 0000016 - Disclosure - Reportable Segments Sheet http://www.plexus.com/role/ReportableSegments Reportable Segments Notes 16 false false R17.htm 0000017 - Disclosure - Guarantees Sheet http://www.plexus.com/role/Guarantees Guarantees Notes 17 false false R18.htm 0000018 - Disclosure - Shareholders' Equity Sheet http://www.plexus.com/role/ShareholdersEquity Shareholders' Equity Notes 18 false false R19.htm 0000019 - Disclosure - Trade Accounts Receivable Sale Programs Sheet http://www.plexus.com/role/TradeAccountsReceivableSalePrograms Trade Accounts Receivable Sale Programs Notes 19 false false R20.htm 0000020 - Disclosure - Revenue from Contracts with Customers Sheet http://www.plexus.com/role/RevenuefromContractswithCustomers Revenue from Contracts with Customers Notes 20 false false R21.htm 0000021 - Disclosure - Restructuring and Impairment Charges Sheet http://www.plexus.com/role/RestructuringandImpairmentCharges Restructuring and Impairment Charges Notes 21 false false R22.htm 0000022 - Disclosure - Basis of Presentation (Policies) Sheet http://www.plexus.com/role/BasisofPresentationPolicies Basis of Presentation (Policies) Policies 22 false false R23.htm 0000023 - Disclosure - Inventories (Tables) Sheet http://www.plexus.com/role/InventoriesTables Inventories (Tables) Tables http://www.plexus.com/role/Inventories 23 false false R24.htm 0000024 - Disclosure - Debt, Finance Lease and Other Financing Obligations (Tables) Sheet http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsTables Debt, Finance Lease and Other Financing Obligations (Tables) Tables http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligations 24 false false R25.htm 0000025 - Disclosure - Derivatives and Fair Value Measurements (Tables) Sheet http://www.plexus.com/role/DerivativesandFairValueMeasurementsTables Derivatives and Fair Value Measurements (Tables) Tables http://www.plexus.com/role/DerivativesandFairValueMeasurements 25 false false R26.htm 0000026 - Disclosure - Earnings Per Share (Tables) Sheet http://www.plexus.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.plexus.com/role/EarningsPerShare 26 false false R27.htm 0000027 - Disclosure - Leases (Tables) Sheet http://www.plexus.com/role/LeasesTables Leases (Tables) Tables http://www.plexus.com/role/Leases 27 false false R28.htm 0000028 - Disclosure - Reportable Segments (Tables) Sheet http://www.plexus.com/role/ReportableSegmentsTables Reportable Segments (Tables) Tables http://www.plexus.com/role/ReportableSegments 28 false false R29.htm 0000029 - Disclosure - Guarantees (Tables) Sheet http://www.plexus.com/role/GuaranteesTables Guarantees (Tables) Tables http://www.plexus.com/role/Guarantees 29 false false R30.htm 0000030 - Disclosure - Revenue from Contracts with Customers (Tables) Sheet http://www.plexus.com/role/RevenuefromContractswithCustomersTables Revenue from Contracts with Customers (Tables) Tables http://www.plexus.com/role/RevenuefromContractswithCustomers 30 false false R31.htm 0000031 - Disclosure - Restructuring and Impairment Charges (Tables) Sheet http://www.plexus.com/role/RestructuringandImpairmentChargesTables Restructuring and Impairment Charges (Tables) Tables http://www.plexus.com/role/RestructuringandImpairmentCharges 31 false false R32.htm 0000032 - Disclosure - Inventories - Schedule of Inventories (Details) Sheet http://www.plexus.com/role/InventoriesScheduleofInventoriesDetails Inventories - Schedule of Inventories (Details) Details 32 false false R33.htm 0000033 - Disclosure - Inventories - Narrative (Details) Sheet http://www.plexus.com/role/InventoriesNarrativeDetails Inventories - Narrative (Details) Details 33 false false R34.htm 0000034 - Disclosure - Debt, Finance Lease and Other Financing Obligations - Schedule of Debt, Finance Lease and Other Financing Obligations (Details) Sheet http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails Debt, Finance Lease and Other Financing Obligations - Schedule of Debt, Finance Lease and Other Financing Obligations (Details) Details 34 false false R35.htm 0000035 - Disclosure - Debt, Finance Lease and Other Financing Obligations - Narrative (Details) Sheet http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsNarrativeDetails Debt, Finance Lease and Other Financing Obligations - Narrative (Details) Details http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsTables 35 false false R36.htm 0000036 - Disclosure - Derivatives and Fair Value Measurements - Schedule of Fair Values of Derivative Instruments (Details) Sheet http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValuesofDerivativeInstrumentsDetails Derivatives and Fair Value Measurements - Schedule of Fair Values of Derivative Instruments (Details) Details 36 false false R37.htm 0000037 - Disclosure - Derivatives and Fair Value Measurements - Schedule of Derivative Impact on Accumulated Other Comprehensive (Loss) Income (Details) Sheet http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonAccumulatedOtherComprehensiveLossIncomeDetails Derivatives and Fair Value Measurements - Schedule of Derivative Impact on Accumulated Other Comprehensive (Loss) Income (Details) Details 37 false false R38.htm 0000038 - Disclosure - Derivatives and Fair Value Measurements - Schedule of Derivative Impact on (Loss) Gain Recognized in Income (Details) Sheet http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails Derivatives and Fair Value Measurements - Schedule of Derivative Impact on (Loss) Gain Recognized in Income (Details) Details 38 false false R39.htm 0000039 - Disclosure - Derivatives and Fair Value Measurements - Schedule of Amount of Gain (Loss) on Derivatives Recognized in Income (Details) Sheet http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofAmountofGainLossonDerivativesRecognizedinIncomeDetails Derivatives and Fair Value Measurements - Schedule of Amount of Gain (Loss) on Derivatives Recognized in Income (Details) Details 39 false false R40.htm 0000040 - Disclosure - Derivatives and Fair Value Measurements - Schedule of Fair Value Measurements Using Input Levels (Details) Sheet http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails Derivatives and Fair Value Measurements - Schedule of Fair Value Measurements Using Input Levels (Details) Details 40 false false R41.htm 0000041 - Disclosure - Derivatives and Fair Value Measurements - Narrative (Details) Sheet http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails Derivatives and Fair Value Measurements - Narrative (Details) Details 41 false false R42.htm 0000042 - Disclosure - Income Taxes - Narrative (Details) Sheet http://www.plexus.com/role/IncomeTaxesNarrativeDetails Income Taxes - Narrative (Details) Details 42 false false R43.htm 0000043 - Disclosure - Earnings Per Share - Reconciliation of Amounts Utilized in Computation of Basic and Diluted Earnings Per Share (Details) Sheet http://www.plexus.com/role/EarningsPerShareReconciliationofAmountsUtilizedinComputationofBasicandDilutedEarningsPerShareDetails Earnings Per Share - Reconciliation of Amounts Utilized in Computation of Basic and Diluted Earnings Per Share (Details) Details 43 false false R44.htm 0000044 - Disclosure - Earnings Per Share - Narrative (Details) Sheet http://www.plexus.com/role/EarningsPerShareNarrativeDetails Earnings Per Share - Narrative (Details) Details 44 false false R45.htm 0000045 - Disclosure - Leases Schedule of Lease Expense and Other Information (Details) Sheet http://www.plexus.com/role/LeasesScheduleofLeaseExpenseandOtherInformationDetails Leases Schedule of Lease Expense and Other Information (Details) Details 45 false false R46.htm 0000046 - Disclosure - Leases Schedule of Lease Assets and Liabilities (Details) Sheet http://www.plexus.com/role/LeasesScheduleofLeaseAssetsandLiabilitiesDetails Leases Schedule of Lease Assets and Liabilities (Details) Details 46 false false R47.htm 0000047 - Disclosure - Benefit Plans - Narrative (Details) Sheet http://www.plexus.com/role/BenefitPlansNarrativeDetails Benefit Plans - Narrative (Details) Details 47 false false R48.htm 0000048 - Disclosure - Reportable Segments - Schedule of Reportable Segments Information (Details) Sheet http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails Reportable Segments - Schedule of Reportable Segments Information (Details) Details 48 false false R49.htm 0000049 - Disclosure - Reportable Segments - Narrative (Details) Sheet http://www.plexus.com/role/ReportableSegmentsNarrativeDetails Reportable Segments - Narrative (Details) Details 49 false false R50.htm 0000050 - Disclosure - Guarantees - Schedule of Activity Related to Limited Warranty Liability (Details) Sheet http://www.plexus.com/role/GuaranteesScheduleofActivityRelatedtoLimitedWarrantyLiabilityDetails Guarantees - Schedule of Activity Related to Limited Warranty Liability (Details) Details 50 false false R51.htm 0000051 - Disclosure - Guarantees - Narrative (Details) Sheet http://www.plexus.com/role/GuaranteesNarrativeDetails Guarantees - Narrative (Details) Details 51 false false R52.htm 0000052 - Disclosure - Shareholders' Equity - Narrative (Details) Sheet http://www.plexus.com/role/ShareholdersEquityNarrativeDetails Shareholders' Equity - Narrative (Details) Details 52 false false R53.htm 0000053 - Disclosure - Trade Accounts Receivable Sale Programs - Narrative (Details) Sheet http://www.plexus.com/role/TradeAccountsReceivableSaleProgramsNarrativeDetails Trade Accounts Receivable Sale Programs - Narrative (Details) Details 53 false false R54.htm 0000054 - Disclosure - Revenue from Contracts with Customers - Schedule of Disaggregation of Revenue (Details) Sheet http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails Revenue from Contracts with Customers - Schedule of Disaggregation of Revenue (Details) Details 54 false false R55.htm 0000055 - Disclosure - Revenue from Contracts with Customers - Schedule of Contract Assets (Details) Sheet http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofContractAssetsDetails Revenue from Contracts with Customers - Schedule of Contract Assets (Details) Details 55 false false R56.htm 0000056 - Disclosure - Revenue from Contracts with Customers - Narrative (Details) Sheet http://www.plexus.com/role/RevenuefromContractswithCustomersNarrativeDetails Revenue from Contracts with Customers - Narrative (Details) Details 56 false false R57.htm 0000057 - Disclosure - Restructuring and Impairment Charges Schedule of Restructuring Accrual Activity (Details) Sheet http://www.plexus.com/role/RestructuringandImpairmentChargesScheduleofRestructuringAccrualActivityDetails Restructuring and Impairment Charges Schedule of Restructuring Accrual Activity (Details) Details 57 false false R58.htm 0000058 - Disclosure - Restructuring and Impairment Charges (Details) Sheet http://www.plexus.com/role/RestructuringandImpairmentChargesDetails Restructuring and Impairment Charges (Details) Details http://www.plexus.com/role/RestructuringandImpairmentChargesTables 58 false false All Reports Book All Reports plxs-20221231.htm erformofperformancestockun.htm plxs-20221231.xsd plxs-20221231_cal.xml plxs-20221231_def.xml plxs-20221231_lab.xml plxs-20221231_pre.xml plxsf2310-qexhibit311.htm plxsf2310-qq1exhibit312.htm plxsf2310-qq1exhibit321.htm plxsf2310-qq1exhibit322.htm plxsf2310-qq1exhibit991.htm tsrformofperformancestocku.htm plxs-20221231_g1.gif http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 79 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "plxs-20221231.htm": { "axisCustom": 0, "axisStandard": 21, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 488, "http://xbrl.sec.gov/dei/2022": 29 }, "contextCount": 149, "dts": { "calculationLink": { "local": [ "plxs-20221231_cal.xml" ] }, "definitionLink": { "local": [ "plxs-20221231_def.xml" ] }, "inline": { "local": [ "plxs-20221231.htm" ] }, "labelLink": { "local": [ "plxs-20221231_lab.xml" ] }, "presentationLink": { "local": [ "plxs-20221231_pre.xml" ] }, "schema": { "local": [ "plxs-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 371, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 12, "http://xbrl.sec.gov/dei/2022": 5, "total": 17 }, "keyCustom": 20, "keyStandard": 200, "memberCustom": 14, "memberStandard": 30, "nsprefix": "plxs", "nsuri": "http://www.plexus.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0000001 - Document - Document And Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.plexus.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000010 - Disclosure - Derivatives and Fair Value Measurements", "menuCat": "Notes", "order": "10", "role": "http://www.plexus.com/role/DerivativesandFairValueMeasurements", "shortName": "Derivatives and Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativesAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000011 - Disclosure - Income Taxes", "menuCat": "Notes", "order": "11", "role": "http://www.plexus.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000012 - Disclosure - Earnings Per Share", "menuCat": "Notes", "order": "12", "role": "http://www.plexus.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeLeasesPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000013 - Disclosure - Leases", "menuCat": "Notes", "order": "13", "role": "http://www.plexus.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeLeasesPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000014 - Disclosure - Share-Based Compensation", "menuCat": "Notes", "order": "14", "role": "http://www.plexus.com/role/ShareBasedCompensation", "shortName": "Share-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000015 - Disclosure - Litigation", "menuCat": "Notes", "order": "15", "role": "http://www.plexus.com/role/Litigation", "shortName": "Litigation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000016 - Disclosure - Reportable Segments", "menuCat": "Notes", "order": "16", "role": "http://www.plexus.com/role/ReportableSegments", "shortName": "Reportable Segments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000017 - Disclosure - Guarantees", "menuCat": "Notes", "order": "17", "role": "http://www.plexus.com/role/Guarantees", "shortName": "Guarantees", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ProductWarrantyDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000018 - Disclosure - Shareholders' Equity", "menuCat": "Notes", "order": "18", "role": "http://www.plexus.com/role/ShareholdersEquity", "shortName": "Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000019 - Disclosure - Trade Accounts Receivable Sale Programs", "menuCat": "Notes", "order": "19", "role": "http://www.plexus.com/role/TradeAccountsReceivableSalePrograms", "shortName": "Trade Accounts Receivable Sale Programs", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000002 - Statement - Consolidated Statements of Comprehensive Income", "menuCat": "Statements", "order": "2", "role": "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome", "shortName": "Consolidated Statements of Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000020 - Disclosure - Revenue from Contracts with Customers", "menuCat": "Notes", "order": "20", "role": "http://www.plexus.com/role/RevenuefromContractswithCustomers", "shortName": "Revenue from Contracts with Customers", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000021 - Disclosure - Restructuring and Impairment Charges", "menuCat": "Notes", "order": "21", "role": "http://www.plexus.com/role/RestructuringandImpairmentCharges", "shortName": "Restructuring and Impairment Charges", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000022 - Disclosure - Basis of Presentation (Policies)", "menuCat": "Policies", "order": "22", "role": "http://www.plexus.com/role/BasisofPresentationPolicies", "shortName": "Basis of Presentation (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000023 - Disclosure - Inventories (Tables)", "menuCat": "Tables", "order": "23", "role": "http://www.plexus.com/role/InventoriesTables", "shortName": "Inventories (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000024 - Disclosure - Debt, Finance Lease and Other Financing Obligations (Tables)", "menuCat": "Tables", "order": "24", "role": "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsTables", "shortName": "Debt, Finance Lease and Other Financing Obligations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000025 - Disclosure - Derivatives and Fair Value Measurements (Tables)", "menuCat": "Tables", "order": "25", "role": "http://www.plexus.com/role/DerivativesandFairValueMeasurementsTables", "shortName": "Derivatives and Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000026 - Disclosure - Earnings Per Share (Tables)", "menuCat": "Tables", "order": "26", "role": "http://www.plexus.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000027 - Disclosure - Leases (Tables)", "menuCat": "Tables", "order": "27", "role": "http://www.plexus.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000028 - Disclosure - Reportable Segments (Tables)", "menuCat": "Tables", "order": "28", "role": "http://www.plexus.com/role/ReportableSegmentsTables", "shortName": "Reportable Segments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000029 - Disclosure - Guarantees (Tables)", "menuCat": "Tables", "order": "29", "role": "http://www.plexus.com/role/GuaranteesTables", "shortName": "Guarantees (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000003 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "3", "role": "http://www.plexus.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000030 - Disclosure - Revenue from Contracts with Customers (Tables)", "menuCat": "Tables", "order": "30", "role": "http://www.plexus.com/role/RevenuefromContractswithCustomersTables", "shortName": "Revenue from Contracts with Customers (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000031 - Disclosure - Restructuring and Impairment Charges (Tables)", "menuCat": "Tables", "order": "31", "role": "http://www.plexus.com/role/RestructuringandImpairmentChargesTables", "shortName": "Restructuring and Impairment Charges (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000032 - Disclosure - Inventories - Schedule of Inventories (Details)", "menuCat": "Details", "order": "32", "role": "http://www.plexus.com/role/InventoriesScheduleofInventoriesDetails", "shortName": "Inventories - Schedule of Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "plxs:CustomerDepositCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000033 - Disclosure - Inventories - Narrative (Details)", "menuCat": "Details", "order": "33", "role": "http://www.plexus.com/role/InventoriesNarrativeDetails", "shortName": "Inventories - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "ix:continuation", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i5c0adbf6afef493eac7bba3f8ed39861_I20221231", "decimals": "-5", "lang": "en-US", "name": "plxs:CustomerDepositCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000034 - Disclosure - Debt, Finance Lease and Other Financing Obligations - Schedule of Debt, Finance Lease and Other Financing Obligations (Details)", "menuCat": "Details", "order": "34", "role": "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails", "shortName": "Debt, Finance Lease and Other Financing Obligations - Schedule of Debt, Finance Lease and Other Financing Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "lang": "en-US", "name": "plxs:FinanceLeaseObligations", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000035 - Disclosure - Debt, Finance Lease and Other Financing Obligations - Narrative (Details)", "menuCat": "Details", "order": "35", "role": "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsNarrativeDetails", "shortName": "Debt, Finance Lease and Other Financing Obligations - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i64f9f777ecb04e9cb0164a84d0a8649e_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000036 - Disclosure - Derivatives and Fair Value Measurements - Schedule of Fair Values of Derivative Instruments (Details)", "menuCat": "Details", "order": "36", "role": "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValuesofDerivativeInstrumentsDetails", "shortName": "Derivatives and Fair Value Measurements - Schedule of Fair Values of Derivative Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i8a581a5ed67146e0b7136bd69d9f40c3_I20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i204f2c2dcbe74cb69e8359046391ba11_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "plxs:OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000037 - Disclosure - Derivatives and Fair Value Measurements - Schedule of Derivative Impact on Accumulated Other Comprehensive (Loss) Income (Details)", "menuCat": "Details", "order": "37", "role": "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonAccumulatedOtherComprehensiveLossIncomeDetails", "shortName": "Derivatives and Fair Value Measurements - Schedule of Derivative Impact on Accumulated Other Comprehensive (Loss) Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i204f2c2dcbe74cb69e8359046391ba11_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "plxs:OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i8d67155a3b8e44859397f7381aed064e_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000038 - Disclosure - Derivatives and Fair Value Measurements - Schedule of Derivative Impact on (Loss) Gain Recognized in Income (Details)", "menuCat": "Details", "order": "38", "role": "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails", "shortName": "Derivatives and Fair Value Measurements - Schedule of Derivative Impact on (Loss) Gain Recognized in Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i8d67155a3b8e44859397f7381aed064e_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i367b4a99cd524d9dbb75cb0ec085a131_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000039 - Disclosure - Derivatives and Fair Value Measurements - Schedule of Amount of Gain (Loss) on Derivatives Recognized in Income (Details)", "menuCat": "Details", "order": "39", "role": "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofAmountofGainLossonDerivativesRecognizedinIncomeDetails", "shortName": "Derivatives and Fair Value Measurements - Schedule of Amount of Gain (Loss) on Derivatives Recognized in Income (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i367b4a99cd524d9dbb75cb0ec085a131_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000004 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "4", "role": "http://www.plexus.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "ifdb646a626d849e88856b8c5aa726d88_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000040 - Disclosure - Derivatives and Fair Value Measurements - Schedule of Fair Value Measurements Using Input Levels (Details)", "menuCat": "Details", "order": "40", "role": "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails", "shortName": "Derivatives and Fair Value Measurements - Schedule of Fair Value Measurements Using Input Levels (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "ifdb646a626d849e88856b8c5aa726d88_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DerivativeAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000041 - Disclosure - Derivatives and Fair Value Measurements - Narrative (Details)", "menuCat": "Details", "order": "41", "role": "http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails", "shortName": "Derivatives and Fair Value Measurements - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000042 - Disclosure - Income Taxes - Narrative (Details)", "menuCat": "Details", "order": "42", "role": "http://www.plexus.com/role/IncomeTaxesNarrativeDetails", "shortName": "Income Taxes - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "3", "lang": "en-US", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000043 - Disclosure - Earnings Per Share - Reconciliation of Amounts Utilized in Computation of Basic and Diluted Earnings Per Share (Details)", "menuCat": "Details", "order": "43", "role": "http://www.plexus.com/role/EarningsPerShareReconciliationofAmountsUtilizedinComputationofBasicandDilutedEarningsPerShareDetails", "shortName": "Earnings Per Share - Reconciliation of Amounts Utilized in Computation of Basic and Diluted Earnings Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000044 - Disclosure - Earnings Per Share - Narrative (Details)", "menuCat": "Details", "order": "44", "role": "http://www.plexus.com/role/EarningsPerShareNarrativeDetails", "shortName": "Earnings Per Share - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000045 - Disclosure - Leases Schedule of Lease Expense and Other Information (Details)", "menuCat": "Details", "order": "45", "role": "http://www.plexus.com/role/LeasesScheduleofLeaseExpenseandOtherInformationDetails", "shortName": "Leases Schedule of Lease Expense and Other Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "plxs:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000046 - Disclosure - Leases Schedule of Lease Assets and Liabilities (Details)", "menuCat": "Details", "order": "46", "role": "http://www.plexus.com/role/LeasesScheduleofLeaseAssetsandLiabilitiesDetails", "shortName": "Leases Schedule of Lease Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "plxs:AssetsAndLiabilitiesLesseeTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:FinanceLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000047 - Disclosure - Benefit Plans - Narrative (Details)", "menuCat": "Details", "order": "47", "role": "http://www.plexus.com/role/BenefitPlansNarrativeDetails", "shortName": "Benefit Plans - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000048 - Disclosure - Reportable Segments - Schedule of Reportable Segments Information (Details)", "menuCat": "Details", "order": "48", "role": "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails", "shortName": "Reportable Segments - Schedule of Reportable Segments Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i6fa8e64b31bb4b439b3518a581d3c8d7_D20221002-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000049 - Disclosure - Reportable Segments - Narrative (Details)", "menuCat": "Details", "order": "49", "role": "http://www.plexus.com/role/ReportableSegmentsNarrativeDetails", "shortName": "Reportable Segments - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "segment", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "ic83091b5419a4096a7d857a8aa27c23c_I20211002", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000005 - Statement - Consolidated Statements of Shareholders' Equity", "menuCat": "Statements", "order": "5", "role": "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity", "shortName": "Consolidated Statements of Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "ic83091b5419a4096a7d857a8aa27c23c_I20211002", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i60628eb703f9466e8c7027eb1dd20100_I20221001", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StandardProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000050 - Disclosure - Guarantees - Schedule of Activity Related to Limited Warranty Liability (Details)", "menuCat": "Details", "order": "50", "role": "http://www.plexus.com/role/GuaranteesScheduleofActivityRelatedtoLimitedWarrantyLiabilityDetails", "shortName": "Guarantees - Schedule of Activity Related to Limited Warranty Liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i60628eb703f9466e8c7027eb1dd20100_I20221001", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StandardProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i44ed14e876384b4d88f168a6f1349832_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "plxs:StandardProductWarrantyTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000051 - Disclosure - Guarantees - Narrative (Details)", "menuCat": "Details", "order": "51", "role": "http://www.plexus.com/role/GuaranteesNarrativeDetails", "shortName": "Guarantees - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i44ed14e876384b4d88f168a6f1349832_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "plxs:StandardProductWarrantyTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i560a2075f9e84b77bc9030901910c573_I20210811", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000052 - Disclosure - Shareholders' Equity - Narrative (Details)", "menuCat": "Details", "order": "52", "role": "http://www.plexus.com/role/ShareholdersEquityNarrativeDetails", "shortName": "Shareholders' Equity - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i560a2075f9e84b77bc9030901910c573_I20210811", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000053 - Disclosure - Trade Accounts Receivable Sale Programs - Narrative (Details)", "menuCat": "Details", "order": "53", "role": "http://www.plexus.com/role/TradeAccountsReceivableSaleProgramsNarrativeDetails", "shortName": "Trade Accounts Receivable Sale Programs - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000054 - Disclosure - Revenue from Contracts with Customers - Schedule of Disaggregation of Revenue (Details)", "menuCat": "Details", "order": "54", "role": "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails", "shortName": "Revenue from Contracts with Customers - Schedule of Disaggregation of Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetNetCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000055 - Disclosure - Revenue from Contracts with Customers - Schedule of Contract Assets (Details)", "menuCat": "Details", "order": "55", "role": "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofContractAssetsDetails", "shortName": "Revenue from Contracts with Customers - Schedule of Contract Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i273186614dc6471e8440b7d841c2275d_I20220101", "decimals": "-3", "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000056 - Disclosure - Revenue from Contracts with Customers - Narrative (Details)", "menuCat": "Details", "order": "56", "role": "http://www.plexus.com/role/RevenuefromContractswithCustomersNarrativeDetails", "shortName": "Revenue from Contracts with Customers - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i1db0541dd2624786a381f7a54d2f4675_I20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DeferredRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i273186614dc6471e8440b7d841c2275d_I20220101", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000057 - Disclosure - Restructuring and Impairment Charges Schedule of Restructuring Accrual Activity (Details)", "menuCat": "Details", "order": "57", "role": "http://www.plexus.com/role/RestructuringandImpairmentChargesScheduleofRestructuringAccrualActivityDetails", "shortName": "Restructuring and Impairment Charges Schedule of Restructuring Accrual Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i273186614dc6471e8440b7d841c2275d_I20220101", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000058 - Disclosure - Restructuring and Impairment Charges (Details)", "menuCat": "Details", "order": "58", "role": "http://www.plexus.com/role/RestructuringandImpairmentChargesDetails", "shortName": "Restructuring and Impairment Charges (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i6d289ecfe473404fbb146c7e55e24791_D20211003-20220101", "decimals": "-3", "lang": "en-US", "name": "us-gaap:OtherTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "0000006 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000007 - Disclosure - Basis of Presentation", "menuCat": "Notes", "order": "7", "role": "http://www.plexus.com/role/BasisofPresentation", "shortName": "Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000008 - Disclosure - Inventories", "menuCat": "Notes", "order": "8", "role": "http://www.plexus.com/role/Inventories", "shortName": "Inventories", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "0000009 - Disclosure - Debt, Finance Lease and Other Financing Obligations", "menuCat": "Notes", "order": "9", "role": "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligations", "shortName": "Debt, Finance Lease and Other Financing Obligations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "plxs-20221231.htm", "contextRef": "i99750fd7034f41c5a24deb84c880d8a8_D20221002-20221231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 44, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r498" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r499" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r495" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r497" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.plexus.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "plxs_A2022StockRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2022 Stock Repurchase Program", "label": "2022 Stock Repurchase Program [Member]", "terseLabel": "2022 Stock Repurchase Program" } } }, "localname": "A2022StockRepurchaseProgramMember", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "plxs_A2023StockRepurchaseProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2023 Stock Repurchase Program", "label": "2023 Stock Repurchase Program [Member]", "terseLabel": "2023 Stock Repurchase Program" } } }, "localname": "A2023StockRepurchaseProgramMember", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "plxs_A4.05SeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "4.05% Senior Notes [Member]", "label": "4.05% Senior Notes [Member]", "terseLabel": "$4.05% Senior Notes, due June 15, 2025" } } }, "localname": "A4.05SeniorNotesMember", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "domainItemType" }, "plxs_A4.22SeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "4.22% Senior Notes [Member]", "label": "4.22% Senior Notes [Member]", "terseLabel": "$4.22% Senior Notes, due June 15, 2028" } } }, "localname": "A4.22SeniorNotesMember", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "domainItemType" }, "plxs_AerospaceDefenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aerospace/Defense [Member]", "label": "Aerospace/Defense [Member]", "terseLabel": "Aerospace/Defense" } } }, "localname": "AerospaceDefenseMember", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "plxs_AmericasSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Americas Segment [Member]", "label": "Americas Segment [Member]", "terseLabel": "AMER" } } }, "localname": "AmericasSegmentMember", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails", "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "plxs_AmountReceivedFromTradeAccountsReceivableSoldToThirdPartyLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Line Items] for Amount Received From Trade Accounts Receivable Sold To Third Party", "label": "Amount Received From Trade Accounts Receivable Sold To Third Party [Line Items]", "terseLabel": "Amount Received From Trade Accounts Receivable Sold To Third Party [Line Items]" } } }, "localname": "AmountReceivedFromTradeAccountsReceivableSoldToThirdPartyLineItems", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/TradeAccountsReceivableSaleProgramsNarrativeDetails" ], "xbrltype": "stringItemType" }, "plxs_AmountReceivedFromTradeAccountsReceivableSoldToThirdPartyTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount Received From Trade Accounts Receivable Sold To Third Party", "label": "Amount Received From Trade Accounts Receivable Sold To Third Party [Table]", "terseLabel": "Amount Received From Trade Accounts Receivable Sold To Third Party [Table]" } } }, "localname": "AmountReceivedFromTradeAccountsReceivableSoldToThirdPartyTable", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/TradeAccountsReceivableSaleProgramsNarrativeDetails" ], "xbrltype": "stringItemType" }, "plxs_AsiaPacificSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asia Pacific Segment [Member]", "label": "Asia Pacific Segment [Member]", "terseLabel": "APAC" } } }, "localname": "AsiaPacificSegmentMember", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails", "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "plxs_AssetsAndLiabilitiesLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets and Liabilities, Leases [Abstract]", "label": "Assets and Liabilities, Leases [Abstract]" } } }, "localname": "AssetsAndLiabilitiesLeasesAbstract", "nsuri": "http://www.plexus.com/20221231", "xbrltype": "stringItemType" }, "plxs_AssetsAndLiabilitiesLesseeTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets and Liabilities, Lessee [Table Text Block]", "label": "Assets and Liabilities, Lessee [Table Text Block]", "terseLabel": "Schedule of Lease Assets and Liabilities" } } }, "localname": "AssetsAndLiabilitiesLesseeTableTextBlock", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "plxs_CorporateAndReconcilingItemsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corporate And Reconciling Items [Member]", "label": "Corporate And Reconciling Items [Member]", "terseLabel": "Corporate and eliminations" } } }, "localname": "CorporateAndReconcilingItemsMember", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails" ], "xbrltype": "domainItemType" }, "plxs_CustomerDepositCurrent": { "auth_ref": [], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Customer Deposit Current", "label": "Customer Deposit Current", "terseLabel": "Customer deposits" } } }, "localname": "CustomerDepositCurrent", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets", "http://www.plexus.com/role/InventoriesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "plxs_DocumentAndEntityInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Document and Entity Information [Abstract]", "label": "Document And Entity Information [Abstract]", "terseLabel": "Document And Entity Information [Abstract]" } } }, "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.plexus.com/20221231", "xbrltype": "stringItemType" }, "plxs_EMEASegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "EMEA Segment [Member]", "label": "EMEA Segment [Member]", "terseLabel": "EMEA" } } }, "localname": "EMEASegmentMember", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails", "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "plxs_EarningsPerShareDilutedAndBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnings Per Share Diluted and Basic", "label": "Earnings Per Share Diluted and Basic [Abstract]", "terseLabel": "Earnings per share:" } } }, "localname": "EarningsPerShareDilutedAndBasicAbstract", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/EarningsPerShareReconciliationofAmountsUtilizedinComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "plxs_FinanceLeaseObligations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Finance Lease Obligations", "label": "Finance Lease Obligations", "verboseLabel": "Finance lease and other financing obligations" } } }, "localname": "FinanceLeaseObligations", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "monetaryItemType" }, "plxs_HSBCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HSBC [Member]", "label": "HSBC [Member]", "terseLabel": "HSBC RPA" } } }, "localname": "HSBCMember", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/TradeAccountsReceivableSaleProgramsNarrativeDetails" ], "xbrltype": "domainItemType" }, "plxs_HealthcareLifeSciencesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Healthcare/Life Sciences [Member]", "label": "Healthcare/Life Sciences [Member]", "terseLabel": "Healthcare/Life Sciences" } } }, "localname": "HealthcareLifeSciencesMember", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "plxs_IncreaseDecreaseCustomerDeposits": { "auth_ref": [], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) Customer Deposits", "label": "Increase (Decrease) Customer Deposits", "terseLabel": "Customer deposits" } } }, "localname": "IncreaseDecreaseCustomerDeposits", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "plxs_IndustrialMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Industrial", "label": "Industrial [Member]", "terseLabel": "Industrial" } } }, "localname": "IndustrialMember", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "plxs_LeaseAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lease Assets", "label": "Lease Assets", "terseLabel": "Total lease Assets" } } }, "localname": "LeaseAssets", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/LeasesScheduleofLeaseAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "plxs_LeaseExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Lease, Expense", "label": "Lease, Expense", "terseLabel": "Total lease expense" } } }, "localname": "LeaseExpense", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/LeasesScheduleofLeaseExpenseandOtherInformationDetails" ], "xbrltype": "monetaryItemType" }, "plxs_LeaseLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lease Liability", "label": "Lease Liability", "terseLabel": "Total lease liabilities" } } }, "localname": "LeaseLiability", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/LeasesScheduleofLeaseAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "plxs_LongTermDebtAndFinanceLeaseObligations": { "auth_ref": [], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 }, "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails": { "order": 2.0, "parentTag": "plxs_LongTermDebtAndFinanceLeaseObligationsIncludingCurrentMaturities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-Term Debt And Finance Lease Obligations", "label": "Long-Term Debt And Finance Lease Obligations", "terseLabel": "Long-term debt and finance lease obligations, net of current portion", "verboseLabel": "Long-term debt, finance lease and other financing obligations, net of current portion" } } }, "localname": "LongTermDebtAndFinanceLeaseObligations", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets", "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "monetaryItemType" }, "plxs_LongTermDebtAndFinanceLeaseObligationsCurrent": { "auth_ref": [], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails": { "order": 1.0, "parentTag": "plxs_LongTermDebtAndFinanceLeaseObligationsIncludingCurrentMaturities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-Term Debt and Finance Lease Obligations Current", "label": "Long-Term Debt and Finance Lease Obligations Current", "negatedTerseLabel": "Current portion of long-term debt and finance lease obligations", "terseLabel": "Current portion of long-term debt and finance lease obligations" } } }, "localname": "LongTermDebtAndFinanceLeaseObligationsCurrent", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets", "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "monetaryItemType" }, "plxs_LongTermDebtAndFinanceLeaseObligationsIncludingCurrentMaturities": { "auth_ref": [], "calculation": { "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-term Debt and Finance Lease Obligations, Including Current Maturities", "label": "Long-term Debt and Finance Lease Obligations, Including Current Maturities", "totalLabel": "Total obligations" } } }, "localname": "LongTermDebtAndFinanceLeaseObligationsIncludingCurrentMaturities", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "monetaryItemType" }, "plxs_MUFGMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "MUFG [Member]", "label": "MUFG [Member]", "terseLabel": "MUFG RPA" } } }, "localname": "MUFGMember", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/TradeAccountsReceivableSaleProgramsNarrativeDetails" ], "xbrltype": "domainItemType" }, "plxs_OtherAccruedLiabilitiesCurrentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Accrued Liabilities, Current [Member]", "label": "Other Accrued Liabilities, Current [Member]", "terseLabel": "Other accrued liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrentMember", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValuesofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "plxs_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesAndOtherFairValueAdjustmentsNetOfTaxPortionAttributableToParent": { "auth_ref": [], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges and Other Fair Value Adjustments , Net of Tax, Portion Attributable to Parent", "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges and Other Fair Value Adjustments , Net of Tax, Portion Attributable to Parent", "terseLabel": "Derivative instrument and other fair value adjustments" } } }, "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesAndOtherFairValueAdjustmentsNetOfTaxPortionAttributableToParent", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "plxs_OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax", "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax", "terseLabel": "Amount\u00a0of\u00a0Gain Recognized\u00a0in OCL\u00a0on Derivatives" } } }, "localname": "OtherComprehensiveIncomeLossUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonAccumulatedOtherComprehensiveLossIncomeDetails" ], "xbrltype": "monetaryItemType" }, "plxs_OtherLeaseExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other Lease Expense", "label": "Other Lease Expense", "terseLabel": "Other lease expense" } } }, "localname": "OtherLeaseExpense", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/LeasesScheduleofLeaseExpenseandOtherInformationDetails" ], "xbrltype": "monetaryItemType" }, "plxs_PercentageofRevenue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Revenue", "label": "Percentage of Revenue", "terseLabel": "Percentage of Revenue" } } }, "localname": "PercentageofRevenue", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomersNarrativeDetails" ], "xbrltype": "percentItemType" }, "plxs_StandardProductWarrantyTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Standard Product Warranty, Term", "label": "Standard Product Warranty, Term", "terseLabel": "Product warranty specification period" } } }, "localname": "StandardProductWarrantyTerm", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/GuaranteesNarrativeDetails" ], "xbrltype": "durationItemType" }, "plxs_StockIssuedDuringPeriodSharesStockOptionsExercisedandVestingofOtherStockAwards": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Shares, Stock Options Exercised and Vesting of Other Stock Awards", "label": "Stock Issued During Period, Shares, Stock Options Exercised and Vesting of Other Stock Awards", "terseLabel": "Exercise of stock options and vesting of other share-based awards" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercisedandVestingofOtherStockAwards", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity" ], "xbrltype": "sharesItemType" }, "plxs_StockIssuedDuringPeriodValueStockOptionsExercisedandVestingofOtherStockAwards": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Value, Stock Options Exercised and Vesting of Other Stock Awards", "label": "Stock Issued During Period, Value, Stock Options Exercised and Vesting of Other Stock Awards", "terseLabel": "Exercise of stock options and vesting of other share-based awards" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercisedandVestingofOtherStockAwards", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "plxs_StockIssuedDuringPeriodValueStockOptionsExercisedandVestingofOtherStockAwardsIncludingTaxBenefits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock Issued During Period, Value, Stock Options Exercised and Vesting of Other Stock Awards, Including Tax Benefits", "label": "Stock Issued During Period, Value, Stock Options Exercised and Vesting of Other Stock Awards, Including Tax Benefits", "terseLabel": "Exercise of stock options and vesting of other share-based awards, including tax withholding" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercisedandVestingofOtherStockAwardsIncludingTaxBenefits", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "plxs_TransferofFinancialAssetsAccountedforasSalesFacilityAgreementAutomaticExtensionCancellationMinimumNoticePeriodRequired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transfer of Financial Assets Accounted for as Sales, Facility Agreement, Automatic Extension Cancellation, Minimum Notice Period Required", "label": "Transfer of Financial Assets Accounted for as Sales, Facility Agreement, Automatic Extension Cancellation, Minimum Notice Period Required", "terseLabel": "Minimum prior notice required to cancel automatic extension" } } }, "localname": "TransferofFinancialAssetsAccountedforasSalesFacilityAgreementAutomaticExtensionCancellationMinimumNoticePeriodRequired", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/TradeAccountsReceivableSaleProgramsNarrativeDetails" ], "xbrltype": "durationItemType" }, "plxs_TransferofFinancialAssetsAccountedforasSalesMaximumFacilityAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Transfer of Financial Assets Accounted for as Sales, Maximum Facility Amount", "label": "Transfer of Financial Assets Accounted for as Sales, Maximum Facility Amount", "terseLabel": "Maximum facility amount" } } }, "localname": "TransferofFinancialAssetsAccountedforasSalesMaximumFacilityAmount", "nsuri": "http://www.plexus.com/20221231", "presentation": [ "http://www.plexus.com/role/TradeAccountsReceivableSaleProgramsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r199", "r233", "r245", "r246", "r247", "r248", "r249", "r251", "r255", "r297", "r298", "r299", "r300", "r302", "r303", "r305", "r307", "r308", "r523", "r524" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails", "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r199", "r233", "r245", "r246", "r247", "r248", "r249", "r251", "r255", "r297", "r298", "r299", "r300", "r302", "r303", "r305", "r307", "r308", "r523", "r524" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails", "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r197", "r198", "r313", "r340", "r466", "r468" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.plexus.com/role/TradeAccountsReceivableSaleProgramsNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r293", "r294", "r295", "r296", "r376", "r443", "r452", "r459", "r460", "r479", "r491", "r494", "r525", "r543", "r544", "r545", "r546", "r547", "r548" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.plexus.com/role/GuaranteesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r293", "r294", "r295", "r296", "r376", "r443", "r452", "r459", "r460", "r479", "r491", "r494", "r525", "r543", "r544", "r545", "r546", "r547", "r548" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.plexus.com/role/GuaranteesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r293", "r294", "r295", "r296", "r369", "r376", "r379", "r380", "r381", "r441", "r443", "r452", "r459", "r460", "r479", "r491", "r494", "r521", "r525", "r544", "r545", "r546", "r547", "r548" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.plexus.com/role/GuaranteesNarrativeDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r293", "r294", "r295", "r296", "r369", "r376", "r379", "r380", "r381", "r441", "r443", "r452", "r459", "r460", "r479", "r491", "r494", "r521", "r525", "r544", "r545", "r546", "r547", "r548" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.plexus.com/role/GuaranteesNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [ "r197", "r198", "r313", "r340", "r467", "r468" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.plexus.com/role/TradeAccountsReceivableSaleProgramsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r19", "r493" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r262", "r263" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, net of allowances of $2,531 and $1,961, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesNoncurrent": { "auth_ref": [ "r8", "r147", "r157" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.", "label": "Accrued Income Taxes, Noncurrent", "terseLabel": "Long-term accrued income taxes payable" } } }, "localname": "AccruedIncomeTaxesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r32", "r33", "r34", "r171", "r448", "r457", "r458" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r31", "r34", "r101", "r437", "r453", "r454", "r503", "r504", "r505", "r512", "r513", "r514" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r11", "r493" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r383", "r384", "r385", "r512", "r513", "r514", "r536" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r95", "r96", "r377" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "terseLabel": "Share-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash flows from operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r382" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-Based Payment Arrangement, Expense", "verboseLabel": "Share-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/BenefitPlansNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r172", "r264", "r267" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable, allowances" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive Securities Excluded from Computation of Diluted Earnings Per Share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/EarningsPerShareNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_Assets": { "auth_ref": [ "r145", "r156", "r170", "r193", "r241", "r247", "r253", "r265", "r297", "r298", "r300", "r301", "r302", "r304", "r306", "r308", "r309", "r402", "r404", "r421", "r493", "r523", "r524", "r541" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets", "verboseLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets", "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r166", "r174", "r193", "r265", "r297", "r298", "r300", "r301", "r302", "r304", "r306", "r308", "r309", "r402", "r404", "r421", "r493", "r523", "r524", "r541" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrent": { "auth_ref": [ "r193", "r265", "r297", "r298", "r300", "r301", "r302", "r304", "r306", "r308", "r309", "r402", "r404", "r421", "r523", "r524", "r541" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.", "label": "Assets, Noncurrent", "totalLabel": "Total non-current assets" } } }, "localname": "AssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValuesofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r109", "r113" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValuesofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/BasisofPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r53", "r168", "r461" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r48", "r53", "r54" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "End of period", "periodStartLabel": "Beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r48", "r136" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net decrease in cash and cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Equivalents, at Carrying Value [Abstract]", "terseLabel": "Cash and cash equivalents and restricted cash:" } } }, "localname": "CashEquivalentsAtCarryingValueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": { "auth_ref": [ "r126" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.", "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within 12 Months", "terseLabel": "Estimated unrealized gains (losses), net of tax, expected to be reclassified in the next 12 months" } } }, "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r106" ], "lang": { "en-us": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Derivatives in\u00a0cash\u00a0flow\u00a0hedging relationships" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonAccumulatedOtherComprehensiveLossIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfTreasuryStockTable": { "auth_ref": [ "r86", "r87", "r88", "r89" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class of Treasury Stock [Table]", "terseLabel": "Class of Treasury Stock [Table]" } } }, "localname": "ClassOfTreasuryStockTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r26", "r150", "r160" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]", "terseLabel": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r512", "r513", "r536" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r10", "r80" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "End of period (in shares)", "periodStartLabel": "Beginning of period (in shares)", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r10", "r493" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.01 par value, 200,000 shares authorized, 54,133 and 54,084 shares issued, respectively, and 27,612 and 27,679 shares outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [ "r91", "r92", "r93", "r97" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.", "label": "Compensation and Employee Benefit Plans [Text Block]", "verboseLabel": "Share-Based Compensation" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ShareBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_CompensationRelatedCostsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Compensation Related Costs [Abstract]", "terseLabel": "Compensation Related Costs [Abstract]" } } }, "localname": "CompensationRelatedCostsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r35", "r180", "r182", "r187", "r445", "r449" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Total comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]", "terseLabel": "Comprehensive income:" } } }, "localname": "ComprehensiveIncomeNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r527" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "terseLabel": "Schedule of Contract Assets" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetNetCurrent": { "auth_ref": [ "r353", "r354", "r366" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.", "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current", "terseLabel": "Contract assets" } } }, "localname": "ContractWithCustomerAssetNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets", "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofContractAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerAssetReclassifiedToReceivable": { "auth_ref": [ "r480" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time from transfer to receivable due to right to consideration becoming unconditional.", "label": "Contract with Customer, Asset, Reclassified to Receivable", "terseLabel": "Amounts collected or invoiced" } } }, "localname": "ContractWithCustomerAssetReclassifiedToReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofContractAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod": { "auth_ref": [ "r361" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from performance obligation satisfied or partially satisfied in previous reporting periods. Includes, but is not limited to, change in transaction price.", "label": "Contract with Customer, Performance Obligation Satisfied in Previous Period", "terseLabel": "Revenue recognized" } } }, "localname": "ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofContractAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r62", "r246", "r247", "r248", "r249", "r255", "r517" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Corporate and other costs" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r39", "r444" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of sales" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "terseLabel": "Cost of sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsNarrativeDetails", "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsNarrativeDetails", "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtAndCapitalLeaseObligationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt and Lease Obligation [Abstract]", "terseLabel": "Debt and Capital Lease Obligations [Abstract]" } } }, "localname": "DebtAndCapitalLeaseObligationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r79", "r191", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r326", "r333", "r334", "r336" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt, Finance Lease and Other Financing Obligations" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligations" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r4", "r5", "r6", "r146", "r148", "r155", "r199", "r310", "r311", "r312", "r313", "r314", "r316", "r322", "r323", "r324", "r325", "r327", "r328", "r329", "r330", "r331", "r332", "r430", "r474", "r475", "r476", "r477", "r478", "r509" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r6", "r148", "r155", "r337" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-Term Debt, Gross", "terseLabel": "Long-term debt, gross", "verboseLabel": "Long-term debt, gross" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsNarrativeDetails", "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r23", "r311" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Interest Rate, Senior Notes" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsNarrativeDetails", "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r24", "r199", "r310", "r311", "r312", "r313", "r314", "r316", "r322", "r323", "r324", "r325", "r327", "r328", "r329", "r330", "r331", "r332", "r430", "r474", "r475", "r476", "r477", "r478", "r509" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r24", "r81", "r82", "r83", "r84", "r137", "r138", "r140", "r154", "r199", "r310", "r311", "r312", "r313", "r314", "r316", "r322", "r323", "r324", "r325", "r327", "r328", "r329", "r330", "r331", "r332", "r335", "r430", "r474", "r475", "r476", "r477", "r478", "r509" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsNarrativeDetails", "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Credit facility, term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsNarrativeDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r139", "r526" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "negatedTerseLabel": "Unamortized deferred financing fees" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r386", "r387" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r386", "r387" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "terseLabel": "Deferred income taxes payable" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r501" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred Revenue", "terseLabel": "Deferred Revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomersNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r51", "r236" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerecognizedAssetsSecuritizedOrAssetbackedFinancingArrangementAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding": { "auth_ref": [ "r442" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transferred financial assets in which the transferor has continuing involvement with the assets underlying the transaction that have been derecognized. Continuing involvement includes, but is not limited to, servicing, recourse, and restrictions on transferor's interests in transferred financial assets.", "label": "Continuing Involvement with Derecognized Transferred Financial Assets, Amount Outstanding", "terseLabel": "Trade accounts receivable sold, not yet collected" } } }, "localname": "DerecognizedAssetsSecuritizedOrAssetbackedFinancingArrangementAssetsAndAnyOtherFinancialAssetsManagedTogetherPrincipalAmountOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/TradeAccountsReceivableSaleProgramsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetNotionalAmount": { "auth_ref": [ "r532", "r533", "r534" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payments on the derivative asset.", "label": "Derivative Asset, Notional Amount", "terseLabel": "Notional amount of forward exchange contracts" } } }, "localname": "DerivativeAssetNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r176", "r177", "r420", "r468" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative Asset" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofAmountofGainLossonDerivativesRecognizedinIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonAccumulatedOtherComprehensiveLossIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValuesofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r30", "r111", "r143", "r175", "r468" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset", "terseLabel": "Fair value of derivative asset" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValuesofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r30", "r111", "r143", "r175", "r468" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "terseLabel": "Fair value of derivative liability" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValuesofDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from effective portion of derivative instrument reclassified from accumulated other comprehensive income (AOCI) into income.", "label": "Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]", "terseLabel": "Derivative Instrument, Gain (Loss) Reclassified from AOCI into Income, Effective Portion, Statement of Income or Comprehensive Income [Extensible Enumeration]" } } }, "localname": "DerivativeInstrumentGainLossReclassifiedFromAociIntoIncomeEffectivePortionStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r110", "r112", "r118", "r120", "r468" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofAmountofGainLossonDerivativesRecognizedinIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonAccumulatedOtherComprehensiveLossIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValuesofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r107", "r110", "r118" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonAccumulatedOtherComprehensiveLossIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r107", "r110", "r118", "r120", "r124", "r125", "r408" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonAccumulatedOtherComprehensiveLossIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonAccumulatedOtherComprehensiveLossIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet": { "auth_ref": [ "r116", "r119" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net", "terseLabel": "Amount\u00a0of Loss Reclassified\u00a0from Accumulated\u00a0OCL\u00a0into Income" } } }, "localname": "DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r176", "r177", "r420", "r468" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "terseLabel": "Derivative Liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes derivative liability.", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Derivative Asset (Liability), Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofAmountofGainLossonDerivativesRecognizedinIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r103", "r104", "r105", "r107", "r108", "r114", "r118", "r122", "r123", "r125", "r409" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofAmountofGainLossonDerivativesRecognizedinIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativesAndFairValueTextBlock": { "auth_ref": [ "r127", "r134" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.", "label": "Derivatives and Fair Value [Text Block]", "verboseLabel": "Derivatives and Fair Value Measurements" } } }, "localname": "DerivativesAndFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativesFairValueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivatives, Fair Value [Line Items]", "terseLabel": "Derivatives, Fair Value [Line Items]" } } }, "localname": "DerivativesFairValueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValuesofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Derivatives\u00a0designated as\u00a0hedging\u00a0instruments" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonAccumulatedOtherComprehensiveLossIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValuesofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomersNarrativeDetails", "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r365", "r481", "r482", "r483", "r484", "r485", "r486", "r487" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomersNarrativeDetails", "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r528" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomersTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r188", "r205", "r206", "r207", "r208", "r209", "r213", "r215", "r220", "r221", "r222", "r226", "r412", "r413", "r446", "r450", "r469" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "verboseLabel": "Basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.plexus.com/role/EarningsPerShareReconciliationofAmountsUtilizedinComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r188", "r205", "r206", "r207", "r208", "r209", "r215", "r220", "r221", "r222", "r226", "r412", "r413", "r446", "r450", "r469" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.plexus.com/role/EarningsPerShareReconciliationofAmountsUtilizedinComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r223", "r224", "r225", "r227" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r422" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "verboseLabel": "Effect of exchange rate changes on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r389" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective Income Tax Rate Reconciliation, Percent" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r21" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued salaries and wages" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Employee Termination and Severance Costs" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RestructuringandImpairmentChargesScheduleofRestructuringAccrualActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Equity, Class of Treasury Stock [Line Items]", "terseLabel": "Equity, Class of Treasury Stock [Line Items]" } } }, "localname": "EquityClassOfTreasuryStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r80", "r163", "r183", "r184", "r185", "r200", "r201", "r202", "r204", "r210", "r212", "r228", "r266", "r352", "r383", "r384", "r385", "r393", "r394", "r411", "r423", "r424", "r425", "r426", "r427", "r428", "r437", "r453", "r454", "r455" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EquitySecuritiesByIndustryAxis": { "auth_ref": [ "r472" ], "lang": { "en-us": { "role": { "documentation": "Information by industry sector, examples include but are not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.", "label": "Industry Sector [Axis]", "terseLabel": "Industry Sector [Axis]" } } }, "localname": "EquitySecuritiesByIndustryAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquitySecuritiesIndustryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Industry sector consisting of government, private and corporate entities engaged in business activities, including but not limited to, commercial, industrial, agricultural, financial services, technology, healthcare and real estate.", "label": "Industry Sector [Domain]", "terseLabel": "Industry Sector [Domain]" } } }, "localname": "EquitySecuritiesIndustryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r128", "r129", "r130", "r131", "r132" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "terseLabel": "Schedule of Derivatives Fair Value Measurements Using Input Levels" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r324", "r370", "r371", "r372", "r373", "r374", "r375", "r415", "r438", "r439", "r440", "r475", "r476", "r488", "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r414", "r415", "r416", "r417", "r419" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r324", "r370", "r375", "r415", "r438", "r488", "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r324", "r370", "r375", "r415", "r439", "r475", "r476", "r488", "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r324", "r370", "r371", "r372", "r373", "r374", "r375", "r415", "r440", "r475", "r476", "r488", "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Fair Value, Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r324", "r370", "r371", "r372", "r373", "r374", "r375", "r438", "r439", "r440", "r475", "r476", "r488", "r489", "r490" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r418", "r419" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Recurring" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r133", "r135" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "verboseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/BasisofPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": { "auth_ref": [ "r109", "r114", "r124" ], "lang": { "en-us": { "role": { "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]", "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]" } } }, "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValuesofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r434", "r436", "r492" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease, Interest Expense", "terseLabel": "Interest on lease liabilities" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/LeasesScheduleofLeaseExpenseandOtherInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r432" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease, Liability, Current", "terseLabel": "Current finance lease liabilities" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/LeasesScheduleofLeaseAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.", "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/LeasesScheduleofLeaseAssetsandLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r432" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance Lease, Liability, Noncurrent", "terseLabel": "Long-term finance lease liabilities" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/LeasesScheduleofLeaseAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.", "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/LeasesScheduleofLeaseAssetsandLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinanceLeaseRightOfUseAsset": { "auth_ref": [ "r431" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "terseLabel": "Finance lease right-of-use assets" } } }, "localname": "FinanceLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/LeasesScheduleofLeaseAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r434", "r436", "r492" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, Amortization", "terseLabel": "Amortization of right-of-use assets" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/LeasesScheduleofLeaseExpenseandOtherInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignExchangeForwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.", "label": "Foreign Exchange Forward [Member]", "terseLabel": "Foreign Exchange Forward [Member]" } } }, "localname": "ForeignExchangeForwardMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofAmountofGainLossonDerivativesRecognizedinIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonAccumulatedOtherComprehensiveLossIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValuesofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments": { "auth_ref": [ "r110", "r117" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in earnings in the period from the increase (decrease) in fair value of foreign currency derivatives not designated as hedging instruments.", "label": "Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments", "terseLabel": "Amount of Gain (Loss) on Derivatives Recognized in Income" } } }, "localname": "GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofAmountofGainLossonDerivativesRecognizedinIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r38", "r193", "r241", "r246", "r252", "r255", "r265", "r297", "r298", "r300", "r301", "r302", "r304", "r306", "r308", "r309", "r421", "r471", "r523" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_GuaranteesAndProductWarrantiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Guarantees and Product Warranties [Abstract]" } } }, "localname": "GuaranteesAndProductWarrantiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r107", "r408" ], "lang": { "en-us": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofAmountofGainLossonDerivativesRecognizedinIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonAccumulatedOtherComprehensiveLossIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValuesofDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofAmountofGainLossonDerivativesRecognizedinIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonAccumulatedOtherComprehensiveLossIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValuesofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonAccumulatedOtherComprehensiveLossIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "The name of the impaired assets to be held and used by the entity.", "label": "Impaired Long-Lived Assets Held and Used, Asset Name [Domain]", "terseLabel": "Fixed Asset and Operating ROU Asset Impairment" } } }, "localname": "ImpairedLongLivedAssetsHeldAndUsedAssetNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RestructuringandImpairmentChargesScheduleofRestructuringAccrualActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r36", "r144", "r151", "r162", "r241", "r246", "r252", "r255", "r447", "r471" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income before income taxes", "verboseLabel": "Income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r278", "r283" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofAmountofGainLossonDerivativesRecognizedinIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofAmountofGainLossonDerivativesRecognizedinIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r195", "r390", "r391", "r392", "r395", "r397", "r399", "r400", "r401" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r196", "r211", "r212", "r239", "r388", "r396", "r398", "r451" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income tax expense", "verboseLabel": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.plexus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r50" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r50" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedTerseLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedTaxesPayable": { "auth_ref": [ "r508" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period of all taxes owed but not paid, including income, property and other taxes.", "label": "Increase (Decrease) in Accrued Taxes Payable", "terseLabel": "Accrued income taxes payable" } } }, "localname": "IncreaseDecreaseInAccruedTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerAsset": { "auth_ref": [ "r508" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.", "label": "Increase (Decrease) in Contract with Customer, Asset", "negatedTerseLabel": "Contract assets" } } }, "localname": "IncreaseDecreaseInContractWithCustomerAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r50" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedTerseLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities, excluding impacts of currency:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r50" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase (Decrease) in Other Operating Assets", "negatedLabel": "Other current and non-current assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "auth_ref": [ "r50" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Liabilities", "terseLabel": "Other current and non-current liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r216", "r217", "r218", "r222", "r378" ], "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "terseLabel": "Dilutive effect of share-based awards and options outstanding (in shares)" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/EarningsPerShareReconciliationofAmountsUtilizedinComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r139", "r153", "r186", "r235", "r429" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense", "negatedTerseLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterimPeriodCostsNotAllocableDomain": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "This element represents the type of costs and expenses incurred during an interim period that cannot be readily identified with the activities or benefits of other interim periods and are charged to the interim period in which incurred.", "label": "Interim Period, Costs Not Allocable [Domain]", "terseLabel": "Interim Period, Costs Not Allocable [Domain]" } } }, "localname": "InterimPeriodCostsNotAllocableDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RestructuringandImpairmentChargesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntersegmentEliminationMember": { "auth_ref": [ "r233", "r245", "r246", "r247", "r248", "r249", "r251", "r255" ], "lang": { "en-us": { "role": { "documentation": "Eliminating entries used in operating segment consolidation.", "label": "Intersegment Eliminations [Member]", "terseLabel": "Elimination of inter-segment sales" } } }, "localname": "IntersegmentEliminationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails", "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoriesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property held for sale in the ordinary course of business, or in process of, or to be consumed in, production for sale.", "label": "Inventories [Member]", "terseLabel": "Inventory" } } }, "localname": "InventoriesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/InventoriesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryCurrentTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.", "label": "Inventory, Current [Table]", "terseLabel": "Inventory, Current [Table]" } } }, "localname": "InventoryCurrentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/InventoriesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]", "terseLabel": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r268" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "Inventory Disclosure [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r64", "r463" ], "calculation": { "http://www.plexus.com/role/InventoriesScheduleofInventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Inventory [Line Items]", "terseLabel": "Inventory [Line Items]" } } }, "localname": "InventoryLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/InventoriesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r173", "r462", "r493" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.plexus.com/role/InventoriesScheduleofInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories, net", "totalLabel": "Total inventories, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets", "http://www.plexus.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r64", "r465" ], "calculation": { "http://www.plexus.com/role/InventoriesScheduleofInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory, Raw Materials, Net of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r64", "r464" ], "calculation": { "http://www.plexus.com/role/InventoriesScheduleofInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work-in-process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/InventoriesScheduleofInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r41", "r234" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest income", "verboseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r540" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Schedule of Lease Expense and Other Information" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "auth_ref": [ "r72" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.", "label": "Legal Matters and Contingencies [Text Block]", "terseLabel": "Litigation" } } }, "localname": "LegalMattersAndContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/Litigation" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r435" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r20", "r193", "r265", "r297", "r298", "r300", "r301", "r302", "r304", "r306", "r308", "r309", "r403", "r404", "r405", "r421", "r470", "r523", "r541", "r542" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r15", "r149", "r159", "r493", "r510", "r519", "r537" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and shareholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r22", "r167", "r193", "r265", "r297", "r298", "r300", "r301", "r302", "r304", "r306", "r308", "r309", "r403", "r404", "r405", "r421", "r493", "r523", "r541", "r542" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r1", "r2", "r3", "r6", "r7", "r193", "r265", "r297", "r298", "r300", "r301", "r302", "r304", "r306", "r308", "r309", "r403", "r404", "r405", "r421", "r523", "r541", "r542" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities, Noncurrent", "totalLabel": "Total non-current liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAverageOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Average amount borrowed under the credit facility during the period.", "label": "Line of Credit Facility, Average Outstanding Amount", "terseLabel": "Average daily borrowings" } } }, "localname": "LineOfCreditFacilityAverageOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum amount borrowed under the credit facility at any time during the period.", "label": "Line of Credit Facility, Maximum Amount Outstanding During Period", "terseLabel": "Highest daily borrowings" } } }, "localname": "LineOfCreditFacilityMaximumAmountOutstandingDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.", "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]", "terseLabel": "Trade Accounts Receivable Sale Programs" } } }, "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/TradeAccountsReceivableSalePrograms" ], "xbrltype": "textBlockItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-Term Debt, Fair Value", "terseLabel": "Fair value of debt" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r24", "r78" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Movement in Standard Product Warranty Accrual [Roll Forward]", "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]" } } }, "localname": "MovementInStandardProductWarrantyAccrualRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/GuaranteesScheduleofActivityRelatedtoLimitedWarrantyLiabilityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NatureOfExpenseAxis": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Information by type of cost or expense.", "label": "Nature of Expense [Axis]", "terseLabel": "Nature of Expense [Axis]" } } }, "localname": "NatureOfExpenseAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RestructuringandImpairmentChargesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r190" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Cash flows provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r190" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Cash flows used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r48", "r49", "r52" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Cash flows used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r37", "r52", "r152", "r161", "r165", "r178", "r181", "r185", "r193", "r203", "r205", "r206", "r207", "r208", "r211", "r212", "r219", "r241", "r246", "r252", "r255", "r265", "r297", "r298", "r300", "r301", "r302", "r304", "r306", "r308", "r309", "r413", "r421", "r471", "r523" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income", "totalLabel": "Net income", "verboseLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows", "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity", "http://www.plexus.com/role/EarningsPerShareReconciliationofAmountsUtilizedinComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recently Adopted Accounting Pronouncements & Recently Issued Accounting Pronouncements Not Yet Adopted" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/BasisofPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Derivatives\u00a0not designated as\u00a0hedging\u00a0instruments" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofAmountofGainLossonDerivativesRecognizedinIncomeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValuesofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ReportableSegmentsNarrativeDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r241", "r246", "r252", "r255", "r471" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating income", "verboseLabel": "Operating income (loss):" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r538" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/LeasesScheduleofLeaseExpenseandOtherInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r432" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Current operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/LeasesScheduleofLeaseAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.", "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]", "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]" } } }, "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/LeasesScheduleofLeaseAssetsandLiabilitiesDetails" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r432" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Long-term operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets", "http://www.plexus.com/role/LeasesScheduleofLeaseAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r431" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets", "http://www.plexus.com/role/LeasesScheduleofLeaseAssetsandLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r245", "r246", "r247", "r248", "r249", "r255" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails", "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r55", "r56", "r58", "r102" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/BasisofPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r21" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities, Current", "terseLabel": "Other accrued liabilities" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r169" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r98", "r99", "r100" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "terseLabel": "Foreign currency translation adjustments" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss):" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r98", "r99", "r100", "r179", "r182" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "terseLabel": "Other comprehensive income (loss)", "totalLabel": "Other comprehensive income (loss)" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r25" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r52" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedTerseLabel": "Other, net" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r42" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Miscellaneous, net", "verboseLabel": "Miscellaneous, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).", "label": "Other Nonoperating Income (Expense) [Member]", "terseLabel": "Miscellaneous, net" } } }, "localname": "OtherNonoperatingIncomeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofAmountofGainLossonDerivativesRecognizedinIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherTaxExpenseBenefit": { "auth_ref": [ "r194", "r529", "r531" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other income tax expense (benefit).", "label": "Other Tax Expense (Benefit)", "terseLabel": "Other Tax Expense (Benefit)" } } }, "localname": "OtherTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RestructuringandImpairmentChargesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "auth_ref": [ "r506", "r507" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.", "label": "Payments for (Proceeds from) Other Investing Activities", "negatedTerseLabel": "Other, net" } } }, "localname": "PaymentsForProceedsFromOtherInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r46" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchases of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r189" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "negatedTerseLabel": "Payments related to tax withholding for share-based compensation" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r43" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Payments for property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r9", "r338" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r9", "r338" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r9", "r493" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.01 par value, 5,000 shares authorized, none issued or outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r502" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid expenses and other" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.", "label": "Prepaid Expenses and Other Current Assets [Member]", "terseLabel": "Prepaid expenses and other" } } }, "localname": "PrepaidExpensesAndOtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValuesofDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromLongTermLinesOfCredit": { "auth_ref": [ "r45" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Proceeds from Long-Term Lines of Credit", "terseLabel": "Borrowings under debt agreements" } } }, "localname": "ProceedsFromLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r44", "r94" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds from Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyDisclosureTextBlock": { "auth_ref": [ "r77" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.", "label": "Product Warranty Disclosure [Text Block]", "terseLabel": "Guarantees" } } }, "localname": "ProductWarrantyDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/Guarantees" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProductWarrantyLiabilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Warranty Liability [Line Items]", "terseLabel": "Product Warranty Liability [Line Items]" } } }, "localname": "ProductWarrantyLiabilityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/GuaranteesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProductWarrantyLiabilityTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about product warranty liability, including, but not limited to, reductions in the liability for payments made under the warranty, changes in the liability for accruals related to product warranties issued, and changes in the liability for accruals related to preexisting warranties.", "label": "Product Warranty Liability [Table]", "terseLabel": "Product Warranty Liability [Table]" } } }, "localname": "ProductWarrantyLiabilityTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/GuaranteesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": { "auth_ref": [ "r520", "r539" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization", "terseLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]", "terseLabel": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": { "auth_ref": [ "r47" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.", "label": "Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security", "negatedLabel": "Payments on debt and finance lease obligations" } } }, "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r53", "r54", "r168" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents, Current", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r280", "r282", "r285", "r291", "r292" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring and Impairment Charges" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RestructuringandImpairmentCharges" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r51", "r286", "r288", "r522" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "terseLabel": "Restructuring and impairment charges" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.plexus.com/role/RestructuringandImpairmentChargesDetails", "http://www.plexus.com/role/RestructuringandImpairmentChargesScheduleofRestructuringAccrualActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringChargesMember": { "auth_ref": [ "r69", "r71" ], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about restructuring charges have been included.", "label": "Restructuring Charges [Member]", "terseLabel": "Restructuring Charges" } } }, "localname": "RestructuringChargesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RestructuringandImpairmentChargesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [ "r281", "r282", "r288", "r289" ], "lang": { "en-us": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RestructuringandImpairmentChargesScheduleofRestructuringAccrualActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RestructuringandImpairmentChargesDetails", "http://www.plexus.com/role/RestructuringandImpairmentChargesScheduleofRestructuringAccrualActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r282", "r287" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "terseLabel": "Restructuring Reserve" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RestructuringandImpairmentChargesScheduleofRestructuringAccrualActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveAccrualAdjustment1": { "auth_ref": [ "r282", "r289" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability.", "label": "Restructuring Reserve, Accrual Adjustment", "terseLabel": "Amounts utilized" } } }, "localname": "RestructuringReserveAccrualAdjustment1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RestructuringandImpairmentChargesScheduleofRestructuringAccrualActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r12", "r85", "r158", "r456", "r458", "r493" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r163", "r200", "r201", "r202", "r204", "r210", "r212", "r266", "r383", "r384", "r385", "r393", "r394", "r411", "r453", "r455" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r232", "r233", "r245", "r250", "r251", "r257", "r258", "r260", "r364", "r365", "r444" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenue from Contract with Customer" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "auth_ref": [ "r232", "r233", "r245", "r250", "r251", "r257", "r258", "r260", "r364", "r365", "r444" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.", "label": "Revenue from Contract with Customer, Including Assessed Tax", "terseLabel": "Net sales" } } }, "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r355", "r356", "r357", "r358", "r359", "r360", "r362", "r363", "r367", "r368" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue from Contracts with Customers" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomers" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility", "verboseLabel": "Borrowings under Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsNarrativeDetails", "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r116" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.", "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Derivative Impact on (Loss) Gain Recognized in Income" } } }, "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r24", "r81", "r82", "r83", "r84", "r137", "r138", "r140", "r154", "r475", "r477", "r511" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Debt, Finance Lease and Other Financing Obligations" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r115" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.", "label": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Derivative Impact on Accumulated Other Comprehensive (Loss) Income" } } }, "localname": "ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r114" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "verboseLabel": "Schedule of Fair Values of Derivative Instruments" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Reconciliation of Amounts Utilized in Computation of Basic and Diluted Earnings Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r0", "r16", "r17", "r18" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventory, Current [Table Text Block]", "verboseLabel": "Schedule of Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r117", "r535" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.", "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]", "terseLabel": "Schedule of Amount of Gain (Loss) on Derivatives Recognized in Income" } } }, "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r76" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule of Product Warranty Liability [Table Text Block]", "terseLabel": "Schedule of Activity Related to Limited Warranty Liability" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/GuaranteesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r281", "r282", "r283", "r284", "r288", "r289", "r290" ], "lang": { "en-us": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RestructuringandImpairmentChargesDetails", "http://www.plexus.com/role/RestructuringandImpairmentChargesScheduleofRestructuringAccrualActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r67", "r68", "r70" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Restructuring and Related Costs [Table Text Block]", "terseLabel": "Schedule of Restructuring Accrual Activity" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RestructuringandImpairmentChargesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r59", "r60", "r61", "r65" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r59", "r60", "r61", "r65" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Reportable Segments Information" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ReportableSegmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r229", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r255", "r260", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r284", "r290", "r473", "r549" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails", "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r229", "r230", "r231", "r241", "r244", "r249", "r253", "r254", "r255", "r256", "r257", "r259", "r260", "r261" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Reportable Segments" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ReportableSegments" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r40" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofDerivativeImpactonLossGainRecognizedinIncomeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeniorNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.", "label": "Senior Notes [Member]", "terseLabel": "Senior Notes" } } }, "localname": "SeniorNotesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/DebtFinanceLeaseandOtherFinancingObligationsScheduleofDebtFinanceLeaseandOtherFinancingObligationsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r50" ], "calculation": { "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Share-based compensation expense and related charges" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareRepurchaseProgramAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by share repurchase program.", "label": "Share Repurchase Program [Axis]", "terseLabel": "Share Repurchase Program [Axis]" } } }, "localname": "ShareRepurchaseProgramAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareRepurchaseProgramDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the share repurchase program.", "label": "Share Repurchase Program [Domain]", "terseLabel": "Share Repurchase Program [Domain]" } } }, "localname": "ShareRepurchaseProgramDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StandardProductWarrantyAccrual": { "auth_ref": [ "r75" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.", "label": "Standard Product Warranty Accrual", "periodEndLabel": "Limited warranty liability, ending balance", "periodStartLabel": "Limited warranty liability, beginning balance" } } }, "localname": "StandardProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/GuaranteesScheduleofActivityRelatedtoLimitedWarrantyLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualPayments": { "auth_ref": [ "r73" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual, Decrease for Payments", "negatedTerseLabel": "Settlements (in cash or in kind) during the period" } } }, "localname": "StandardProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/GuaranteesScheduleofActivityRelatedtoLimitedWarrantyLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r74" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual, Increase for Warranties Issued", "terseLabel": "Accruals for warranties issued during the period" } } }, "localname": "StandardProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/GuaranteesScheduleofActivityRelatedtoLimitedWarrantyLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r164", "r229", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r255", "r260", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r279", "r284", "r290", "r473", "r549" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails", "http://www.plexus.com/role/RevenuefromContractswithCustomersScheduleofDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r28", "r80", "r163", "r183", "r184", "r185", "r200", "r201", "r202", "r204", "r210", "r212", "r228", "r266", "r352", "r383", "r384", "r385", "r393", "r394", "r411", "r423", "r424", "r425", "r426", "r427", "r428", "r437", "r453", "r454", "r455" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsNarrativeDetails", "http://www.plexus.com/role/DerivativesandFairValueMeasurementsScheduleofFairValueMeasurementsUsingInputLevelsDetails", "http://www.plexus.com/role/ReportableSegmentsScheduleofReportableSegmentsInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r200", "r201", "r202", "r228", "r444" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Authorized repurchase amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount", "terseLabel": "Remaining authorized repurchase amount" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r10", "r13", "r14", "r63", "r493", "r510", "r519", "r537" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "End of period", "periodStartLabel": "Beginning of period", "totalLabel": "Total shareholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets", "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]", "terseLabel": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r90", "r192", "r339", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350", "r351", "r352", "r410" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Shareholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceAxis": { "auth_ref": [ "r486", "r528" ], "lang": { "en-us": { "role": { "documentation": "Information by timing of transfer of good or service to customer.", "label": "Timing of Transfer of Good or Service [Axis]", "terseLabel": "Timing of Transfer of Good or Service [Axis]" } } }, "localname": "TimingOfTransferOfGoodOrServiceAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomersNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TimingOfTransferOfGoodOrServiceDomain": { "auth_ref": [ "r486", "r528" ], "lang": { "en-us": { "role": { "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.", "label": "Timing of Transfer of Good or Service [Domain]", "terseLabel": "Timing of Transfer of Good or Service [Domain]" } } }, "localname": "TimingOfTransferOfGoodOrServiceDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomersNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized": { "auth_ref": [ "r141" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition.", "label": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized", "terseLabel": "Trade accounts receivable sold" } } }, "localname": "TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/TradeAccountsReceivableSaleProgramsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount": { "auth_ref": [ "r142" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before counterparty netting, of cash proceeds received in transfers of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction.", "label": "Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount", "terseLabel": "Cash proceeds" } } }, "localname": "TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/TradeAccountsReceivableSaleProgramsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TransferredOverTimeMember": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "Contract with customer in which good or service is transferred over time.", "label": "Transferred over Time [Member]", "terseLabel": "Transferred over Time" } } }, "localname": "TransferredOverTimeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RevenuefromContractswithCustomersNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased.", "label": "Treasury Stock Acquired, Average Cost Per Share", "verboseLabel": "Average repurchase price (in dollars per share)" } } }, "localname": "TreasuryStockAcquiredAverageCostPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_TreasuryStockCommonShares": { "auth_ref": [ "r86" ], "lang": { "en-us": { "role": { "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Shares", "terseLabel": "Treasury stock, shares (in shares)" } } }, "localname": "TreasuryStockCommonShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockCommonValue": { "auth_ref": [ "r29", "r86", "r89" ], "calculation": { "http://www.plexus.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.", "label": "Treasury Stock, Common, Value", "negatedLabel": "Common stock held in treasury, at cost, 26,521 and 26,405 shares, respectively" } } }, "localname": "TreasuryStockCommonValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r27", "r86" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury stock" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r10", "r80", "r85" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "negatedLabel": "Treasury shares purchased (in shares)", "terseLabel": "Amount repurchased (in shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity", "http://www.plexus.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r80", "r85", "r86" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedTerseLabel": "Treasury shares purchased", "terseLabel": "Amount repurchased" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofShareholdersEquity", "http://www.plexus.com/role/ShareholdersEquityNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [ "r281", "r282", "r288", "r289" ], "lang": { "en-us": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/RestructuringandImpairmentChargesScheduleofRestructuringAccrualActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnderlyingAssetClassAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by underlying asset class.", "label": "Underlying Asset Class [Axis]", "terseLabel": "Underlying Asset Class [Axis]" } } }, "localname": "UnderlyingAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/InventoriesNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnderlyingAssetClassDomain": { "auth_ref": [ "r121" ], "lang": { "en-us": { "role": { "documentation": "Major types of referenced/underlying asset classes (for example, corporate debt, sovereign debt, and structured finance).", "label": "Underlying Asset Class [Domain]", "terseLabel": "Underlying Asset Class [Domain]" } } }, "localname": "UnderlyingAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/InventoriesNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefitsPeriodIncreaseDecrease": { "auth_ref": [ "r530" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in unrecognized tax benefits attributable to uncertain tax positions taken in tax returns.", "label": "Unrecognized Tax Benefits, Period Increase (Decrease)", "terseLabel": "Unrecognized Tax Benefits, Period Increase (Decrease)" } } }, "localname": "UnrecognizedTaxBenefitsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/IncomeTaxesNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r214", "r222" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "verboseLabel": "Diluted weighted average shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.plexus.com/role/EarningsPerShareReconciliationofAmountsUtilizedinComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted average shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r213", "r222" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic (in shares)", "verboseLabel": "Basic weighted average common shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.plexus.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.plexus.com/role/EarningsPerShareReconciliationofAmountsUtilizedinComputationofBasicandDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "820", "URI": "https://asc.fasb.org/topic&trid=2155941", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(2)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(e))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "https://asc.fasb.org/topic&trid=2175745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL108322424-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921835-210448", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r495": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r496": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r497": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r498": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r499": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r518": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/subtopic&trid=2196772", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "4CC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r55": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "https://asc.fasb.org/topic&trid=2122394", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e639-108305", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(c))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1),(c)(5)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "460", "URI": "https://asc.fasb.org/topic&trid=2155896", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "710", "URI": "https://asc.fasb.org/topic&trid=2127225", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "https://asc.fasb.org/topic&trid=2197446", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "https://asc.fasb.org/topic&trid=2235017", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 80 0000785786-23-000012-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000785786-23-000012-xbrl.zip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